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Summary
Transgenic mice provide means to dissect and model events during developmental processes 
or human diseases. They are commonly generated by Random Integration (RI) of the 
transgene into the genome of murine Embryonic Stem (mES) cells and subsequent injection 
or aggregation of manipulated mES cell clones into/with early mouse embryos. The 
chromosomal integration site of the gene of interest has a strong impact on expression 
patterns in the animal (“position effect”), which is in particular critical for regulated transgene 
expression. Hence, generation of a transgenic mouse model is hindered by high screening 
efforts to identify an integration site supporting adequate (and well regulated) expression 
levels in all tissues required. Strategies devised to circumvent the problems of RI, e.g. site 
specific integration by homologous recombination or integration of large Bacterial Artifical 
Chromosomes, suffer from various limitations like the limited number of suitable integration 
sites currently available and difficult handling.
Consequently, the aim of this work was to screen for chromosomal loci in mES cells that 
allow for high and well regulated transgene expression in mice and to render them reusable 
via Recombinase Mediated Cassette Exchange (RMCE). The screening cassette applied for 
this purpose contained an autoregulatory positive feedback loop driven by the reverse 
transactivator of the tet system (rtTA). Since the properties of autoregulated transgene 
expression have not yet been examined in detail on transgenic mouse level, evaluation of this 
mode of regulated expression was a major issue of this work.
For targeting chromosomal loci previously tagged with Flp recombinase recognition target 
sequences via RMCE, a puromycin acetyl transferase/∆neomycin phosphotransferase 
selection strategy could be shown to work highly efficient in mES cells. 
Random tagging of sites with the screening cassette yielded low numbers of clones expressing 
adequate amounts of luciferase reporter in a tet regulated manner. Luciferase levels in two 
tagged, well regulated mES cell clones and a clone carrying the autoregulated construct 
integrated in the ROSA26 reference locus revealed strong variations that seem to be specific 
to autoregulation. In vivo bioluminescence analysis of transgenic mice derived from the two 
above mentioned clones showed a strong heterogeneity of expression between individuals of 
the same line with some animals completely shutting off expression. As expected for the 
autoregulated design, luciferase expression in one transgenic mouse line could only be 
induced by doxycycline if the animal had previously shown detectable basal levels of 
expression. This induction was fast (1-4 days) and reversible. For both transgenic lines 
activity of the cassette was restricted to certain tissues which was probably due to the nature 
of the respective integration site. This may also be the cause for lack of regulation in the 
second mouse line.
In conclusion, proof of principle for the envisioned “tag-and-target” strategy has been
provided by this work and the tools and methods have been established to start large scale 
screening. Autoregulated, tet dependent expression from predefined, RMCE reusable loci in 
mES cells will allow the rapid and simple generation of mice with conditional transgene 
expression.
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1 Introduction
1.1 Regulated transgene activity in mammalian cells and transgenic mice
Expression of transgenes in mice is a fundamental technology applied to answer biological 
questions as well as an essential model of human diseases and for gene therapy approaches. In 
a multitude of situations tightly controlled conditional activity of the introduced transgene is 
required. For instance, if a transgene’s constitutive expression disturbs embryogenesis it will 
be impossible to elucidate its functions in adult mice. Consequently, a number of strategies 
have been developed over the last 20 years that allow to control expression levels or activity 
of transgene products in cell culture as well as in animals.
A general principle commonly exploited to obtain an inducible transgene in mice is genetic 
regulation (mostly by application of the Cre/loxP system). Here, transcription is blocked by a 
stop sequence flanked by recombinase recognition target sites. The transgene will hence only 
be transcribed after the recombinase has catalysed excision of this stop cassette (e.g. applied 
by Belteki et al., 2005; Hitz et al., 2007). A major drawback of this strategy, however, is that 
once transcription has been activated it cannot be downregulated again. 
Reversibility is accomplished by drug inducible/repressible systems that operate either by 
modulating activity of the protein (post-transcriptional regulation) or by controlling 
transcription of the transgene (transcriptional regulation). The ideal regulation system should 
fulfil the following demands (Fussenegger 2001):
A) Specificity: In early attempts to regulate transgene expression endogenous regulatory 
elements were utilised that were activated by exogenous or stress signals (e.g. heat, 
hypoxia, metal ions). However, this strategy interfered with (stress) response mechanisms 
from the host cell leading to unpredictable effects. Thus, the regulation system should 
respond to heterologous or modified endogenous inducing/repressing molecules that are 
not toxic and do not crossreact with host regulatory networks avoiding pleiotropic side 
effects. 
B) Inducibility: Low basal activity and high expression levels upon induction are 
favoured. The extent of inducibility is measured by the regulation factor (expression level 
after induction/basal expression level).
C) Bioavailability of the drug: For in vivo applications the inducer/repressor should 
rapidly penetrate all cells and tissues including blood-brain and placental barriers.  
1 Introduction
2
D) Reversibility: The system should allow repeated induction and repression of transgene 
expression by addition or depletion of the regulating drug. The time that is required to 
reach basal/maximal expression levels after aministration/removal of the respective drug 
is dependent on the degradation rate of the chemical (in vivo high pharmacokinetic 
turnover of the drug in all tissues is desired).
E) Immunogenicity: Components of the regulatory system should not evoke any 
immunogenic response from  the host when applied in vivo. 
F) Dose-dependence: Expression levels of the regulated transgene should proportionally 
correlate to concentrations of the regulating agent.     
Post-transcriptional regulation
Control over a protein’s activity may be gained by fusion of the transgene to a steroid-binding 
domain (SBD). The most common domains used for this purpose are derived from the 
glucocorticoid and oestrogen receptors (Picard et al., 1988; Mader et al., 1993). In the 
absence of the respective hormone, the large heat shock protein 90 (Hsp90) complex binds to 
the SBD leading to inactivation of the fused protein (e.g. by cytosolic retention in the case of 
a transcription factor). Addition of the steroid induces an allosteric change by binding to the 
SBD. Hsp90 is then released rendering the SBD fusion active. Major disadvantages of these 
systems include pleiotropic side effects of the inducing hormone and - vice versa - leakiness 
of repression due to endogenous hormone signalling of the host. However, this could partly be 
overcome by the development of a mutated oestrogen binding domain that does not recognise 
17β-oestradiol but solely responds to 4-hydroxytamoxifen (Feil et al., 1997). Another factor 
impairing general application of this approach is that activity of SBD fusions proteins may 
differ from that of the original proteins.
Transcriptional regulation
Drug inducible transcriptional regulation systems consist of two components: 1) a 
transactivator/transrepressor initiating or blocking transcription dependent on presence or 
absence of a certain molecule (e.g. an antibiotic) and 2) a responsive promoter driving 
expression of the gene of interest (GOI) (reviewed by May et al., 2006). 
The first transcriptional regulation system applied in mammalian cells was based on 
components of the E. coli lac operon (Hu and Davidson, 1987, Figge et al., 1998). The Lac 
repressor (LacI) expressed in the cells binds to its cognate operator sequence (lacO) in the 
DNA. If lacO is located in a promoter region, LacI will silence expression of the downstream 
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gene. Repression is abolished by the allolactose analogue IPTG whose binding diminishes 
affinity of LacI to lacO. 
Another approach to regulate gene expression employs chemically induced dimerisation 
(CID). DNA binding and transactivating domains of the transactivator are separately 
expressed as fusions with a dimerisation domain that binds a certain drug. Upon addition of 
this drug the fusion proteins form heterodimers thereby constituting the functional 
transactivator. This principle is carried out in the FK506 binding protein 12 (FKBP)/FK506 or 
rapamycin and cyclophilin/cyclosporin regulation systems (Spencer et al., 1993).
Prominent regulated expression systems currently in use are controlled by dimerisation of 
transactivator homodimers or their conformational change induced by certain small molecules 
(mostly antibiotics). This determines the transactivator’s capacity to bind to its target DNA 
sequence. Examples for this kind of regulation mechanism are the streptogramin system 
(Pip/pristinamycin; Fussenegger et al., 2000), the macrolide based system (E/erythromycin, 
clarithromycin, and roxithromycin; Weber et al., 2002) and most notably the tetracycline (tet) 
regulated system which will be described in detail later on (Gossen and Bujard, 1992). 
Combined use of these systems to create artificial regulatory networks allowed for 
sophisticated fine tuning of expression (Kramer et al., 2003). Also, independent expression of 
multiple genes can be managed by non interacting regulation systems, which is of interest e.g. 
to elucidate effects of different gene products in cascades. To extend the scope of drug 
regulated gene expression systems available, the cumate, the coumermycin/novobiocin and 
the TraR based systems have been developed recently (Mullick et al., 2006, Zhao et al., 2003, 
and Neddermann et al., 2003, respectively). These take advantage of regulatory elements 
from bacteria and viruses alike the previously described systems, a strategy that avoids 
possible interactions with host regulation networks. 
Only a limited set of the systems described above is available for reversible transcriptional 
regulation in transgenic mice. Neither streptogramin nor macrolide regulated expression in 
transgenic mice has been established so far and the same is true for the novel cumate, 
coumermycin/novobiocin and TraR systems. CID employing FKBP or cyclophilin suffers 
from the immunosuppressive activity of the inducers FK506 or rapamycin and cyclosporin, 
respectively. Initial attempts to exploit the lac system in mice failed due to silencing of lac 
genes or the tendency of bacterial sequences to be excised from the host (reviewed by 
Scrable, 2002). No more than a few years ago, efforts by Cronin et al. proved that the lac 
system is functional in transgenic mouse lines (Cronin et al., 2001; Cronin et al., 2003, Ryan 
and Scrable, 2004). Although lac is a promising tool to regulate transgenes in vivo, the tet 
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system has a considerable head start as earliest reports of its application in mice reach back to 
the mid nineties (e.g.: Furth et al., 1994; Hennighausen et al., 1995; Kistner et al., 1996). 
Thus, the well established tet system still is the method of choice to govern reversible 
transgene expression in mice. 
1.1.1 Tetracycline (tet) regulated gene expression
The tet system for regulated gene expression in eukaryotic cells was developed from the E. 
coli tetracycline resistance operon. There, the tet repressor (TetR, Postle et al., 1984) 
homodimer senses the presence of the protein synthesis inhibiting antibiotic. Upon binding of 
tet, TetR changes its conformation and does not recognise its operator sequence (tetO) in the 
DNA anymore (Müller et al., 1995). Thereby repression of the TetA gene is abolished, which 
codes for a membrane transporter that removes tet from the cell (overview e.g. by Hillen and 
Berens, 1994). 
After studies had shown that this principle could be exploited for regulated gene expression in 
plants (Frohberg et al., 1991; Gatz and Quail, 1988, Gatz et al., 1991), Gossen and Bujard 
adapted it for the use in mammalian cells (Gossen and Bujard, 1992). The regulation 
mechanism of the so called TetOFF  system is depicted in figure 1. 
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A) no tet
B) + tet
transactivator                       transactivator dependent 
                                                        promoter
P  TetR     VP16                  7 x tetO   Pmin              GOI
P TetR VP16 7 x tetO   Pmin GOI
Figure 1: The TetOFF system mode of operation
A) The transactivator tTA consisting of the TetR repressor domain fused to the VP16 transactivation domain is 
constitutively expressed and homodimerises. In the absence of tet or its analogues (doxycycline or 
anhydrotetracycline), the repressor domain binds to the tet operator sequences (tetO) proximal of the minimal 
promoter PhCMV*-1. The transactivating domain triggers expression of the downstream transgene. B) When tet 
(black triangles) is added it is bound by tTA which in turn changes its conformation. Thereby, binding of tTA to 
tetO is blocked and expression is shut off.
In the TetOFF system the transactivator tTA is constitutively expressed. It harbours a TetR 
repressor domain recognising tetO and a Herpes simplex virus VP16 transactivation domain 
(Triezenberg et al.,1988 a and b; Sadowski et al., 1988). Homodimers of this fusion protein 
bind to the PhCMV*-1 promoter which consists of 7 tetO repeats close to the human 
Cytomegalovirus minimal promoter PhCMV (Boshart et al., 1985). Thereby, the VP16 domain 
is capable of initiating transcription of the downstream transgene by recruitment of 
endogenous transcription factors like TFIIB (Lin et al., 1991), TBP (Ingles et al., 1991), or 
TAFII40 (Goodrich et al., 1993). Addition of tet or its analogues, e.g. doxycycline (dox) or 
anhydrotetracycline leads to a conformational change of tTA rendering the protein unable to 
bind to the promoter. Consequently, the transgene ceases to be transcribed.
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1.1.1.1 Modifications and improvements of the tet dependent transactivator
Since its first application in mammalian cells the transactivator of the tet system has been 
modified to improve performance and to broaden its abilities.
Gossen et al. (1995) found that when only 4 amino acids in the TetR domain of tTA were 
changed the phenotype of the molecule was inverted (TetON). This reverse transactivator 
(rtTA) binds only to tetO in the presence of tet. However it has to be noted that rtTA is only 
marginally activated by tet but well inducible by its analogue dox. Application of tTA is 
advantageous when a transgene should be active and needs to be quickly repressed while rtTA 
allows a rapid induction of expression. 
One pitfall of the early tTA version lies in the viral VP16 transactivation domain which can 
induce large-scale chromatin decondensation and interacts with a multitude of transcription 
factors (Tumbar et al., 1999; transcription factor interactions reviewed by Flint and Shenk, 
1997). High amounts of this molecule lead to an overall depletion of transcription factors 
needed for host RNA production which can result in cell death. This process is called 
“squelching” and was first observed when overexpressing Gal4 in yeast (Gill and Ptashne, 
1988). To reduce adverse effects that were observed with high concentrations of (r)tTA 
(Gossen and Bujard 1992; Damke et al., 1995; Saez et al., 1997; Gallia and Khalili, 1998; 
Strathdee et al., 1999), the VP16 domain was substituted for different fusions of modified 12 
amino acid minimal transactivation domains derived of VP16 (Baron et al., 1997). A motif 
consisting of 3 so called F domains strongly reduced negative effects (reduction to 33% of full 
VP16 domain) while retaining almost the full transactivation activity (98%); this tTA version 
was called tTA2. Higher tolerance to tTA2 is probably due to lack of multiple binding sites 
for transcription factors in comparison to the initial VP16 sequence. For instance, Oct-1 
(Hayes and O’Hare, 1993), TAFII40 (Goodrich et al., 1993), and ADA2 (Silverman et al., 
1994; Candau et al., 1996) are not capable of binding to the minimal transactivation domain 
repeats. Alongside to tTA also rtTA has been modified by substituting the full VP16 domain 
for repeats of minimal domains (Kämper et al., 2002). In addition, other modifications like 
removal of potential splice sites and sequences that could form hairpin structures from 
synthetic VP16 domains improved performance of these rtTA versions (Urlinger et al., 
2000a).
An alternative approach to avoid potential negative effects of VP16 was to use non viral 
transactivation domains, e.g. p65 (Schmitz and Bäuerle, 1991) and E2F4 (Ginsberg et al., 
1994). Fusions of p65 with TetR proved to be as efficient as the VP16 transactivator while 
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E2F4 has a lower transcriptional activation potential (Urlinger et al., 2000b; Akagi et al., 
2001).
Transcription can not only be induced by the tet system but also be efficiently silenced when 
TetR is fused to the KRAB (Krüppel-associated box) repressor domain of e.g. the human 
Kox1 protein (Margolin et al., 1994; Deuschle et al., 1995). The resulting molecule is 
accordingly called tTS (transcriptional silencer) while the reversely active transrepressor is 
termed rtTS (Hayakawa et al., 2006). 
Since mutually exclusive TetR dimerisation domains derived from different gram-negative 
bacteria strains have been developed (Rossi et al., 1998; Baron et al., 1999), tTA, rtTA, and 
tTS may be used in the same cell avoiding formation of non active heterodimers. 
Alternatively, expression of two molecules of the transrepressor or of the transactivator linked 
by a small amino acid linker enforces homodimerisation (single chain 
transactivators/transrepressors; Krueger et al., 2003; Hayakawa et al., 2006). Combination of 
compatible tet regulating elements is for example exploited to reduce basal levels by using 
rtTA in combination with tTS: in the absence of tet, tTS binds to the tet dependent promoter 
and represses minimal expression. When tet is added tTS is displaced by rtTA which induces 
transcription (view e.g. Freundlieb et al., 1999; Förster et al., 1999; Bornkamm et al., 2005;  
Krueger et al., 2006). 
Performance of transactivators is not only determined by the transactivation domain but also 
by their ability to translocate to the nucleus. Thus, fusion of a nuclear localisation sequence 
(nls) to tTA (Yoshida and Hamada, 1997) or rtTA (Gossen et al., 1995) improved the 
induction/repression potential of the transactivators by increasing the nuclear transfer rate.
Also, binding affinity of the transactivators to the tetO sequences in the responsive promoter 
is a determinant factor (Hinrichs et al., 1994; Orth et al., 1998; Baron et al., 1999). By 
subjecting the TetR domain to random mutagenesis rtTA variants could be identified that 
displayed enhanced DNA binding potential (Urlinger et al., 2000a).
1.1.1.2 Application of tet dependent transgene expression (in transgenic mice) 
Tet regulated transgene expression has been utilised in a vast number of experimental 
approaches in different mammalian cell lines including HeLa, HEK293T and CHO. 
Regulation factors and basal expression levels are dependent on the individual cell line, 
indicating that cell specific factors influence performance of the system (Howe et al., 1995; 
Leuchtenberger et al., 2001). 
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Also murine embryonic stem (mES) cells can be manipulated by tet regulated transgene 
expression, facilitating studies concerning the intricate balance between self-renewal and 
differentiation of these pluripotent cells. For example, Masui et al. (2007) investigated the 
mechanism of Sox2 maintained pluripotency by tTA governed Sox2 expression in otherwise 
Sox2 null mES cells. In contrast, Kyba et al. (2002) used rtTA regulated HoxB4 expression to 
enforce hematopoietic differentiation of mES cells. 
With the help of mES cells harbouring tet regulated transgenes or by pronuclei injection of tet 
regulated constructs into oocytes it is possible to generate mice that express/repress certain 
transgenes upon administration of dox (e.g.: Furth et al., 1994; Hennighausen et al., 1995; 
Kistner et al., 1996). Today, an increasing number of mouse strains expressing tTA or rtTA 
under control of different promoters allows to generate transgenic mice with tissue specific 
transgene expression by mating with mice that carry the GOI driven by a tet dependent 
promoter. This strategy permits spatial (tissue specific tTA/rtTA) as well as temporal 
(administration of dox) control of transgene expression. A table listing available tTA, rtTA 
and responder mouse strains is provided at: http://www.zmg.uni-mainz.de/tetmouse/. 
Application of the tet system in transgenic mice for example enabled investigation of the 
circadian clock. Hong et al. (2007) generated mice carrying the Clock gene or a mutant 
dominant negative allele thereof under control of  brain specific tTA. They observed discrete 
changes of circadian locomotor rhythms that reversed to the wild type phenotype upon 
administration of dox. Ernst et al. (2007) set out to devise a small animal model for Hepatitis 
C virus (HCV) infection by putting the HCV core protein or the complete ORF under control 
of liver restricted rtTA. Expression of the viral gene(s) can thus be switched on after 
maturation of the immune system circumventing immune tolerance to the viral protein(s). 
However, the authors detected significant transgene expression in the kidneys of induced 
mice. In addition, mosaic expression led to variable expression levels in individual mice of 
the same line implicating that the model still needs to be improved.
The tet system has also been used in combination with the Cre recombinase, for instance by 
controlling Cre expression by activity of tTA/rtTA (Schönig et al., 2002) or by subordinating 
rtTA expression to Cre mediated stop cassette excision (Belteki et al., 2005, Yu et al., 2005). 
A new strategy does not employ the tet system for regulated expression of transgenes but for 
conditional knockdown of endogenous genes by RNA interference (RNAi, e.g. Matthess et 
al., 2005; Szulc et al., 2006). Seibler et al. (2007) placed tetO downstream of the U6 or H1 
polymerase III promoters commonly used for shRNA expression. TetR was constitutively 
expressed and hence blocked transcription. Upon dox administration TetR detached from the 
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DNA allowing the shRNA coding sequence to be transcribed. By using an insulin receptor 
specific shRNA it was possible to induce severe hyperglycemia in transgenic mice within 7 
days of dox administration. When a microRNA based shRNA is used, RNAi can also be 
controlled by conventional tet dependent polymerase II promoters. This allowes mating of 
mice carrying RNAi responder constructs to already existing (r)tTA strains. Dickins et al. 
(2007) employed this strategy to achieve tissue specific, reversible knockdown of the tumor 
suppressor gene p53.
A major concern of regulated expression in particular in transgenic mice is the basal activity 
in the repressed state, i.e. the system’s “leakiness”. Indeed, the tet system displays varying 
degrees of basal expression in vivo due to residual activity of the minimal, tet dependent 
promoter (reviewed by Sun et al., 2007). This may be tolerated if basal levels of the 
respective transgene are too low to elicit a phenotype. In case tightness of the tet system is 
critical, basal expression may be suppressed by the combined use of rtTA and tTS as 
described by Zhu et al. (2001). The authors had observed inflammation and other evidence for 
leaky expression in the lungs of mice harbouring an interleukin 13 (IL-13) transgene under 
the control of lung specific rtTA. However, this could be circumvented by simultaneous lung 
specific expression of tTS. While this did not influence inducibility of the rtTA regulated 
transgene, the phenotype in the repressed state was efficiently eliminated.
In conclusion, the tet system has been successfully applied in a number of transgenic mouse 
models to date. Its most important advantage is provided by the reversibility of transgene 
expression, overcoming a major limitation of classical (genetic) regulation systems.
1.1.1.3 Autoregulated, tet dependent expression
The basic tet system consits of two separate units: a constitutively active promoter driving 
(r)tTA and a responsive promoter controlling expression of the transgene. As constant high 
levels of transactivator have been shown to have cytotoxic or growth arresting effects 
probably due to squelching (e.g. Gossen and Bujard, 1992; Damke et al., 1995; Saez et al., 
1997), autoregulated expression systems have been developed where levels of transactivator 
in the uninduced state are significantly reduced. In these systems, (r)tTA governs its own 
expression. Different strategies to achieve autoregulated expression are outlined in figure 2. 
Initiation of expression in these systems is dependent on a certain basal expression providing 
enough transactivator molecules to trigger transcription. After activation of transcription, a 
positive feedback loop of expression is generated. 
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Figure 2: Different modes of autoregulated expression
1) The transactivator dependent promoter drives expression of the transactivator. 2) The transactivator binds to 
the operator sequence of the promoter and in turn triggers expression of more transactivator. 3) At the same time, 
expression of a transgene is induced. A) Dual promoter system: transactivator and transgene are driven by their 
own, transactivator dependent promoter. These two expression units may reside on separate or on the same 
plasmid. B) The transactivator dependent promoter drives expression of a bicistronic mRNA. Translation of the 
second cistron is mediated by an internal ribosomal entry site (IRES). C) A bidirectional transactivator 
dependent promoter governs transcription of both transactivator and transgene.
Initial attempts to apply autoregulated tet systems showed cellular toxicity (Gallia and Khalili, 
1998; Strathdee et al., 1999). However, this was most likely not specific for autoregulated 
expression but due to the use of old transactivator variants harbouring the full VP16 
transactivation domain. Autoregulated tet systems and their expression charasteristics have 
been of interest in a number of studies (e.g. Hofmann et al., 1996; Unsinger et al., 2001; 
Unsinger et al., 2004). A prominent advantage of autoregualted cassettes designed as depicted 
in figure 2 panels B and C is their compactness that facilitates single step transduction, e.g. by 
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For instance, viral transduction of tet autoregulated therapeutic genes has been envisaged for 
gene therapy approaches (Gould et al., 2000; Unsinger et al., 2001; Chtarto et al., 2003).  
Kühnel et al. (2004) infected mice with tTA4 autoregulated retroviruses demonstrating that 
this system facilitates inducible gene expression in the liver in vivo. By implementing 
autoregulatory rtTA driven transgene expression in lentiviruses, Markusic et al. (2005) could 
show that the autoregulatory loop was superior to constitutive rtTA expression: 1) viral titers 
were higher, 2) rtTA and the transgene were not detectable in the absence of dox, 3) induction 
kinetics were improved, and 4) induction levels were increased. 
The only reports applying an autoregulated tet system in transgenic mice so far have been 
published by Shockett et al. (1995; 2004). There, the authors controlled the recombination 
activating genes 1 and 2 (RAG-1 and RAG-2) by an autoregulated tTA as depicted in figure 2 
panel A (dual promoters). In mice with a RAG-1 or RAG-2 KO background induction of both 
transgenes partially rescued V(D)J joining, reconstituting lymphocyte function to a certain 
degree. 
1.1.1.4 Expression characteristics of the autoregulated tet system
When the transcativator is abundant in cells due to constitutive expression, tet systems 
gradually increase transgene expression with increasing (rtTA)/decreasing (tTA) tet 
concentrations (Baron et al., 1997; Kringstein et al., 1998; Bornkamm et al., 2005). 
Autoregulated systems in contrast display a bimodal response: cells either display basal 
transgene expression or they express maximal levels once a certain level of inducer is reached 
(Becskei et al., 2001; May et al., 2007, submitted). With increasing concentrations of dox 
(referring to rtTA), cells do not express higher amounts of the transgene but rather the 
probability of expression in individual cells is augmented. This expression characteristic is 
typical for positive feedback loops (Becskei et al., 2001). It can be explained by different 
molecular conditions in binary and autoregulated TetON systems: When the transactivator is 
constantly expressed, the degree of regulated expression is only limited by the the amount of 
inducer present. In the autoregulated setting, inducer as well as rtTA are limiting factors for 
initiating transcription.
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1.2 Methods for introducing transgenes in mice 
A prerequisite for the generation of transgenic mice is the integration of the GOI and - if 
desired - regulatory elements into the chromosomes of either mES cells or fertilised oocytes. 
Expression of these cassettes strongly depends on the nature of the integration site, a 
phenomenon which is called the “position effect”. Possible influences by endogenous 
regulatory elements neighbouring the integration site(s) or by heterochromatin formation 
include tissue or cell type restricted expression of the GOI, elevated basal expression levels or 
- very often - complete silencing of the GOI. An extreme example for hetreogenous 
expression due to position effects is provided by Feng et al. (2000): here, 24 different founder 
animals displayed 24 different expression patterns. 
Several methods are available today that overcome the difficulties inherent to random 
integration. These include targeted integration into defined loci by either homologous or site 
specific recombination or shielding the transgene by large DNA sequences employing e.g. 
Bacterial Artificial Chromosomes (BACs). In the following chapters, these methods will be 
described and compared concerning their advantages and disadvantages for the generation of 
transgenic mice.
1.2.1 Homologous Recombination
Homologous recombination (HR) is one of the key mechanisms to create genetic diversity in 
nature. It mediates sequence exchange between chromosomes, thus allowing new 
combinations of  alleles to be tested for their performance and to separate advantageous from 
unfavourable alleles. 
HR is employed as a tool to specifically manipulate loci in living cells – in particular mES 
cells. By transduction of a user-defined DNA sequence flanked by homology arms into the 
cells, this sequence can be introduced into the homologous locus. Thus, gene function can be 
completely abolished (knock-out), modified (e.g. by creating hypomorphic alleles) or new 
transgenes may be introduced (knock-in). Although HR was first utilised in differentiated 
cells (Smithies et al., 1985), its frequency in this background is very low (10-9 – 10-8
events/cell) (Puttini et al., 2005) and it is often masked by the dominance of illegitimate 
recombination. However, attempts are made to alleviate application of site-specific HR in 
highly differentiated cells by stimulation with the meganuclease I-SceI (Puttini et al., 2005).
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Murine ES cells in contrast display a much higher probability of HR (10-6 – 10-5 events/cell) 
and once a gene has been correctly targeted, the probability that a second fragment is 
integrated randomly is approximately 20 fold decreased (Reid et al., 1991). 
Efficiency of HR in mES cells is dependent on the length of homology arms in the targeting 
construct: maximal efficiency is reached at a total length of 14 kbp while homologous arms 
shorter than 1 kbp each are not sufficient for HR (Thomas et al., 1992). Also, targeting 
efficiency by HR is influenced by the individual locus. Screening for correctly targeted cell 
clones can be facilitated by adapted selection protocols. ROSA26 (Friedrich and Soriano, 
1991; Zambrowicz et al., 1997), a locus that is commonly used for knock-in strategies for 
instance can be targeted with an frequency of up to 25% (personal communication J. Haigh). 
As mES cells can be used to generate transgenic mice, e.g. to elucidate gene function during 
ontogenesis or for modeling human diseases, use of HR in mES cells has revolutionised basic 
and biomedical research (reviewed by Downing and Battey, 2004).
1.2.2 Site specific recombination
Next to HR, also site specific recombination allows to manipulate mammalian genomes. Site 
specific recombination systems do not require any endogenous factors and consist of two 
basic components: the site specific recombinase (SSR) enzyme and its cognate recognition  
target (RT) site in the DNA. The most common SSRs currently used are the Cre and Flp 
tyrosine recombinases, which share a common recombination mechanism: DNA is cleaved, 
exchanged and ligated at the specific RTs (Sadowski et al., 1995). Cre was derived form the 
bacteriophage P1 (Sternberg et al., 1986) and recognises so called loxP (locus of crossover) 
sites whereas Flp was found in the yeast 2µ circle and recombines FRT (Flp recognition 
target) sites. While both types of RTs differ in their nucleotide sequence, their overall 
structure is similar: an asymmetric spacer sequence is flanked by two 13 bp inverted repeats 
(figure 3).
ATAACTTCGTATA TATACGAAGTTATATGTATGC
TATTGAAGCATAT ATATGCTTCAATATACATACG
GAAGTTCCTATTC GTATAGGAACTTCTCTAGAAA
CTTCAAGGATAAG CATATCCTTGAAGAGATCTTT
A) Cre loxP site                                                               B) FLP FRT site
5'
3' 5'
3' 5'
3' 5'
3'
Figure 3: Sequences of lox P and FRT sites
RTs of both Cre and Flp share a common structure: an asymmetric 8bp core or spacer sequence (indicated by 
triangle) is flanked by inverted 13 bp repeats (marked by arrows). A) Cre recombinase RT loxP B) Flp 
recombinase RT FRT
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Recombinase monomers bind to their respective RTs promoting formation of a DNA synaptic 
complex and recombination between two identical RTs in the same orientation (Hoess et al., 
1985a and b; Amin et al., 1991). Thus, spacer asymmetry determines the outcome after 
recombination of varying positions and orientations of RTs (figure 4). DNA flanked by 
inverted RTs will be inverted by the SSRs (figure 4 panel A) whereas direct repeats lead to 
excision of a circular molecule of flanked DNA (figure 4 panel B). The opposite reaction, 
namely integration of circular DNA carrying an RT into the linear molecule, can also occur 
albeit with a much lower frequency due to thermodynamic reasons (figure 4 panel B). RTs 
positioned on separate DNA molecules result in translocation of distal sequences (figure 4 
panel C).  
Inversion Excision/Integration Translocation
Excision              Integration
Recombinase target sites
Figure 4: Outcome of recombination reactions mediated by Cre and Flp 
RTs of Cre and Flp and their respective orientation are indicated by arrows. A) Inverted RTs on the same 
molecule lead to inversion of the flanked DNA sequence after recombination. B) Direct repeats of RTs on the 
same molecule result in excision of a DNA circle. Excision is much more efficient than the integration reaction 
as indicated by arrows. C) RTs on different DNA molecules result in DNA exchange of part of the linear 
molecules.
Cre recombinase works satisfyingly in mammalian cells in spite of its prokaryotic codon bias; 
codon optimisation yielded an enzyme version termed iCRE, which showed only slightly 
improved performance (Shimshek et al., 2002). Wild type Flp in contrast suffered from low 
activity at 37°C (Buchholz et al., 1996), a drawback that was overcome by generating a 
mutant with an adequate optimum temperature termed Flpe (enhanced Flp; Buchholz et al., 
1998). Recently, a new mutant of Flpe recombinase called Flpo (optimised Flp) has been 
published, which is claimed to be more efficient for recombination due to codon optimisation 
for mammalian cells (Raymond and Soriano, 2007). 
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Both SSRs were further refined by fusion to an oestrogen receptor ligand binding domain 
(LBD), rendering them inactive in the absence of ligand and hence attaining temporal control 
over SSR activity. The LBD version employed is the ER(T2) mutant (chapter 1.1), which 
solely binds 4-hydroxytamoxifen (CreER(T2): Feil et al., 1997; FlpeER(T2): Hunter et al., 
2005). 
Cre and Flpe are in particular valuable tools for genetic analyses in mice (reviewed by Branda 
and Dymecki, 2004; Schnütgen et al., 2006). They enable conditional gene expression by 
removal or inversion of a transcriptional stop cassette, conditional knockout of targeted genes, 
removal of undesired selection markers and Recombinase Mediated Cassette Exchange 
(RMCE), which is described below. Today, a multitude of mouse strains are available that 
express Cre in a tissue specific and/or inducible manner (“Cre-zoo”; listed at: 
http://www.mshri.on.ca/nagy/) and the number of analogous Flpe lines is increasing (Farley et 
al., 2000; Rodriguez et al., 2000; Awatramani et al., 2003). These strains facilitate spatial and 
temporal control over transgene expression in vivo by simple mating to responder lines of 
interest. 
A new Cre-like recombinase termed “Dre” was identified that is a new candidate for 
engineering mammalian genomes (Sauer and McDermott, 2004). Since it recognises its own 
specific set of RTs it could be used in parallel to Cre and Flpe thus expanding possibilities of 
genetic manipulation.
Another recombinase that has already been successfully applied in mammalian cells was 
derived from the phage ΦC31 (Thorpe and Smith, 1998; Andreas et al., 2002; Smith and 
Thorpe, 2002;  Groth et al., 2000). ΦC31 belongs to the serine family of recombinases and 
follows a mechanism that is distinct from Cre, Dre and Flp (depicted in figure 5 panel B). 
This enzyme recombines the non identical attB and attP sites, inserting a DNA sequence and 
creating attL and attR sites. AttL and attR cannot recombine so that the integration reaction 
mediated by ΦC31 is essentially irreversible. ΦC31 has been proven to work efficiently in 
mES cells (Belteki et al., 2003) and for gene therapy approaches (Olivares et al., 2002; Ortiz-
Urda et al., 2002) indicating its potential for future application.
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1.2.2.1 Recombinase Mediated Cassette Exchange (RMCE)
Transgene expression levels strongly depend on the individual integration site of the 
transgene since neighbouring elements like silencers or chromosomal structures have a strong 
impact on transcription. Random integration (RI) of a GOI thus suffers from unpredictable, 
potentially unstable expression characteristics. This problem can be circumvented by HR; 
however, only a limited number of well described loci suitable for transgene expression is 
available so far and reasonably efficient use of HR is restricted to mES cells. 
Utilisation of SSRs for Recombinase Mediated Cassette Exchange (RMCE) presents an 
alternative tool for targeted integration of transgenes that is applicable in all cell types. In 
addition, RMCE allows for more efficient selection strategies to identify correct integration 
events than HR. 
A prerequisite for RMCE employing Cre and Flpe was the development of heterologous, non 
interacting loxP and FRT sites, respectively (reviewed by Branda and Dymecki, 2004). These 
mutant sites fall into two classes: spacer variants and inverted-repeat variants. Spacer variants 
carry substituted nucleotides in the 8bp core sequence. As long as the spacer length is not 
changed, recombination is possible but restricted to homotypic pairs of RTs (Hoess et al., 
1986; Senecoff et al., 1988). As ΦC31 recombines the non identical attB and attP sites, the 
naturally occuring heterotypic sites may be used for RMCE in this case.
RMCE involves two basic steps:
1) “tagging” of a genomic locus by intergrating  heterotypic RTs either via HR or RI. In 
the case of RI, expression characteristics of the randomly tagged locus can be 
evaluated by a co-integrated reporter gene to determine its usefulness for further 
approaches.
2) “targeting” of the tagged site allows to exchange the tagging cassette for the desired 
transgene flanked by the same set of RTs (depicted in figure 5).
Applying this technique, pre-defined chromosomal loci may be reused or modified 
circumventing extensive screening procedures (reviewed by Bode et al., 2000; Baer and 
Bode, 2001).
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GENE X
GENE Y
Cre/Flp
GENE Y
loxP/FRT         loxP mut/FRT mut
loxP/FRT         loxP mut/FRT mut
GENE Y
attP
ΦC31
attB
GENE Y
attL attR
attP
attB
GENE X
A) RMCE with Cre/loxP and Flp/FRT                       B) RMCE with C31 Φ
Figure 5 (from Wirth et al., 2007): Principle of Recombinase Mediated Cassette Exchange (RMCE)
A) Flp and Cre recombinases recognise their specific target sequences (loxP and FRT, respectively) in the 
previously tagged genomic DNA and the incoming targeting vector. After integration of the targeting vector via 
either of the RTs and subsequent resolution of the intermediates formed, the genomic locus will have acquired 
gene y. Suitable selection strategies permit the recovery of the desired exchange event. Complete excision is 
prevented by using heterospecific (mutant) LoxP or FRT sites. Alternatively, inverted orientation of the RTs 
with respect to each other may be employed. P: promoter; the dashed lines indicate the prokaryotic vector 
backbone. ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
by two attB sequences is integrated into the genomic site and hybrid attL and attR sites are generated which are 
not compatible for any further recombination events. Thus, integration of the desired cassette is strictly 
unidirectional.
Several parameters influence efficiency of RMCE and by manipulating them the number of 
correct targeting events can be significantly enhanced. 
For example, different site specific selection strategies have been devised to counterselect 
random integration of the targeting vector. One of these strategies is complementing a 
truncated version of a positive selection marker with its missing sequence from the incoming 
targeting plasmid and subsequent selection with the respective drug (e.g. complementing 5’ ∆
neomycin phosphotransferase with ATG, e.g. Schucht et al., 2006; or reconstituting an HPRT 
minigene as in Wallace at al., 2007). In a similar approach a promoterless positive selection 
marker is only expressed by a matching promoter from the parental locus after correct 
integration (Cobellis et al., 2005). In addition, a negative selection marker such as the 
thymidine kinase gene may be included in the initial tagging construct, thus allowing to 
specifically eliminate all cells with the non exchanged cassette (selection with ganciclovir for 
absence of thymidine kinase; e.g. Toledo et al., 2006; Wong et al., 2005). A third possibility 
is to place diphteria toxin A in the non exchanged region of the targeting plasmid in order to 
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select against random integration into the genome (Araki et al., 2006 ). However, it has been 
reported that the ratio of correct RMCE events versus random integration may be acceptable 
even in the absence of any site specific selection (2 correct clones/30 analysed by Cobellis et 
al., 2005; 50% efficiency observed by Masui et al., 2005). 
In order to perform RMCE, not only the targeting vector has to be present in the cell but also 
adequate amounts of the recombinase protein. Mostly, a second plasmid encoding for the 
recombinase is cotransduced (by transfection or electroporation) which leads to transient 
production of the protein. Alternatively, fusions of Cre (and Flp, unpublished data by 
Edenhofer et al.: Mouse Molecular Genetics Meeting, Heidelberg 2005) with the TAT 
sequence from HIV-1 have been created so that the enzyme can be directly administered to 
the cells and pass through the membranes of its own accord (Peitz et al., 2002). By retroviral 
pseudotransduction it is even feasible to obtain transient recombinase activity in a certain 
subset of cells dependent on the receptor specificity of the pseudovirus (Galla et al., 2004).
?????????? ????????? ??? ???? ???????????? ??? ??????????? ??? ???? ????? ??? ???? ???? ????? ????????
higher enzyme levels over an extended period of time have been shown to be harmful for the 
cells (Cre: Loonstra et al., 2001; Schmidt-Supprian and Raj???????????????????????????et 
al., 2006, Liu et al., 2006a). This is caused by the presence of cryptic loxP and attB/P sites in 
the genome that may be recognised and recombined leading to chromosomal rearrangements.  
To circumvent this problem - especially in Cre transgenic mice - , timely restricted Cre 
activity is utilised (described in chapter: 1.2.2). Of note, no overt adverse effects of Flp 
recombinase have been reported so far.
RMCE has been exploited in multiple fields ranging from basic reseach to biotechnological 
applications, e.g. for generation of recombinant virus producer cell lines providing high and 
predictable virus titers (Schucht et al., 2006; reviewed by Wirth et al., 2007). Endeavours to 
trap every gene in mES cells to generate (conditional) knockout mouse strains (Austin et al., 
2004; Auwerx et al., 2004) have been made compatible with RMCE by including 
heterospecific RTs in the trapping vectors. Thus, trapped chromosomal loci in mES cells are 
readily accessible by RMCE (proof of principle e.g. by Cobellis et al., 2005). Available 
trapped mES cell clones are provided by the International Gene Trap Consortium (IGTC) at 
http://www.genetrap.org.
Recently, Wallace et al. (2007) impressively demonstrated the faculties of RMCE by 
replacing the murine α-globin regulatory domain for the syntenic human sequence. This 
exchange involved a segment larger than 100 kbp and produced an accurate mouse model for 
human α-thalassemia.  
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1.2.3 Bacterial Artificial Chromosomes (BACs) 
Besides specifically targeting a transgene to predefined loci in order to avoid unwanted 
position effects, large DNA segments (up to 300 kb) in the form of BACs may be exploited to 
intercept influences from the host’s genome. Since recombination systems were established 
that allow to manipulate BACs, transgenes may be modified if desired and introduced into the 
mouse germline via this route (reviewed by Giraldo and Montoliu, 2001; Sparwasser and 
Eberl, 2007). Either the GOI is kept in its endogenous surrounding thereby retaining potential 
regulatory elements that are not located in the immediate proximity, or it may be inserted into 
a BAC derived from any “neutral” locus (e.g. ROSA26: Giel-Moloney at al., 2007). The 
observation that expression levels are proportional to the integrated number of copies 
indicates that expression from BACs is largely liberated from position effects (e.g. Bender et 
al., 2007).
1.2.4 Comparison of HR, Site Specific Recombination, and BACs for generation of 
transgenic mice
The above described techniques to evade position effects of integrated transgene expression 
differ in their capabilities. HR employed to target endogenous loci for instance requires 
screening of a considerable number of clones since the gene targeting vector frequently 
integrates randomly. In addition, the large homology arms needed for efficient recombination 
hamper vector manipulation by simple cloning strategies. Another constraint of HR is the 
limited number of supportive loci available. 
RMCE in contrast facilitates targeted integration with an efficiency of up to 100% (e.g. 
Schucht et al., 2006) due to apt selection strategies involving comparatively small constructs 
that are easy to handle. However, this method requires a previous integration step of the RTs 
by either HR or random integration. 
BAC transgenesis on the one hand profits from the cointegration of sequences flanking the 
transgene thereby maintaining its cognate environment in the host. On the other hand, these 
sequences can as well contain other genes that may be coexpressed and potentially lead to 
unpredictable effects (reviewed by Matthaei, 2007). 
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1.3 In vitro differentiation of mES cells
mES cells were first successfully isolated from blastocysts and propagated in vitro in 1981 
(Evans and Kaufman 1981; Martin, 1981). A prerequisite for mES cell culture was to identify 
conditions that support pluripotency, i.e. the potential to differentiate into cell types of all 
three germ layers. Maintenance of an undifferentiated yet pluripotent state of mES cells is 
dependent on factors present in the media, most notably leukaemia inhibitory factor (LIF) and 
BMP4 (Ying et al., 2003). Removal of these factors induces spontaneous differentiation of the 
cells which may be directed to specific lineages by appropriate cues like cytokines.
Thus, manipulated mES may not only be exploited to establish mouse models but can also 
serve to model embryonic development in vitro. Besides its value for basic research, in vitro
differentiation of ES cells may also be utilised as an inexpensive tool for drug testing (e.g. 
Reppel et al., 2007), in particular if teratogenicity is concerned. Since the isolation of human 
ES cells in 1998 (Thomson et al., 1998), in vitro differentiation of ES cells has attracted 
notice as a potential source for cells and tissues for the treatment of various diseases. 
A multitude of in vitro differentiation protocols have been developed that allow generation of 
cell types of all three germ layers from mES cells, e.g. neuronal, cardiac, pancreatic and 
hepatic cells (reviewed by Wiese et al., 2006; Keller, 2005).
Pilat et al. (2005) differentiated mES cells in vitro to hematopoietic precursors that were 
almost indistinguishable from isolated bone marrow cells. These so called ES-HCs (ES cell 
derived hematopoietic stem cells) had a similar potential to reconstitute the hematopietic 
compartment in irradiated mice as adult hematopoietic stem cells (HSCs). This underlines that 
fate decision during in vivo differentiation may be reproduced with high accuracy in vitro if 
ES cells are subjected to adequate signalling. 
1.4 Objective of this work
Random integration of transgenes into mammalian chromosomes mostly results in 
unpredictable and/or unstable expression patterns due to position effects. This in particular 
applies for regulated transgene expression. The aim of this work was to identify approaches 
that allow high and strictly controllable expression of TetON regulated transgenes in mES cells
for establishing mice with tightly regulated transgene expression. One approach should 
employ a single cassette harbouring an autoregulated reporter gene to screen for suitable loci 
in the mouse genome (“tagging”). In light of the fact that expression of genes governed in an 
autoregulated manner has not been investigated in detail on transgenic mouse level so far, a 
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central issue in this regard should be to characterise the performance of autoregulated 
cassettes and to evaluate their potential for further applications. 
Transgene expression is frequently altered upon differentiation of mES cells to somatic cells, 
potentially resulting in tissue or cell type specificity or even complete silencing of the 
transgene in mice. Hence, another aspect should be to test strategies for evaluating expression 
after in vitro differentiation protocols to facilitate pre-screening for mES cell clones with 
suitable expression properties.
Potential reuse of tagged loci in such pre-characterised clones for further applications should 
be envisaged by implementing an approach applying site specific recombinases for cassette 
exchange.
On the whole, mES cell lines with reusable loci should be generated that provide high and 
well regulated transgene expression in transgenic animals. Time consuming screenings of 
mES cell clones as well as transgenic mice for adequate expression levels would be 
circumvented by the specific use of predefined, well characterised chromosomal loci with 
predictable expression characteristics.
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2 Results
The objective of this work was to create mES cell lines that allow to establish transgenic mice 
with predictable, uniform and regulatable expression characteristics. For this purpose 
autoregulated expression modules based on the tet system were used, in which both 
expression of the gene of interest (GOI) and of the transactivator are controlled by 
doxycycline (dox). Since the performance of regulated gene expression is massively 
influenced by neighbouring sequences, the rationale was to characterise randomly tagged loci 
in mES cells by determining tet system regulated reporter activity. Subsequently, these loci 
may be reused by Recombinase Mediated Cassette Exchange (RMCE), a method that 
comprises two basic steps: 1) “Tagging” random loci with a reporter construct and 2) 
“targeting” sites conferring appropriate expression levels of the reporter gene with the GOI. 
Thereby it is possible to reuse a precharacterised locus.
2.1 Overall strategy for screening and reuse of chromosomal loci providing regulated 
expression
The overall strategy is depicted in figure 6. It includes the following steps: first, mES cells are 
transduced with an autoregulated reporter construct that also introduces FRT sites required for 
RMCE and a selection marker. After drug selection for stable integration, mES cell clones 
displaying low basal reporter gene expression and maximum expression levels when induced 
are singled out. Thus, established clones are not only screened for high expression levels but 
also for their ability to support adequate regulation. Appropriately performing clones are 
subsequently screened for the presence of only one copy of the tagging vector. 
Gene expression from a given locus can change during the process of differentiation – it may 
be completely silenced in the transgenic animal or become restricted to certain tissues or cell 
types. Consequently, tagged integration sites have to be further evaluated by in vitro
differentiation and teratoma formation as means to validate clones before generation of 
reporter mice. Finally, transgenic animals are established and analysed.
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Figure 6: Overview strategy
Chromosomal loci in mES cells are randomly tagged with a dox inducible, FRT flanked screening cassette. 
Clones with high and well regulated expression are subjected to diverse differentiation approaches to evaluate 
their behaviour after commitment to mature cell types. ES cell clones characterised by these means are used for 
site specific integration of the GOI into the tagged locus via RMCE. Targeted mES cells can be directly used for 
the rapid generation of transgenic mice circumventing extensive screening procedures, for precharacterised loci 
admit predictable, high and well regulated transgene expression. 
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2.2 Tagging mES cells with an autoregulated, tet-dependent reporter cassette
To identify and retarget appropriate integration sites in mES cells, the pTagTK/NPT screening 
vector (figure 7) was employed which comprises the following elements: 1) firefly luciferase 
as a sensitive reporter controlled by the TetON system in an autoregulated fashion, 2) 
heterologous FRT sites to reuse tagged loci via RMCE and 3) a fusion of thymidine kinase 
(tk) and neomycin phosphotransferase genes (npt) for selection of tagged clones.
FRTwt                                                     FRT5/loxP     loxP
luciferase         Pbi            rtTA         IRES tk npt
amp                     ori
S           P
Figure 7: Schematic view of  the tagging vector pTagTK/NPT
Two separate transcripts are produced from the bidirectional, tet dependent promoter (Pbi): One codes for firefly 
luciferase mutant luc+ and the second comprises the reverse transactivator variant rtTA2(S)-M2 and a fusion of 
the thymidine kinase gene (tk) with the neomycin phosphotransferase gene (npt). Translation of this fusion is 
mediated by the Encephalomyocarditis virus internal ribosombal entry site (IRES). The FRT wild type and 
mutant FRT5 sites are indicated by black and white arrowheads, repectively. 
grey diamonds: wild type loxP sites; amp = ampicillin resistance gene; ori = origin of replication; S = SspI
restriction site; P = PvuI restriction site
Firefly luciferase mutant luc+ (Promega) was chosen for the screening since it is a very 
sensitive reporter. Its expression is controlled by the bidirectional, tet dependent promoter 
(Baron et al., 1995) which at the same time drives expression of the reverse transactivator 
(rtTA; variant rtTA2(S)-M2, Urlinger et al., 2000a) of the tet system (Gossen and Bujard, 
1992). This arrangement of the different components creates a regulatory positive feedback 
loop (figure 8): In the absence of the inducer doxycycline (dox), the tet dependent promoter is 
only marginally active allowing for a certain level of basal expression. When dox is added it 
is bound by the few molecules of rtTA present which will dimerise and bind to the 
bidirectional tet dependent promoter. This initiates transcription of the reporter and rtTA, 
hence promoting and enhancing transcription. The fact that transcription can only be started 
when the cassette is not completely silent without any dox has to be taken into account for the 
design of experiments with this system. 
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luciferase         Pbi            rtTA         IRES tk        npt
A)  no dox
luciferase         Pbi            rtTA         IRES tk        npt
B)  with dox
luciferase         Pbi            rtTA         IRES tk        npt
Figure 8: Autoregulated positive feedback loop
A) In the absence of dox basal activity of the promoter leads to the production a low concentration of rtTA. 
B) When added, dox is bound by rtTA which in turn dimerizes, binds to the promoter and enhances transcription. 
A positive feedback loop is generated because the reverse transactivator triggers production of its own mRNA. 
An Encephalomyocarditis virus (EMCV) internal ribsomal entry site (IRES) mediates 
translation of a fusion of the thymidine kinase gene (tk) with the neomycin 
phosphotransferase gene (npt). Thymidine kinase operates as a negative selection marker: it 
phosphorylates ganciclovir (GCV) which is toxic for the cells as a triphosphate. Npt is a 
positive selection marker for eukaryotic cells for it confers resistance to the selection drug 
G418. A wild type FRT site is placed next to the 3’ end of the luciferase gene while the 
mutant FRT5 site is integrated in frame in-between the tk and the npt part of the fusion. 
The non identical FRTwt and FRT5 sites flank the expression core unit and allow tagging of 
chromosomal loci and their subsequent reuse by RMCE (details for exchange strategy given 
in chapter 2.3). This specific pair of recombination target sites has been shown to work 
efficiently before (e.g. Schucht et al., 2006).
In addition, loxP sites flanking npt allow to remove this selection marker (figure 7). As npt
has been reported to have a negative influence on expression in some cases, this option was 
implemented. Tk expression leads to male sterility in mice (Cesari et al., 2004; Braun et al., 
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1990), but since animals are established without dox (i.e. in the off state) this should not 
impede generation of a mouse line. 
2.2.1 Generation of mES cell clones tagged with pTagTK/NPT
For stable integration into mouse ES cells, pTagTK/NPT plasmid DNA was linearised with a 
restriction enzyme that cuts within or close to the ampicillin resistance gene. The digest left 
bacterial sequences flanking the actual tagging cassette (PvuI: ~850 bp/ SspI: ~470 bp next to 
the FRTwt site and PvuI: ~1,4kb/SspI: ~1,84 kb next to the polyadenylation signal of the 
tk/npt fusion). The bacterial backbone of the vector was not removed to protect the cassette 
from nucleases that would affect the integrity of the tag. 
Low passage IB10 mES cells (subclone of E14 derived from 129/Ola mice; Robanus-
Maandag et al., 1998) were electroporated under different conditions as given in table 1. The 
tagging step was done by electroporation, because this transduction method leads to a relative 
high percentage of cells with a single copy integration and does not interfere with germ line 
competence of the cells. Electroporated cells were induced with dox after one day and put 
under pressure with 0,4 mg/ml G418 two days after electroporation.
Table 1: Conditions for electroporation of mES cells with TagTK/NPT and clones generated
P = DNA purified with phenol 
Q = purification of DNA via Qiagen columns 
N = no purification, heat inactivation and precipitation by ethanol
RT = room temperature; exp.: experiment
In relation to the number of cells subjected to each electroporation very few G418 resistant 
clones could be established. As a positive control a vector expressing npt driven by the 
constitutively active human phosphoglycerate kinase (PGK) promoter was electroporated in 
exp. no. of 
cells
DNA restriction
enzyme
purification 
of DNA
voltage capacity incubation 
cells + DNA
no. of 
clones
1 107 8 µg PvuI P 240 V 475 µF 30 min on ice 
before pulse
9
2 107 33 µg SspI Q 240 V 475 µF 30 min on ice 
before pulse
1
3 107 25 µg SspI N 240 V 475 µF 30 min on ice 
before pulse
12
4 106 10 µg PvuI P 240 V 475 µF 30 min on ice 
before pulse
-
5 107 10 µg PvuI N 250 V 25 µF 30 min on ice 
before pulse
-
6 107 20 µg PvuI N 280 V 475 µF 15 min at RT 
after pulse
80
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parallel with experiments 5 and 6. A significant number of clones could be generated in both 
experiments (54 and > 200 clones, respectively), showing that the applied electroporation and 
selection protocol as such is adequately efficient for the stable transduction of mES cells. The 
low number of clones obtained with pTagTK/NPT possibly indicates a lower transcriptional 
activity of the screening cassette.
2.2.2 Two cell clones show adequate and regulated luciferase expression and contain a 
single copy of pTagTK/NPT
To identify mES cell clones with regulated expression of the reporter cassette, the tagged 
mES cells were examined concerning their luciferase expression levels. Unexpectedly, very 
few clones expressed luciferase after addition of dox as shown in table 2. These clones were 
tested for luciferase activity in the presence and absence of dox (figure 9). All expressing 
clones were found to be regulated. Possible reasons for complete lack of reporter expression 
in the majority (i.e. ~ 94%) of G418 resistant clones will be discussed in chapter 3.2.1.
Table 2: Number of luciferase expressing, G418 resistant clones after induction with dox
G418 resistant clones were expanded, cultivated on gelatinized 6-wells with dox for 4 days 
and checked for luciferase activity. exp.: experiment
exp. no. of luciferase expressing clones/ 
no. of G418 resistant clones
1 2/9
2 0/1
3 0/12
6 4/80
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clone 1.1 clone 1.2 clone 6.1 clone 6.2 clone 6.3 clone 6.4 IB 10 wt
 - dox
 + dox
Figure 9: Regulated luciferase expression in mES cell clones tagged with pTagTK/NPT
Luciferase activity is given in relative light units (rlu)/µg protein; mES cells were cultivated on gelatinised 6-
wells and dox was added for 4d for induced samples. Cells were harvested and checked for luciferase expression 
(details in “Material and Methods”). Clone 1.1 and clone 1.2 were obtained from experiment # 1; clones 6.1 - 6.4 
from experiment # 6. IB10 wt cells were used as a negative control. Their luciferase activity did not exceed 
background levels and was hence set to 1. n = 1
Clones 1.1 and 6.2 displayed the highest luciferase expression and were therefore 
characterised for the number of integrated vector copies. Genomic DNA from each clone was 
digested with EcoRV which cuts within the cassette (figure 10). This enzyme also cuts in the 
genomic DNA next to the inserted vector, thus creating fragments whose length depend on the 
individual integration site. These fragments are detectable by hybridisation to appropriate 
probes, their number reflecting the number of individual integration sites. Sequences from the 
luciferase and npt genes were used as probes for a Southern blot. Both clones 1.1 and 6.2 
displayed only a single band (figure 10). This was confirmed by additional experiments using 
different enzymes and probes (data not shown), proving that clones 1.1 and 6.2 carry a single 
integrated vector molecule. 
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kb
21
5
kb
21
5
clone 1.1      clone 6.2
 probe      probenpt luc+
Figure 10: Single copy integration of pTagTK/NPT in 
clones 1.1 and 6.2
Genomic DNA from both clones was digested with  
(E, two restriction sites close to each other); The  probe 
(1261 bp) was obtained by digestion of pTagTK/NPT with 
 and   and the probe (654 bp) by restriction 
with . Southern Blot was performed as described in 
“Material and Methods”. White lines show start of lanes and 
single bands indicate that a single copy of the tagging vector 
has been integrated into the genomic DNA.
EcoRV
luc+
BstBI SgrAI npt 
BssHI
luciferase         Pbi            rtTA         IRES tk         npt
FRTwt                                                           FRT5
luc+ probe  E      npt probe 
In order to more thoroughly characterise inducible expression, clones 1.1 and 6.2 were 
assayed for their luciferase activity by several independent experiments. Unexpectedly, 
luciferase activity strongly varied in different experiments for both clones although the cells 
had been treated identically. It will be shown later that this reflects an intrinsic property of the 
positive feedback cassette (chapter 2.2.2.2). For convenience, ranges of luciferase expression 
levels will be discussed and possible reasons for variations will be outlined in chapter 3.2.2.
In the following, clones 1.1 and 6.2 were characterised in detail concerning the time that is 
needed to reach complete induction and repression after addition or depletion of dox, 
respectively.  Inducibility of the clones is measured by the regulation factor (expression levels 
in the induced state vs. basal expression), that gives information about how manifold 
expression of the transgene can be increased. In addition, autoregulated as well as constitutive 
luciferase expression from the ROSA26  locus was examined as a reference. 
2.2.2.1 pTagTK/NPT supports fast induction and repression of autoregulated 
expression in clones 1.1 and 6.2
A prominent advantage of the tet system in contrast to other conditional gene expression 
techniques (e.g. induction of a gene by cre mediated removal of a stop cassette in front of the 
transcriptional start) is its reversibility. Gene expression in the tet on system is strictly 
dependent on the presence of the inducer and can be switched off again by depletion of the 
same. To determine the time required for induction/repression, luciferase levels of clones 1.1 
and 6.2 were measured at different timepoints after addition/depletion of dox (switch on and 
switch off, respectively; figures 11 and 12). 
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Figure 11: Switch on kinetics of luciferase expression for clones 1.1 and 6.2 
Cell were cultured on gelatinised 6-wells. Samples were harvested at the indicated time points after addition of 
dox and luciferase levels were determined. rlu = relative light units; n = 2 
As mentioned above, luciferase levels strongly vary in both clones. So, to determine the time 
the clones need to reach highest expression levels after induction, the first peak of each 
switch-on curve is considered as maximum.
When switched on clone 1.1 already reached the highest luciferase activity after 1d of 
induction. Clone 6.2 showed maximal expression after 2d when induced by dox. However, the 
measured luciferase level after 1d already amounted to 72% of the maximum and  the values 
after 3 and 7 days were again lower than that after 2d.
Thus, in both clones induction is accomplished within 1 – 2d.
swit ch o f f  clo ne 1.1
128699
978591255
12563
0
20000
40000
60000
80000
100000
120000
140000
d0 d1 d2 d3 d7
switch off clone 6.2
5443
633
108 48 37
0
1000
2000
3000
4000
5000
6000
d0 d1 d2 d3 d7
Figure 12 : Switch off kinetics of luciferase expression for clones 1.1 and 6.2 
Cell were cultured in the presence of dox for 4d. They were then seeded to gelatinised 6-wells while dox was 
removed. Samples were harvested at the indicated time points after depletion of dox and luciferase levels were 
determined. rlu = relative light units; n = 2 
In clone 1.1 luciferase expression was efficiently shut off after removal of dox (switch off).
After 24 hours expression was already reduced to ~ 10% of the initial level and 2d later it was 
only slightly above basal expression. An almost identical induction/repression kinetic was 
observed for clone 6.2: luciferase activity was decreased to approximatly 12% after 24 h and 
basal expression level was reached after 2d. The fact that the shut down of expression is 
slower than induction of the system can be explained by the longer time that is needed for 
clearance of dox from the cells and for degradation of luciferase. These results show that the 
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tet on system is a useful tool for regulating gene expression that allows for a fast induction 
and suppression of the transgene.
2.2.2.2 Performance of clones 1.1 and 6.2 in comparison to expression from the 
ROSA26 locus
As indicated before, the autoregulated cassette in clones 1.1 and 6.2 is characterised by a 
significant fluctuation of expression. To exclude that this is a specific feature of the randomly 
obtained, unknown chromosomal integration sites, clones 1.1 and 6.2 were compared to 
ROSAautoLuc cells. In these cells a similar cassette had been integrated into the ROSA26 
locus (figure 13), which is open in mES cells and in differentiated cells (Friedrich and 
Soriano, 1991; Zambrowicz et al., 1997). As a control mES cells with luciferase 
constitutively expressed from the ROSA26 promoter were checked (termed ROSAEMLuc, 
figure 13). To evaluate the performance of the autoregulated cassette in the 3 different 
integration sites multiple experiments were performed to determine the level of luciferase 
expression and its fluctuations. Ranges of luciferase expressions, mean values and average 
regulation factors from multiple experiments are summed up in table 3.
exon 1             luciferase         Pbi            rtTA         IRES     npt
ROSA 26
exon 1             luciferase            IRES npt
ROSA 26            SA
ROSAautoLuc
ROSAEMLuc
SD
Figure 13: Schemes of an autoregulated and a constitutive cassette integrated in ROSA26
ROSAautoLuc ES cells carry a cassette similar to pTagTK/NPT which is integrated in the ubiquitously 
expressed ROSA26 locus. ROSAEMLuc cells in contrast express luciferase under the control of the 
constitutively active ROSA26 promoter. Both cell lines were generated by U. Sandhu and S. Bantner (described 
in detail in “Material and Methods”) Pbi = tet dependent, bidirectional promoter; rtTA = reverse transactivator of 
the tet system, mutant rtTA2(S)-M2, IRES = Encephalomyocarditis virus internal ribosomal entry site, npt = 
neomycin phosphotransferase gene, SD = splice donor, SA = splice acceptor; black and white arrowheads: 
FRTwt and FRT5 sites, respectively 
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Table 3: Range of luciferase expression levels and regulation factors observed for clones 1.1, 6.2,  
ROSAautoLuc, and ROSAEMLuc
Values from kinetics experiments were included: induced = induced for 24 h or more, non induced = absence of 
dox for 72h or longer; ROSAEMLuc was only checked in the absence of dox; s.d.  = standard deviations from 
average values, n = number of independent assays, RF = regulation factor, mean value induced state/mean value 
basal level
uninduced [rlu/µg protein] induced [rlu/µg protein]
min max average s.d. min max average s.d. 
average
RF
clone 1.1 97 891 441
n  = 20
78 % 2203 179913 47642
n  = 34
94 % 108
clone 6.2 4 116 53
n  = 20
66 % 175 6923 3347
n  = 34
67 % 63
ROSAautoLuc 17 4144 1195
n  = 5
144 % 381 14378 5263
n  = 34
92 % 4
ROSAEMLuc
(constitutive 
expression)
358761 889920 633836
n  = 66
15 % --- --- --- --- ---
Standard deviations of mean values for autoregulated expression are extremely high  (66% 
and more). In contrast, constitutive luciferase expression under control of the ROSA26 
promoter deviates to 15%. Strong variations in luciferase activity are most likely associated to 
the design of the expression cassette, since they occur in three independent integration sites. 
Comparing mean luciferase levels in the induced state, clone 1.1 performs best (~ 9 times 
higher expression than ROSAautoLuc) while clone 6.2 shows half as much reporter activity 
as ROSAautoLuc. All three autoregulated clones display a certain basal activity, which 
amounts to 1% of average induced levels for clone 1.1, 1,6% for clone 6.2 and 22,7% for 
ROSAautoLuc. As a result of high basal activity ROSAautoLuc can apparently only be 
induced 4 fold. However, sample size for the uninduced state of ROSAautoLuc was 
comparatively small, so that this value might not be statistically relevant. Clone 6.2 has an 
average regulation factor of 63 and clone 1.1 can even be induced by two orders of 
magnitude. Switch on and switch off kinetics of ROSAautoLuc were comparable to that of 
clones 1.1. and 6.2 (data not shown).
On the whole, clone 6.2 shows less luciferase expression in the induced state than 
ROSAautoLuc, but its basal expression is much lower and its regulation factor consequently 
higher. In addition, mean values in absence/presence of dox indicate that the integration site 
of clone 1.1 is clearly superior to ROSA26 on mES cell level.
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2.2.3 Evaluation of clones 1.1 and 6.2 in the differentiated state
Chromatin structures in mES cells are considered to be open as many genes are expressed in 
the pluripotent state. Transcription activity fundamentally changes during differentiation to 
mature cells and a multitude of loci are silenced. This affects not only endogenous genes but 
also randomly integrated transgenes. Accordingly, when establishing a transgenic mouse line 
there is a certain probability that the GOI is silenced completely or shows a heterogeneous
expression pattern throughout the animal depending on the nature of its integration site(s). 
Due to unpredictable expression levels of the GOI after differentiation the standard protocol 
requires generation of more than one mouse line from ES cell clones with different integration 
sites. 
To evaluate the expression characteristics of the tagged sites in clones 1.1 and 6.2 the next 
step of this work was to determine luciferase expression of both clones in the differentiated 
state. For this purpose several techniques were applied: (1) in vitro differentiation of the ES 
cells, (2) injection of ES cell clones into blastocysts and analysis of mouse embryonic 
fibroblasts (MEFs) from chimaeric embryos, (3) teratoma formation in immunosuppressed 
recipients and (4) analysis of transgenic mice themselves (chapters 2.4.1.2, 2.4.1.3). 
2.2.3.1 Clones 1.1 and 6.2 maintain regulated luciferase expression after in vitro
differentiation
mES cells were differentiated in vitro as described in “Material and Methods”. In short,  the 
cells were kept in suspension culture in the absence of LIF for the formation of embryoid 
bodies (EBs). After 5 days EBs were collected and seeded to gelatinised culture dishes where 
they were allowed to further differentiate for 4 more days. The cells were then harvested, split 
and kept for 4d in the presence/absence of dox. This differentiation protocol does not direct 
the cells to specific lineages but should result in a pool of randomly differentiated progenitors 
of different cell types. Results of these experiments are given in figure 14. Switch on and 
switch off kinetics were not followed in this case because the number of cells obtained was 
not sufficient.
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Figure 14: Luciferase expression levels of clones 1.1 and 6.2 before/ after in vitro differentiation
Differentiated cells were harvested after 4d in the presence/absence of dox. ES = mean values of ES cell state 
(sample size uninduced state: n = 20/induced state: n = 34 as given in table 3);  ivd = in vitro differentiation; A, 
B, C = independent experiments (sample size uninduced/induced: A: 3/3, B: 6/6, C: 6/6, clone 6.2 ivd: 3/3); IB 
10 wt cells were used as a negative control (ES cell state n = 6/6, ivd n = 6/6)
Luciferase expressions after differentiation of clones 1.1. and 6.2 lie within the ranges for the 
mES cell state indicated in table 3 (except uninduced state of in vitro differentiation 
experiment A with clone 1.1). Although values in the induced state are lower than the average 
of mES cells, it can be concluded that luciferase expression is not significantly silenced after 
in vitro differentiation. Also, regulation of expression is maintained. Variations between 
different experiments (experiments A-C with clone 1.1) may be due to the fluctuations of 
expression as observed for mES cells. Another possible cause might be changing 
contributions of different progenitor cell types to each differentiation cell pool.
2.2.3.2 Mouse embryonic fibroblasts (MEFs) isolated from chimaeric embryos derived 
from clone 6.2 show increased, regulated reporter gene expression
In order to gain more insight into the expression characteristics of clones 1.1 and 6.2 after 
differentiation, mES cells were injected into blastocysts and embryos were harvested at day 
13,5. MEFs isolated were selected with G418 in the presence of dox to purify transgenic cells 
from chimaeric embryos. Resistant cells were subsequently analysed concerning luciferase 
rl
u/
µ
g
pr
ot
ei
n
controls
2 Results
35
expression. Table 4 gives information about the total number of embryos isolated and the 
percentage of embryos with G418 resistant cells, i.e. chimaeric embryos. 
Table 4: Analysis of injected embryos for transgenesis
clone 1.1 clone 6.2
total number of embryos analysed 48 44
embryos yielding G418 resistant cells - 10
No transgenic MEFs could be generated after injection of clone 1.1, which could have two 
reasons: either injection of mES into blastocysts cells was not efficient and no chimaeric 
embryos were present or the tagging cassette was not expressed in MEFs leading to loss of 
resistance to drug selection. The latter case would contradict the results obtained after in vitro
differentiation and it cannot be ruled out at this point that ES cell injection of clone 1.1 into 
blastocysts completely failed. Since it was possible to generate chimaeric animals for 
establishing transgenic mice from this clone in a separate experiment (chapter 2.4.1.1), 
blastocyst injections of clone 1.1 to analyse chimaeric embryos were not repeated.
G418 resistant MEFs derived from clone 6.2 were analysed for their luciferase expression 
(figure 15).
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Figure 15: Luciferase expression in MEFs isolated from chimaeric embryos after injection of clone 6.2 
Isolated MEFs were selected with G418 in the presence of dox for 10 days (controls dead), seeded to 6-wells and 
kept with/without dox for 6d; n = 3; emb. 11 G418 s = unselected MEFs from a G418 sensitive embryo; clone 
6.2 ES = average values of mES cells, n = 20/34
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In all cases expression was strongly increased in MEFs as compared to the mES cell state, the 
average of induced MEFs being more than 50fold higher than the mean readout observed for 
clone 6.2 mES cells. Also, basal expression levels increased and mostly even reached or 
exceeded mean induced state levels of mES cells. This results in a relatively small regulation 
factor that averages 37 which is lower than that observed for mES cells. On the whole, 
luciferase activities in MEFs isolated from different embryos were quite homogeneous and 
while overall expression levels were at least 15 times increased for the uninduced state and 5 
times for the induced state (lowest MEF value/highest mES value), regulation was maintained 
to a significant level. Lack of strong variations of luciferase expression in MEFs could be 
explained by the fact that only a single experiment was performed. Still, expression levels of 
MEF pools from individual embryos were interestingly homogeneous.
2.2.3.3  Teratomas derived from clones 1.1 and 6.2 show luciferase expression
Another approach to compare performance of transgenic mES cells before and after 
differentiation is injecting them subcutaneously into isogenic or immunodeficient mice and 
examining the resulting tumors (i.e. teratocarcinomas, teratomas; e.g. described in Lange et 
al., 2000, Bonner et al., 2004). mES cells are pluripotent and randomly differentiate into cell 
types of all three germ layers in the “in vivo” environment of the recipient mouse.
Clone 1.1. and clone 6.2 ES cells were injected subcutaneously into immunodeficient Rag-2/ 
?????????????????????????????????????????????????????????????????????????????????????????????
Methods”; model first described by Mazurier et al., 1999). As a negative control, IB10 wt 
cells were injected and mES cells constitutively expressing luciferase driven by the ROSA26 
promoter served as a positive control (ROSAEMLuc). After 4 weeks teratomas had formed in 
some of the transplanted mice, but not in all (details and limitations concerning the technique 
of teratoma induction will be discussed in “Material and Methods”). Mice bearing tumors 
were then kept with/without dox administered via drinking water (2mg/ml as described by 
Kistner et al., 1996).  Table 5 gives an overview about the animals that had developed tumors 
and the applied induction protocol. Luciferase intensity emitted from the teratomas was 
determined by in vivo bioluminescent imaging (BLI) with a Xenogen IVIS 200 system. 
Briefly, mice were anaesthetised, depilated and after i.p. injection of luciferin emission of 
light was measured. Individual tumors grew with different growth rates, so that only 
qualitative analysis of luciferase expression after differentiation was possible.  
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Table 5: Overview of mice bearing teratomas and treatment with dox
Animal #2 had to be killed due to tumor size. 
mouse no. left side right side  administration of dox
1 - IB10 wt 8 d –dox ; 4 d + dox
2 - ROSAEMLuc 8 d –dox; killed
3 clone 1.1 - 8 d +dox ; 4 d –dox
4 clone 1.1 - 8 d –dox ; 4 d + dox
5 clone 1.1 ROSAEMLuc 8 d +dox ; 3 d –dox
6 clone 6.2 ROSAEMLuc 8 d -dox ; 3 d +dox
1) -/IB10                                                    2) -/R
-dox                4d +dox                                           -dox
et: 2 min              2 min                                              30 s
3) 1.1/-                          4) 1.1/-
  8d +dox        4d -dox               -dox              4d +dox
et: 2 min        2 min                                     2 min 2 min
  8d +dox             3d -dox                   -dox              3d +dox
et: 2 min               30 s                                      30 s       2 min
5) 1.1/R                                  6) 6.2/R
Figure 16: In vivo bioluminescent imaging of mice bearing teratoma
Mice were administered 2mg/ml dox in the drinking water as indicated in table 5. For in vivo bioluminescent 
imaging they were anaesthetised with 2-2,5% isoflurane (Isoflo, Abbott), treated with depilatory cream and 
injected i.p. with 100µl of luciferin (30mg/ml in PBS; Synchem OHG). They were put into the Xenogen IVIS 
200 imaging chamber and luciferase activity was measured under constant inflow of isoflurane via nose cones. 
Rainbow scales indicate number of photons measured per second x cm2 x steradian. Imaging conditions: field of 
view: 19.6; binning: medium, aperture: f1, et = exposure time, given for each image. Exposition time had to be 
reduced from 2 min to 30 s when signal intensity was too strong. White arrows indicate positions of tumors 
when these do not emit any signal. Numbers of panels and animals are identical and the source of teratomas is 
indicated as follows: IB10 = tumor derived from IB10 wt, R = tumor derived from ROSAEMLuc, 1.1 = tumor 
derived from clone 1.1, 6.2 tumor derived from clone 6.2, - = no tumor
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Controls
The IB10 tumor (mouse 1) did not give any signal both in the absence and presence of dox as
expected (figure 16 panel 1) Mice injected with ROSAEMLuc cells showed very high 
luciferase activity from these teratomas (figure 16 panels 2, 5 and 6, right side). Differences in 
signal intensity were due to varying tumor sizes. 
Clone 1.1
The three tumors derived from clone 1.1 behaved inconsistently when assayed for luciferase 
expression. Mouse 4 showed no basal expression and could be induced by application of dox 
(figure 16 panel 4). Unexpectedly, animal 3 only gave a very faint signal after removal of the 
inducer (figure 16 panel 3). Mouse 5 did not display any luciferase expression from the clone 
1.1 tumor (figure 16 panel 5). However, this might be due to the very intensive signal from 
the ROSAEMLuc control tumor which could decrase sensitivity so that a potential weak 
signal from the clone 1.1 teratoma might not be detectable (note that exposition time had to be 
decreased from 2 min to 30 s for the second image of panel 5). 
Clone 6.2
Without dox, no basal expression could be observed for the clone 6.2 teratoma of mouse 6 
(figure 16 panel 6). After three days of dox administration, a clear signal could be deteced 
(note decrease of exposition time to 30s instead of 2min), indicating that autoregulated 
expression is well inducible after differentiation of cells.
Both clones 1.1 and 6.2 show expression of luciferase after differentiation of mES cells by 
teratoma formation. Regulation is maintained in the case of clone 6.2 as judged by mouse 6. 
Expression of differentiated clone 1.1 cells seems to be heterogeneous and not reliably 
regulated. A possible reason for this could be restriction of expression to a certain tissue or 
cell type due to the chromosomal integration site of the cassette. Varying contributions of 
differentiated lineages in each tumor would then lead to heterogeneous expression. The results 
obtained after teratoma formation will be discussed later in context with the data obtained 
from transgenic mice (chapters 3.2.3, 3.3.1).  
Taking together the results from all differentiation approaches it can be concluded that both 
clone 1.1 and 6.2 maintained luciferase expression after in vitro and in vivo (MEFs, teratoma) 
differentiation. While clone 6.2 was still well regulated by addition/depletion of dox in all 
2 Results
39
performed assays, regulation of clone 1.1 was accomplished in vitro whereas it was 
ambiguous in teratomas.   
2.3 Targeting mES cells via Flp mediated recombination
The applied strategy was designed to specifically reuse a defined locus that is tagged by 
recombination target sites. While expression of randomly integrated transgenes is 
heterogeneous and strongly depends on their integration sites, this method can provide 
predictable expression characteristics of the site specifically integrated GOI. To show that the 
tagged loci of clones 1.1 and 6.2 can be reused via RMCE, targeting of both cell lines was 
followed.
Cells with stably integrated pTagTK/NPT are resistant to G418 and sensitive to GCV in the 
presence of dox. For exchange of the reporter cassette a targeting vector and a Flp 
recombinase expression plasmid are cotransfected into the cells. Flp recombinase mediates 
recombination between identical FRT sites so that the FRT wild type and mutant 5 sites from 
the tagged locus will only interact with their respective counterparts in the targeting vector. 
The incoming cassette eliminates the tk reading frame and provides a functional start codon 
for the truncated npt, leaving targeted clones resistant to both GCV and G418. Accordingly, 
cells are selected with both drugs after cotransfection of targeting and Flp recombinase 
vectors (figure 17). 
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luciferase          Pbi            rtTA          IRES
FRTwt                                                           FRT5          
pAutoTar
selection with 
GCV and G418
FRTwt                                                           FRT5      
ATG
Flpe
parental locus
GCV sensitive
G418 resistant
luciferase          Pbi            rtTA         IRES          ∆ npt
FRTwt                                                           FRT5          
ATG
targeted locus
GCV resistant
G418 resistant 
luciferase          Pbi            rtTA          IRES tk          npt
Figure 17: pTagTK/NPT cassette exchange strategy
Flpe expression and targeting plasmids are cotransduced into cells with the FRT tagged locus. Flpe mediates 
recombination between homotypic sites thus exchanging the cassettes. Selection with GCV and G418 in 
presence of dox recovers only correctly targeted clones. 
Pbi: bidirectional, tet dependent promoter; rtTA: reverse transactivator variant rtTA2(S)-M2; tk/npt: fusion of the 
thymidine kinase gene with the neomycin phosphotransferase gene; IRES: Encephalomyocarditis virus internal 
ribosombal entry site; FRTwt and  FRT5 sites are indicated by black and white arrowheads, repectively. 
Sustained G418 pressure forces the cells to consistently express npt. This should exclude 
resistance by simple inactivation of tk. To evaluate the necessity of retained G418 pressure in 
addition to GCV selection, a growth assay under different selection conditions with clone 1.1 
and IB10 wt cells was performed (data not shown). The results indeed showed that eradication 
of dox induced pTagTK/NPT bearing cells by GCV was accomplished in the presence of 
G418 but insufficient in its absence. IB10 wt cells were not affected by the GCV 
concentrations applied as expected. 
Thus, for later targeting experiments cells were selected in presence of all three drugs since 
this regimen reliably kills all cells carrying the parental construct. Clone 6.2 was treated in the 
same way as it was expected to behave identical to clone 1.1 with respect to its selection 
properties.
2.3.1 Attempts to target clones 1.1 and 6.2
Targeting, i.e. specific exchange of the FRT flanked sequence for a new cassette, is routinely 
performed by cotransfection of the targeting plasmid itself along with a Flp recombinase 
expression vector (e.g. Seibler et al., 1997). Although various transfection methods, selection 
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regimens and targeting vectors were applied in a multitude of experiments, it was impossible 
to target either clone 1.1 or clone 6.2.
Efficiency of RMCE is influenced by multiple parameters that include a) integrity of FRT 
sites, b) transfection efficiency, c) design of the targeting plasmids, d) adequate Flpe 
expression levels and e) appropriate selection protocols. These issues will be discussed in the 
following paragraphs.
a) Integrity of FRT sites is essential for efficient cassette exchange. Sequencing of FRT 
sites in pTagTK/NPT plasmid DNA revealed that both wild type and mutant 
sequences are intact. To exclude the possibility that FRT sites were mutated or lost 
during integration into chromosomal DNA, genomic DNA of clone 6.2 was used to 
amplify the regions surrounding these sites (data not shown). Resulting PCR 
fragments were purified and sequenced with appropriate primers. This confirmed that 
also in clone 6.2 both FRT sites are unimpaired. FRT sites of clone 1.1 were not 
examined.
b) For cotransduction of targeting and Flpe expression plasmids various electroporation 
and transfection protocols were applied (for electroporation view e.g. Liu et al., 
2006b; Cobellis et al., 2005; transfection reagents applied: FuGENE6, Roche; 
Lipofectamine2000, Invitrogen). These protocols had been successfully used to target 
the ROSA26 locus by RMCE, albeit in combination with a different selection strategy 
that will be delineated later. Although clones 1.1 and 6.2 were transfected under 
identical conditons as the ROSA26 FRT tagged clone, targeting was not succesful. As 
a definite proof that DNA was properly delivered to the cells, eGFP and DsRed 
expression vectors were cotransfected using Lipofectamine 2000 and transfection 
efficiency was determined by FACS analysis. Both plasmids are sufficiently expressed 
in transfected cells and more than 15% of all cells had taken up both vectors (data not 
shown). Consequently, transfection efficiency is not the limiting step for targeting 
clones 1.1 and 6.2.
       c) Initially, the vector pAutoTar was used for targeting attempts (figure 18), which is 
composed of the same features as the tagging vector except that the tk gene is missing 
and a startcodon is included to conserve npt expression. Targeting with pAutoTar 
would hence allow to directly compare luciferase expression levels and regulation 
before and after cassette exchange. However, as first targeting experiments did not 
yield any clones the strategy was changed to transfecting simpler constructs that are 
not dox dependent but constitutively expressed. When targeting attempts with the 
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plasmid pFCL3ETKNF5 did not work out, a non site specific selection approach was 
applied using the plasmid pFCL3EPF5 which renders targeted cells resistant to 
puromycin. Of course, also random integration of the cassette will result in resistant
clones. Cobellis et al. (2005) showed that 2 out of 30 clones were correctly targeted 
using non site specific selection after RMCE while Masui et al. (2005) even observed 
an efficiency of 50%. In this case, random integration scarcely took place: only 6 
puromycin resistant subclones of clone 1.1 and 7 of clone 6.2 could be generated from 
several different experiments, using 3,3x106 and 3,5x106 cells on the whole. After 
analysis by PCR or Southern blot all these clones turned out to be established solely 
by random integration of the targeting vector but not from correct targeting events 
(data not shown). 
luciferase          Pbi            rtTA         IRES tk        npt
A) parental locus
luciferase         Pbi            rtTA         IRES
B) pAutoTar ATG
PC  luciferase           IRES   
C) pFCL3ETKNF5                                            ATG
D) pFCL3EPF5
FRTwt                                                           FRT5
PC  luciferase           IRES         pac   
Figure 18: Schematic view of pTagTK/NPT tagged locus and targeting vectors
A) Schematic view of the tagged locus B) Autoregulated, tet dependent targeting cassette C) Constitutively 
active targeting cassette for site specific selection via loss of tk D) Constitutively active targeting cassette for non 
site specific selection by puromycin; black and white arrowheads: FRTwt and  FRT5 sites, respectively;  Pbi: 
bidirectional, tet dependent promoter; rtTA: reverse transactivator variant rtTA2(S)-M2; tk/npt: fusion of the 
thymidine kinase gene with the neomycin phosphotransferase gene; IRES: Encephalomyocarditis virus internal 
ribosombal entry site; PC: CAGGS promoter (Araki et al., 1997); pac: puromycin acetyl transferase gene
d) Efficient targeting is dependent on the activity of the Flpe recombinase. To drive Flpe 
expression the CAGGS promoter (Araki et al., 1997) was used, which works well in 
particular for mES cells (Schaft et al., 2001). To enforce Flpe expression the so called 
“puro shock” method was tested: the Flpe vector contains an IRES - puromycinacetyl 
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transferase (pac) element. After transfection, puromycin is added for two days which 
forces the cells to transiently express pac and also Flpe. As transient Flpe expression 
did not yield targeting, clones 1.1 and 6.2 were transfected with the above described 
Flpe-puro vector and selected with puromycin. 4 stably Flpe expressing subclones 
were randomly chosen for each clone 1.1 and 6.2 and transfected with the targeting 
vector. However, targeting also failed when Flpe was constantly present. 
In principle, FRTwt and FRT5 sites should not interact as they are not identical. If 
there still was a certain level of recombination between these sites, excision of the 
sequence flanked by them could occur leading to loss of G418 resistance. To exclude 
this, a Southern blot was performed showing that for all 8 subclones the cassette was 
kept intact even if Flpe was stably expressed (data not shown). 
2.3.1.1 TK/NPT selection strategy for targeting
Site specific selection was performed by induction with dox 24h after transfection and 
addition of GCV and G418 at least another day later to ensure sufficient tk and npt expression 
levels. Resistance to GCV is dependent on the absence of TK protein; hence, complete 
degradation of the protein in targeted subclones is a prerequisite for successful selection. 
Taking this into account selection with GCV was started 4 to 6d after transfection in some 
experiments. 
Another critical factor is the so called “bystander effect”, i.e. non targeted cells in close 
proximity to targeted subclones lead to cell death of these correctly exchanged cells. To avoid 
this, cells were seeded sparsely on dishes with feeder cells prior to selection.
Transfection for targeting was performed both with and without dox in several experiments. 
On the one hand, induction by dox and transcription should open the chromatin structure and 
might make it more accessible for Flpe and the targeting plasmid. On the other hand, the 
transcriptional apparatus and the whole process of transcription might block the FRT tagged 
site for targeting. Both approaches were not successful, though.
Since all the potential causes of defect described above could be excluded, lack of targeting in 
clones 1.1 and 6.2 could be either due to integration sites which are refractory to RMCE or to 
an extremely low efficiency of the applied exchange strategy in mES cells. The fact that both 
clones readily express luciferase upon induction indicates that the tagged loci are principally 
accessible for modifications and hence dismisses the first possibility. As pac requires higher 
expression levels to mediate resistance to puromycin than npt to detoxify G418, relatively low 
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expression from both loci might be the cause for failure of the non site specific selection 
exchange strategy as described by Cobellis et al. (2005). Accordingly, an alternative tag and 
target strategy described below was pursued.
2.3.2 Efficient targeting of ES cell clones with the PAC/∆NPT selection strategy
It was assumed that the design of the selection strategy contributed to the failure of targeting 
clones 1.1 and 6.2. Thus, an alternative selection strategy that had succeeded in targeting the 
ROSA26 locus was employed for tagging and targeting of random loci. This strategy involves 
selection for puromycin resistance in the tagging step and site specific complementation of an 
ATG deficient npt gene after targeting. Hence, a new tagging construct (pTagPAC/∆NPT) 
was developed and used for tagging IB10 mES cells (new tag and target strategy depicted in 
(figure 19). 
A) pTagPAC/ NPT∆
luciferase          Pbi            rtTA         IRES pac            ∆ npt
FRTwt                                                           FRT5      loxP    
amp                     ori
S                                                               B
126 bp420 bp
luciferase          Pbi            rtTA         IRES
FRTwt                                                           FRT5          pAutoTar
selection with G418
luciferase          Pbi            rtTA         IRES pac            ∆ npt
FRTwt                                                           FRT5      
ATG
Flpe
parental locus
puromycin 
resistant
G418 sensitive
luciferase          Pbi            rtTA         IRES          ∆ npt
FRTwt                                                           FRT5          
ATG
targeted locus
puromycin sensitive
G418 resistant 
B) pTagPAC/NPT cassette exchange strategy
Figure 19: new tag and target strategy with pTagPAC/∆NPT 
A) Scheme of pTagPAC/∆NPT which mediates puromycin resistance in the presence of dox; ∆NPT is not 
functional. B) Targeting of the parental locus renders cells G418 resistant and puromycin sensitive. Pbi: 
bidirectional, tet dependent promoter; rtTA: reverse transactivator variant rtTA2(S)-M2; pac: puromycin 
acetyltransferase gene; ∆npt: truncated neomycin phosphotransferase gene; IRES: Encephalomyocarditis virus 
internal ribosombal entry site; FRTwt and  FRT5 sites are indicated by black and white arrowheads, repectively. 
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2.3.2.1 Generation of  ES cell clones tagged with pTagPAC/∆NPT
pTagPAC/∆NPT plasmid DNA was linearised following two different approaches: digestion 
with BstZ17I alone linearised the vector in the backbone while double digestion using BstZ17I
and SspI removed a large part of potentially unfavourable bacterial sequences (figure 19). 
Linearised DNA was electroporated into IB10 mES cells as indicated in table 6. 
Table 6: Conditions for electroporation of mES cells with pTagPAC/∆NPT and clones generated 
Experiments 3 and 4 were performed with the Microporator technology from Peqlab using 100µl  
electroporation tips. Cells were cultivated with dox 24h after electroporation and 1 µg/ml puromycin was added 
to the media another day later. Clones were picked after 14  and 16d of selection (plates I + II and plate III, 
respectively).
exp. no. of 
cells
DNA restriction
enzyme
purification 
of DNA
voltage pulse 
width
pulse 
number
no. of 
clones
3 5x106 100 µg BstZ17I P 1350 V 20 ms 2 44
4 5x106 100 µg BstZ17I +
SspI
P 1350 V 20 ms 2 157
P= DNA purified with phenol 
N = no purification, heat inactivation and precipitation by ethanol
RT = room temperature
ms = milliseconds
Numbers of resistant clones could be significantly increased by using an adapted 
electroporation protocol for the transduction of pTagPAC/∆NPT that probably causes less cell 
death. Thus, a larger amount of clones was available for screenings.
To identify luciferase expressing clones, puromycin resistant cells were grown with dox on 
gelatinised microtiter plates to confluence. These plates were then imaged with the Xenogen 
IVIS 200 system as depicted in figure 20. 
exp. no. of 
cells
DNA restriction
enzyme
purification 
of DNA
voltage capacity incubation 
cells + DNA
no. of 
clones
1 5x106 45µg BstZ17I N 280 V 475 µF 15 min at RT 
after pulse
-
2 5x106 45µg BstZ17I +
SspI
N 280 V 475 µF 15 min at RT 
after pulse
-
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Figure 20: Evaluation of luciferase activity in pTagPAC/∆NPT tagged clones
Clones were grown on gelatinised microtiter plates and induced with dox for 3 days. For bioluminescence 
imaging the medium was removed, cells were washed once with PBS and 50µl of luciferin/ATP reaction buffer  
were added to each well (described in detail in “Material and Methods”). Plates were imaged under the following 
conditions: field of view: 13; binning: medium for A and B, small for C; aperture: f1, exposure time: 20 s for A 
and B, 1 s for C. Empty wells are marked by an “x” or a white line. As a positive control, the ROSAEMluc clone 
constitutively expressing luciferase under control of the ROSA26 promoter was cocultured (indicated by +). 
Clones that were selected for targeting experiments are designated by a white circle. Clones carrying 
pTpagPAC/∆NPT digested with BstZ17I: plate I A1-C12, plate III A1 – B6; clones tagged with double digested 
pTagPAC/∆NPT (BstZ17I + SspI): plate I D1 – H12, plate II A1 – E11, plate III B7 – E12 (~20 small clones 
from this electroporation were not picked). 
In line with the results from clones tagged with pTagTK/NPT, most pTagPAC/∆NPT clones 
again did not express luciferase although they were resistant to the respective selection drug 
in the presence of dox. However, while only 6% (6/102) of pTagTK/NPT tagged clones 
showed luciferase activity, approximately 20% of the 201 pTagPAC/∆NPT clones gave a 
clear signal. Possible reasons for the relatively low percentage of luciferase expressing clones 
among drug resistant cells will be discussed in detail in chapter 3.2.1. 
To evaluate the new RMCE selection strategy, 7 inducible pTagPAC/∆NPT tagged clones 
were chosen as indicated in figure 20 for targeting experiments. The number of integrated 
copies was not determined beforehand because of time constraints.
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2.3.2.2 Successful targeting of 5 independent pTagPAC/∆NPT tagged clones 
Clones IA5, IA10, IB3, IE4, IF1, IH4 and IIIC5 were cotransfected with Flpe expression and  
targeting plasmids. Transfection conditions and numbers of G418 resistant clones obtained 
after selection are given in table 7. The targeting plasmid pAutoTar had the same 
autoregulated arrangement of components as the tagging vector so that expression levels 
before and after targeting were directly comparable (figure 19).
Table 7: Transfection of pTagPAC/∆NPT tagged clones for targeting and number clones obtained after 
selection
5x105 cells of each clone were seeded to gelatinised 6-wells and cotransfected with 2,5 µg pCflpe and 1,5 µg 
pAutoTar using 7 µl of Lipofectamine 2000 (Invitrogen) transfection reagent as recommended by the 
manufacturer. Cells were transferred to feeder coated 10cm dishes and dox was added 24 h after transfection. 0,4 
mg/ml G418 were added another 24h later. Colonies were counted and if possible 4 subclones each were picked 
after 12 days of selection.
parental clone number of G418r subclones
IA5 ~ 440
IA10 -
IB3 112
IE4 -
IF1 ~ 230
IH4 ~ 140
IIIC5 ~ 270
All tagged clones except IA10 and IE4 yielded significant numbers of G418 resistant 
subclones. 4 subclones each were analysed for correct targeting by PCR as shown in figure 
21.
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 A  B 1  2  3  4   A B  1  2  3  4    
IA5                        IB3
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2 kb
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800 bp
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  A  1  2  3  4   A 1  2  3 4   A  1 
IA5                  IB3           IF1
 2  3  4  A  1   2  3 4   A  1  2  3
IF1             IH4              IIIC5
   4      ESwt
400 bp
1,5 kb
2 kb2 kb
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1,5 kb
2) PCR A with primers P1 and P3
3) PCR A with primers P1 and P3; PCR B with primers P2 and P3
200 bp
400 bp
200 bp
400 bp
200 bp
400 bp
200 bp
1) Primer binding sites and expected fragment sizes
H O  2
luciferase          Pbi            rtTA         IRES pac            ∆ npt
FRTwt                                                           FRT5          
luciferase          Pbi            rtTA         IRES          ∆ npt
FRTwt                                                           FRT5          
ATG
P1                      P2       P3
P1              P3
parental locus
targeted locus
Figure 21: PCR analysis of G418 resistant subclones 
Cells were cultured on gelatinised 96-wells, genomic DNA was harvested and PCR performed with 3µl of this 
template as described in “Material and Methods”. 
1)aSchemes of parental and targeted locus with primer binding sites (not true to scale); the table gives 
information about expected fragment sizes for each primer combination and locus configuration. 2) PCR A with 
parental clones (indicated with “A”) and 4 G418r subclones. The 300bp band in subclones shows that targeting 
has taken place. PCR failed for parental clones due to suboptimal amplification con ditions for the expected 
1,8kb fragment. The last two lanes are empty. 3) PCR A for parental clones (“A”) and PCR B for parental clones 
(“B”) and subclones. The 1,8kb band could sucessfully be generated in PCR A this time (except for clone IA5 
and clones IA10and IE4). PCR B reveals the expected 820 bp band for the tagged constellation in the parental 
clones as well as in the targeted subclones. PCR B did not yield any band for IA5 and its subclones 1 and 2. 
However, as this band is clearly detectable in clones 3 and 4 it can be concluded that the parental construct is 
present in IA5, 1 and 2.
Pbi: bidirectional, tet dependent promoter; rtTA: reverse transactivator of the tet system rtTA2(S)-M2; IRES: 
Encephalomyocarditis virus internal ribosombal entry site; pac: puromycin acetyltransferase gene, npt: 
neomycin phosphotransferase gene; ESwt: IB10 wt genomic DNA
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PCR analysis using a primer pair binding in the IRES element and in npt (PCR A) clearly 
showed that all 4 subclones of each parental clone have been successfully targeted (figure 21 
panel 2). PCR specifically detecting the parental configuration (PCR B) also revealed the 
presence of non targeted cassette(s), thereby implying that clones IA5, IB3, IF1, IH4 and 
IIIC5 carry more than one copy of pTagPAC/∆NPT. Multiple copies of the tagging cassette 
may have led to the extremely high numbers of targeted subclones, since only one copy 
needed to be exchanged to gain resistance to G418. Nevertheless, the PAC/∆NPT selection 
strategy is also efficient for a single tagged locus (60-80% correctly targeted/resistant clones 
when targeting ROSA26 by RMCE; personal communication  from S. Bantner).
Lack of targeting in clones IA10 and IE4 could be due to loss of part of the npt gene during 
integration of the tagging cassette into the chromosomal DNA, since PCR B did not yield a 
band for either clone (figure 21  panel C).
Altogether, these results show that the PAC/∆NPT selection strategy works efficiently to 
retarget randomly tagged loci in mES cells via RMCE.
2.4 Potential applications for targetable mES cells supporting autoregulated, tet 
dependent expression
The work described above yielded achievements that give direction to future experiments. It 
could be shown that the PAC/∆NPT selection strategy is well suited for tagging/targeting 
approaches mES cells. In contrast to the strategy employing TK as a negative marker 
previously designed to select for targeted subclones, complementation of a truncated npt gene 
by the incoming vector efficiently allows to reuse tagged sites of interest. Accordingly, 
screening of pPAC/∆NPT tagged cells will be performed to identify clones that qualify for 
application by a) carrying a single integrate b) displaying good inducibility by dox and c) 
retaining expression and regulation in differentiation assays. 
Potential applications of mES cell clones carrying RMCE targetable loci which support 
regulated gene expression include rapid generation of transgenic mice as well as in vitro
differentiation.
Differentiation of mES cells towards cell types of specific lineages in vitro represents a source 
for somatic cells that circumvents the time consuming process needed to establish transgenic 
mice. Transgenes might be specifically integrated into precharacterised loci by RMCE, thus 
ensuring predictable and - if desired - regulated expression levels. As proof of principle, clone 
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6.2 and an mES cell clone carrying a tet regulated reporter cassette in ROSA26 were 
differentiated to hematopoietic progenitors as described by Pilat et al. (2005; chapter 4.7.11).
Finally, transgenic mice were established from clones 1.1 and 6.2 and analysed by 
bioluminescent imaging for validation of the differentiation assays used to characterise clones 
1.1 and 6.2 and to evaluate performance of the autoregulated cassette in vivo. 
2.4.1 Evaluation of autoregulated cassettes in transgenic mice
2.4.1.1 Generation of transgenic mice
Differentiation experiments indicated that luciferase expression of clones 1.1 and 6.2 is 
maintained after commitment of mES cells and can still be regulated by dox at least in the 
case of clone 6.2. To characterise rerporter gene activity concerning potential tissue 
specificity and induction levels in vivo, transgenic mice were established from both clones in 
the central mouse facility under guidance of the “Experimental Immunology” department 
headed by Dr. Werner Müller. Briefly, ES cells were injected into Balb/C blastocysts which 
were then transplanted into foster animals. Resulting chimaeras were identified by coat colour 
(silver grey for IB10 derived fur on white Balb/C background). Male animals showing the 
highest contribution of injected ES cells as judged by coat colour chimaerism were chosen for 
matings with Balb/C females. Their offspring was genotyped by analysis of tail tip DNA 
either by Southern blot or PCR. Table 8 shows an overview of generated chimaeras. Both 
clones yielded germline transmission and transgenic mice were bred for evaluation 
experiments.
Table 8: Chimaeras obtained after blastocyst injection for generation of transgenic mice
m = male; f = female; only male chimaeras were mated because IB10 derived ES cells are male. Female 
chimaeras consequently very rarely yield transgenic offspring. One of the clone 1.1 derived chimaeras died 5 
weeks after birth. However, this is most probably not related to chimaerism but due to general effects during 
blastocyst injection, as 3 non chimaeric animals died as well.
injected clone chimaeras transgene transmitting/
mated males
clone 1.1 2 m (one died before mating) 1/1
clone 6.2 9 m / 2f 3/5
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2.4.1.2 Luciferase expression in mice derived from clones 1.1 and 6.2
When regulated expression of a GOI is implemented in transgenic mice, several parameters 
need to be considered and characterised. For instance, levels of basal expression need to be 
determined as they might be critical when e.g. a toxic gene is being regulated. Basal 
expression is influenced by the individual integration site and by the design of the expression 
cassette. As induction of the autoregulated setting is dependent on a certain basal expression 
of the system, a detectable level of basal activity is expected (described in chapter 2.2). The 
nature of the integration site may also restrict expression to certain cell types or tissues which 
needs to be ascertained. Eventually, times required for complete induction and repression in 
transgenic animals after administration or removal of dox (kinetics) have to be determined.   
Thus, transgenic animals derived from clones 1.1 and 6.2 were administered with dox or left 
untreated and examined by in vivo bioluminescence imaging with the Xenogen IVIS 200 
system. Images were analysed concerning the following properties: 
a) basal expression in the absence of dox 
b) kinetics of dox induced expression 
c) reversibility of induction  
d) potential tissue restriction of expression.
e) homogeneity of expression
Results for both transgenic lines will be presented together.
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Transgenic mice derived from clone 6.2
A) no luciferin 30 s         B) no dox                        C) 1d  dox                        D) 2d doxA) no luciferin, 30s           B) no dox                          C) 1d dox                           D) 2d dox
1     2       3    4      5          1     2      3     4      5          1       2       3      4    5          1      2    3     4      5
E) 3d dox                          F) 4d dox                           G) 5d dox                          H) 6d dox
1     2       3    4      5          1     2      3     4      5          1       2       3      4    5          1      2    3     4      5
I) 7d dox                             J) 10d dox
1     2       3    4      5          1     2      3     4      5      
K) no luciferin, 30 s        L) 10d dox                       M) 2d -dox/12d dox
N) 4d -dox/14d dox         O) 6d -dox/16d dox           P) 10d -dox/20d dox
 6     7      8    9     10          6      7    8       9   10         6      7    8      9     10
 6     7      8      9     10         6     7     8      9     10         6      7     8      9    10
switch on
switch off
Figure 22:  Luciferase expression of transgenic mice derived from clone 6.2
Two groups of  5 transgenic female mice each were kept with/without dox for 10 days (2mg/ml dox in drinking 
water). In vivo BLI was performed on both groups and dox conditions were changed. Mice 1-5 were measured 
daily for one week after switching on while the switch off group (6-10) was imaged every other day. Mice # 9 
and 10 were constantly kept with dox to check luciferase expression over a longer period of time. Coat colour of 
imaged mice was either light grey or white, depending on the backcross status into Balb/C. Imaging conditions: 
field of view: 19.6; binning: medium, aperture: f1, exposure time: 2 min if not stated otherwise. Images A) and 
K) were taken before luciferin injection, showing that no light is emmitted without the substrate. Sensitivity is 
high in these cases leading to high background activity. Non transgenic control mice are shown in figure 24.
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a) A significant level of basal expression could be detected in 2/5 mice in the switch on 
group, e.g. in mouse 1 (figure 22 panel B). This animal showed a weak signal 
throughout the whole body while mouse 3 displayed luciferase activity mainly in the 
stomach region and in the head. Mice 2, 4 and 5 hardly showed any basal luciferase 
activity at all. 
b) When dox was administered via drinking water (switch on), a change could be 
observed already after 24h (figure 22 panel C): Mouse 1 now emitted a stronger signal 
from the left upper flank as indicated by a small green focus (cp. rainbow scale). This 
focus became stronger over the time and seemed to move from one side of the animal 
to the other while approximately retaining the same height. In panels F, I and J a 
second signal in this region was discernible. At the same time, also the mouth of 
animal 1 gave a slightly higher luciferase signal than before. Mice 3 and 4 showed a 
weak increase in signal intensity after 24h of dox administration. However, the 
strongest signals were detected after 4d of induction (figure 22 panel F). Mouse 3 
exhibited the same pattern as mouse 1 now: mouth and stomach region showed 
relatively high luciferase activity. Animal 4 did not experience such a strong change, 
but it did show weak signals from the same parts of the body as did mice 1 and 3 while 
it had not shown any significant basal expression prior to induction (figure 22 panel 
B). Mice 2 and 5 could not be induced by dox administration – they exhibited weak, 
patchy basal expression on some days but appeared to be almost silent the next day 
(e.g. figure 22 panels C/D;  panels I /J).
The switch off group of mice was kept with dox for 10d and was imaged before and 
after removal of the inducer. When first imaged, these mice displayed the same pattern 
as the switch on group after 10d of induction (figure 22 panel L): some animals 
showed distinct luciferase signals from mouth and upper abdomen (mice 8, 9, 10) 
while others displayed a patchy, unpredictable expression that was not influenced by 
dox (mouse 6) or even no expression at all (animal 7). Mice 9 and 10 were kept with 
dox for 10 more days and retained approximately the same expression levels as before 
(figure 22 cp. panels L and P). Only mouse 8 could be evaluated for switch off 
kinetics, as mice 6 and 7 had not expressed significant amounts of luciferase in the 
first place. Animal 8 lost the expression focus in the stomach region within two days 
(figure 22 panel M). As expression seemed to be higher again after 4 and 10d of 
removal of dox (figure 22 panels N and P, respectively), it can be concluded that the 
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image taken after 2d already showed basal expression levels. Therefore, switch off in 
clone 6.2 transgenic mice probably is accomplished within 2d.
c) When switched off, mouse 8 reduced luciferase expression levels showing that 
induction by dox was reversible.
d) To define organs that strongly express luciferase in clone 6.2 derived mice more 
specifically, animals 1 and 9 were injected with luciferin, sacrificed 3-4min later and 
their isolated organs were analysed with the Xenogen IVIS system (figure 23). These 
images demonstrate that inducible luciferase expression is strongest in stomach and 
brain, which resulted in the signals from  upper abdomen and the mouth, respectively,
in the whole animal BLI. For animal 1, some small spots of signal could also be 
detected from the spleen.
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Figure 23: Bioluminescent imaging data form isolated organs of mice 1 and 9
B = brain; H = heart; K = kidneys; L = liver; SP = spleen; ST = stomach; partly opened and cleaned from 
contents. Imaging conditions: field of view: 13; binning: medium, aperture: f1, exposure time: 2 min
e) Altogether, animal BLI experiments indicate that luciferase expression in clone 6.2 
derived mice was heterogeneous – although all animals were transgenic, some of them 
expressed more luciferase than others (e.g. figure 22 panel I: cp. mice 1 and 5, panel 
L: cp. mice 8 and 6). Since dox was administered via the drinking water the absolute 
amount of drug taken up by the animals could not be precisely determined. Calculated 
to the concentration of dox in the drinking water according to Kistner et al. (2mg/ml), 
mice had imbibed approximately 1 to 1,8 mg dox/day. Thus, it could not be excluded 
that the heterogeneity of expression was caused by insufficient and/or varying dox 
uptake. To test whether higher, defined amounts of dox result in higher and more 
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consistent luciferase expression levels, a group of transgenic mice was administered 
with 2mg/dose dox twice a day by gavage (figure 24). This mimics plasma levels 
which are twice as high as those of humans administered with 200mg/d (Zeidner et al., 
2004).
A) no dox                            B) 2x2mg dox/d; 2d              C) no dox                        D) no dox/ 2x2 mg dox/d; 1d
- - -      -       +      +      -
K                                                 K                     K     K                       K            K     K                        K
11     12   13    14    15          11            13     14                 16    17    18   19    20        16     17   18    19   20
Figure 24: Bioluminescent imaging of clone 6.2 transgenic mice after high dose dox administration 
(4mg/d)
Mice 12 and 15 died during the experiment due to practical problems. Mice 18 and 19 were therefore fed one 
day later by gavage. Imaging conditions: field of view: 19.6; binning: medium, aperture: f1, exposure time: 
2min.  Mice 14, 16, 17 and 20 are non trangenic controls (labelled “K”) 
Mice 11 and 13 showed clear induction of the autoregulated system after 2d of high 
dose dox administration (figure 24 cp.  panels A and B). However, overall levels were 
not increased as compared to the first experiments (cp. figure 22 panel D and figure 24 
panel B). Even under these controlled conditions still a heterogeneity in expression 
between individual mice was observed (figure 24 cp. mice 11 and 13 in panel B). Mice 
18 and 19 already showed comparatively strong luciferase expression after 24h of dox 
administration, indicating that expression can be efficiently induced within 1 day in 
transgenic mice just as in mES cell culture (cp. figure 11).
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Transgenic mice derived from clone 1.1
5 clone 1.1 transgenic mice were kept with/without dox each for 10d as described before, 
analysed once before changing dox conditions and imaged 7 days later (figure 25).
A) no dox                            B) 7d dox                           C) 10d dox                            D) 7d no dox
E) 7d dox, 2min B) F) 7d no dox, 2 min D)
21          22      23                   21       22         23            24          25         26               24        25        26
   21       22        23                                                            24         25        26 
G) no dox/ 10d dox          H) no dox/ 10d dox, 2min
27  28    29    30                  27  28     29   30
I) 7d dox/ 7d no dox         J) 7d dox/ 7d no dox, 2min
  females switch on                                           females switch off
  males switch on/switch off
Figure 25:  Luciferase expression of transgenic mice derived from clone 1.1
Two groups of  3 transgenic female and 2 male mice each were kept with/without dox for 10d (2mg/ml dox in 
drinking water). In vivo BLI was performed on both groups and dox conditions were changed. Imaging 
conditions: field of view: 13 for A-F, 19.6 for G-J; binning: medium, aperture: f1, exposure time: 30 s if not 
stated otherwise. All imaged animals have white coat colour. Non transgenic control mice are shown in figure 
24.
a) 3/5 transgenic animals derived from clone 1.1 displayed a detectable level of basal 
expresssion (figure 25 panel A mice 21 and 22, panel G mouse 28) while in others the 
cassette was completely silent (panel A: mouse 23 and panel G mouse 27).
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b) The switch on group was not influenced by 7d of dox administration (figure 25  cp. 
mice 21, 22, 23 in panel A with E and mice 27 and 28 in panel G with D). When 
imaged after induction, the female group even seemed to express less luciferase than 
before (figure 25 panel B). However, this weak signal might be caused by imaging too 
soon after luciferin injection, as the acquisition taken a few minutes later demonstrates 
(figure 25 panel E; the same effect is observed in images D/F, G/H and I/J). Still, 
exposure time for image E was 4 times longer than for image A, implicating that 
luciferase expression had not been increased by dox administration. The same is true 
for the male expressing animal 28 (figure 25 cp. panels H/J). 
The switch off group (mice 24, 25, 26, 29 and 30) in contrast displayed two animals in 
which luciferase signals are clearly reduced by depletion of dox and another two mice 
with a slighter yet definite drop of activity (strong decrease: figure 25 mouse 26 panels 
C/F, mouse 29 panels H/J; weaker decrease: figure 25 mouse 25 panels C/F;  mouse 
30 panels  H/J; note possible differences in exposure times!). The fifth animal of this 
group (mouse 24) had not shown any luciferase signal at all. Thus, it remained 
somewhat elusive whether luciferase expression in transgenic mice derived from clone 
1.1 is regulated by dox. 
c) Consequently, it could not be confirmed whether luciferase expresssion in clone 1.1 
transgenic mice is reversible.
d) In all expressing animals, luciferase signals were restricted to the upper abdomen. To 
determine the organ(s) that gave rise to the reporter signal, mice 22 and 28 were 
injected with luciferin, sacrificed 3-4m later and their isolated organs imaged 
immediately. Figure 26 shows that luciferase expression was strictly limited to the 
liver.
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Figure 26: Bioluminescent imaging data form isolated organs of mice 22 and 28
H = heart; K = kidneys; L = liver; SP = spleen; ST = stomach. Imaging conditions: field of view: 13; binning: 
medium, aperture: f1, exposure time: 2 min. Note that rainbow scale is different and absolute signals are 
consequently much weaker!
e) Clone 1.1 derived transgenics showed variable expression levels for individual mice: 
some animals expressed more luciferase than others (e.g. mouse 26 > mouse 25> 
mouse 24, figure 25 panel C). Thus, luciferase expression in this mouse line was 
heterogeneous similar to that of clone 6.2 mice.
2.4.1.3 Conclusions: behaviour of the autoregulated cassette in transgenic mice with 
two different integration sites
Since mice derived from clones 1.1 and 6.2 shared some common features concerning their 
luciferase expression characteristics, results are discussed together.
1) Basal expression strongly varied between individual animals of the same line: some mice 
showed hardly any signal whereas others displayed significant luciferase levels in the absence 
of dox.
2) Expression in clone 6.2 derived mice could be induced to maximum levels within 1-4d by 
administration of dox. However, this was limited to those mice which had previously shown a 
high basal activity. The general observation was that the more luciferase activity was detected 
in the absence of dox, the higher the signal was after induction. Consequently, mice with low 
or no background did not express more luciferase after subjection to dox. This heterogeneity 
of expression was not caused by too low amounts of dox in the animals (figure 24).
Transgenics derived of clone 1.1 displayed the same heterogeneity of luciferase expression as 
described for clone 6.2 animals. However, in vivo bioluminescent imaging experiments of 
transgenic mice and of teratomas did not reliably show regulation by dox.
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3) Induction of luciferase expression in clone 6.2 mice was reversible and basal levels were 
reached within less than 4d after depletion of the inducer.
4) Expression was tissue restricted in both transgenic lines: in clone 1.1 derived mice it was 
strictly limited to the liver. Although some clone 6.2 animals (e.g.  mice 1 and 12, view figure 
22 panel J and figure 24 panel A) displayed a signal througout the whole body, high luciferase 
expression was constrained to the brain and the stomach. In one case, a weak signal could be 
detected from the spleen (figure 23 organs of mouse 1) and a previous experiment had 
revealed strong luciferase expression from the kidneys of one animal (data not shown).
2.4.2 In vitro differentiation of clone 6.2 and ROSArtTAautoLuc to hematopoietic 
progenitors 
Directed in vitro differentiation of mES cells towards the hematopoietic lineage has been 
shown to generate progenitors that closely mimic the behaviour of adult hematopoietic stem 
cells (HSCs) (Pilat et al., 2005). The strong resemblance of these so called mES cell derived 
hematopoietic stem cells (ES-HCs) to HSCs was convincingly demonstrated by their capacity 
to reestablish the hematopoietic system in lethally irradiated recipient mice.
To extend the scope of possible applications for autoregulated expression of transgenes 
targeted to precharacterised loci, clones 6.2 and ROSArtTAautoLuc (established by U. 
Sandhu and S. Bantner) were differentiated to ES-HCs in vitro according to Pilat et al. (2005). 
ROSArtTAautoLuc harbours the autoregulated, tet dependent cassette specifically integrated 
in the ROSA26 locus like the previously described ROSAautoLuc clone. However, an 
additional reverse transactivator reading frame is inserted under the control of the endogenous 
ROSA26 promoter (figure 27). This ensures constant levels of rtTA facilitating induction of 
the positive feedback loop as initiation of expression is independent of basal expression from 
the autoregulated cassette.
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ROSArtTAautoLuc
ROSA 26    SD   SA
exon 1             rtTA              luciferase         Pbi            rtTA         IRES     npt
constitutive expression                                   inducible expression
Figure 27: Schematic view of ROSArtTAautoLuc
The previously described autoregulated, tet dependent cassette is integrated in the ROSA26 locus of IB10 mES 
cells. In addition, the endogenous ROSA26 promoter drives constitutive expression of a second rtTA coding 
sequence. Pbi: bidirectional, tet dependent promoter; rtTA: reverse transactivator of the tet system rtTA2(S)-M2; 
SD = splice donor; SA = splice acceptor; IRES: Encephalomyocarditis virus internal ribosombal entry site; npt: 
neomycin phosphotransferase gene; FRTwt and  FRT5 sites are indicated by black and white arrowheads, 
repectively.
A detailled description of the applied differentiation protocol is given in “Material and 
Methods”. Since ectopic overexpression of the human homeodomain transcription factor 
HoxB4 is required for this differentiation approach, mES cells were first infected with a 
retroviral vector encoding for HoxB4 and GFP and the pool of expressing cells was recovered 
by FACS (fluorescence activated cell sorting; described in “Material and Methods”). Infected 
cells were subjected to the initial differentiation step that involved formation of embryoid 
bodies (EBs) upon withdrawal of LIF in a methylcellulose matrix. After 6 days EBs were 
harvested, dissociated and cells were cultured in suspension with medium that contained 
diverse cytokines needed to gain and sustain ES-HCs (including IL-3, IL-6 and murine Stem 
Cell Factor). 
To evaluate reporter gene expresssion upon induction, dox was added to the media after a 
certain period of cultivation and cells were harvested and assayed for luciferase activity 
(figure 28).   
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Figure 28: Luciferase activity in ROSArtTAautoLuc and clone 6.2 upon induction on ES cell level and 
after in vitro differentiation to hematopoietic progenitors
R ES: ROSArtTAautoLuc mES cells were kept with/without dox for 2d and harvested for the luciferase assay; 
sample size for the uninduced/induced states: 4/18; R ES-HC: ROSArtTAautoLuc hematopoietic progenitors 
were kept in culture for 60d and assayed for luciferase after 2d with/without dox; sample size for the 
uninduced/induced states: 2/2; clone 6.2 ES: mean values for reporter activity as given in table 3; sample size for 
the uninduced/induced states: 20/34; clone 6.2 ES-HC: clone 6.2 hematopoietic progenitors were kept in culture 
for 35d and assayed for luciferase after 2d with/without dox; sample size for the uninduced/induced states: 2/2;
IB10 wt control cells did not exhibit any significant reporter levels neither in the ES cell state nor on ES-HC 
level (data not shown). 
Clone 6.2 derived ES-HCs did not not show any detectable luciferase signal in the presence of 
dox at day 35 of culture just like the IB10 wt control (data not shown). In contrast, 
ROSArtTAautocLuc even displayed regulated luciferase expression after 60d of culture 
albeit with a strongly reduced intensity (more than 500 fold less as compared to mean values 
from ES cells). Interestingly, no basal level of expression could be detected.
To demonstrate the hematopoietic progenitor character of the generated cells, antibody 
stainings are currently being performed to detect ES-HC/HSC specific markers. In addition, 
the cells will be transplanted to lethally irradiated, immunodeficient mice. Long term survival 
of transplanted animals (> 4 months) would prove the cells’ potential to completely 
reconstitute the hematopoietic system, i.e. its “stemcellness”.
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3 Discussion
The aim of this work was to generate mES cell lines providing high and strictly regulated 
reporter gene expression. For this purpose, an autoregulated, dox dependent screening cassette 
was used to randomly tag loci in germline competent mES cells. Concomitantly, 
heterospecific FRT sites flanking the expression cassette were introduced to enable reuse of 
the individual locus by subsequent Flpe mediated cassette exchange (RMCE). 
Tagged mES cell clones were characterised for regulated reporter gene expression and the 
number of integrated vector copies. Two clones harbouring a single copy integrate and 
displaying adequate, regulated reporter levels were surveyed for their expression behaviour 
after differentiation. To this end, in vitro and in vivo differentiation assays were carried out 
which indicated that reporter gene expression of the cassettes in both clones was retained after 
differentiation. Thus, transgenic mice were established from both lines and further 
characterised concerning inducibility and expression levels in the whole animal. 
Upon improving the selection strategy, targeting of loci in mES cells randomly tagged by an 
autoregulated cassette was efficiently performed, yielding proof of principle for the overall 
strategy.
3.1 Flpe mediated cassette exchange of randomly tagged loci in mES cells
Transgene expression in mice is affected by the integration site(s) of the GOI resulting in 
differing expression patterns in mouse lines derived from individual mES cell clones. 
Predictable levels of transgene expression may be achieved by integration into defined 
chromosomal domains. This may be accomplished by application of of BACs, which bring 
along their own chromosomal environment, or by HR exploiting the known expression 
properties of endogenous loci. However, the first method only partially solves the problem of 
reproducible expression (Gong et al., 2003) while the latter suffers from time consuming 
screening procedures required. Reuse of specific loci in mES cells via RMCE in contrast 
facilitates generation of genetically modified mice displaying predictable expression patterns 
and circumventing extensive screening procedures.
Great efforts are currently being undertaken to trap every single gene in mES cells for the 
generation mouse mutants (IGTC; http://www.genetrap.org). Since the gene trapping 
consortia implemented RMCE compatible vectors in their trapping strategy, trapped loci may 
be knocked out or modified to create a range of different alleles at will. 
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Cobellis et al. (2005) showed that trapped genes could be efficiently targeted by RMCE and 
that reporter expression in mice derived of targeted subclones displayed the same expression 
pattern as the intact gene.
This “trap and target” strategy is hence well suited to manipulate endogenous genes. 
However, use of trapped loci to drive transgene expression concomitantly disrupts the 
endogenous reading frame which might perturb the phenotype that is originally evoked by the 
transgene.
Thus, the aim of this work was to “tag and target” loci in mES cells which are not  required 
for the host’s gene functions and support regulated transgene expression.  
3.1.1 Failure of targeting using the TK/NPT selection strategy
The initial tag and target strategy employed npt as a marker for tagged cells and loss of tk (i.e. 
resistance to GCV) for selection for correct targeting events (depicted in figure 17). This 
negative selection strategy has been realised in NIH3T3 cells by C. Wodarczyk (C. 
Wodarczyk, 2003), albeit with a relatively high frequency of additional random integration of 
the targeting cassette. Although experimental factors potentially inhibiting RMCE in clones 
1.1 and 6.2 tagged with pTagTK/NPT, like impairment of FRT sites or lack of transfection 
efficiency could be excluded, no targeted subclones could be isolated. Thus, a low efficiency 
of this selection strategy in mES cell probably compromised the targeting approach. 
Consequently, the tagging vector was redesigned to comply with an alternative selection 
strategy. 
3.1.2  The PAC/∆NPT selection strategy is highly efficient for targeting
The alternative tagging strategy involved screening for tagged loci by puromycin resistance 
and targeting via complementation of a truncated npt gene (figure 19 panel B). 7 puromycin 
resistant clones generated by electroporation with pTagPAC/∆NPT with varying levels of 
luciferase expression were chosen for targeting. 5 of these yielded between 100 and 450 G418 
resistant subclones and PCR analysis of 4 subclones each revealed correct targeting events. 
As the parental clones had not been checked for the number of tagging vectors integrated, it 
cannot be ruled out that this extremely high efficiency is due to multiple copies available for 
targeting in each clone. Still, this proves that also the targeting frequency of a single copy will 
be satisfactory. 
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Lack of targeting in the remaining 2 clones was possibly caused by single integrations of a 3’ 
deleted vector that was not able to confer G418 resistance upon targeting. In conclusion, this 
PAC/∆NPT selection strategy has been demonstrated to be highly efficient and will be the 
strategy of choice for future tag and target approaches in mES cells.
3.2 Autoregulated, tet dependent  reporter gene expression in mES cells, differentiated 
cells and transgenic mice
The most common methods applied to obtain conditional gene expression in transgenic mice 
are the genetical switch mediated by the Cre/loxP system and transcriptional regulation driven 
by the tet system. Since the genetic switch suffers from the prominent disadvantage to be 
irreversible, tet dependent expression in transgenic mice is gaining more and more attention.
Usually, tet regulation in mice is established by mating an inducible responder line harbouring 
the GOI driven by a tet dependent promoter to animals expressing the transactivator in a 
tissue dependent or ubiquitous manner. 
A large number of publications describe the succesful application of this “conventional” tet 
system, i.e. the constitutively expressed transactivator drives expression of the GOI
downstream of the tet dependent promoter. These include for instance ablation studies of 
specific cell types by expression of toxic gene products (Leuchtenberger et al., 2001; Lee et 
al., 1998), modeling of pathogenesis during HCV infection on mouse level (Ernst et al., 
2007), determining the accurate time point when expression of a certain gene is essential for 
correct embryonic development (Shin et al., 1999), or knockdown of endogenous genes by 
conditional expression of miRNAs (Dickins et al., 2007). 
While this allows to utilise all transactivator expressing lines established so far to specifically 
regulate the transgene in various tissues and cell types, two factors make this strategy less 
attractive: 1) when the transgene is randomly integrated into the genome expression levels of 
responder lines are unpredictable and can only be evaluated after mating; thus, multiple 
mouse strains have to be established and mated to ensure generation of a valid model, and 2) 
breeding is very time-consuming and cost-intensive.
If tissue specificity is not required, these problems may be overcome by an autoregulated 
design of transgene expression control that allows to generate a complete regulation system in 
a single step.
Autoregulated expression in transgenic mice subordinating the transactivator to the control of 
its own dependent promoter has only been utilised by Shockett et al. (1995, 2004; 
configuration as depicted in figure 2 panel A), who did not thoroughly monitor the expression 
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characteristics. The authors compared luciferase reporter expression data obtained with the 
conventional TetOFF system by Furth et al. (1994) to autoregulated tTA expression. Furth et 
al. had evaluated inducible reporter gene expression in mice that carried undetermined 
numbers of CMV promoter driven tTA and tet dependent luciferase gene copies integrated in 
random loci. Similarly, Shockett et al. had randomly integrated undefined copy numbers of tet 
dependent tTA and luciferase genes into chromosomal DNA. They found that autoregulation 
yielded approximately two orders of magnitude fold more luciferase activity in thymus and 
lung as compared to constitutive tTA expression and also detected luciferase in tissues which 
had previously shown little or no activity with the conventional system (e.g. kidneys and 
brain). The autoregulated system was used to govern expression of the recombination 
activating genes 1 and 2 (RAG1 and RAG2) in RAG1 or RAG2 deficient mice, providing 
inducible activation of V(D)J recombination and the development of primary lymphocytes 
(Shockett et al., 2004). 
Results of the studies mentioned above are derived from different mouse lines carrying 
undefined numbers of  the regulatory constructs in different integration sites which strongly 
curtails comparability. Further, properties of autoregulated expression in vivo have not yet 
been adressed in detail. Thus, it was a major intent of this work to characterise autoregulated 
tet dependent transgene expression in transgenic mice.
3.2.1 Low efficiency of clone generation by randomly integrating autoregulated, 
inducible cassettes in mES cells
One of the aims of this work was to identify loci in the genome of mES cells that are 
supportive to autoregulated expression. To randomly tag loci for subsequent screening, the 
constructs pTagTK/NPT and pTagPAC/∆NPT were electroporated into IB10 mES cells. Both 
vectors share the same autoregulated configuration of tet regulatory components but differ in 
their selection markers (pTagTK/NPT: G418r, pTagPAC/∆NPT: puromycinr). A total of 6  
electroporations altogether employing ~ 5 x 107 cells and 106 µg of pTagTK/NPT only 
yielded 102 G418r clones (0,0002 % of total cells; table 2). At the same time parallel control 
experiments with a vector carrying a constitutively active npt gene resulted in 10 fold higher 
numbers of resistant clones (0.002 % of total cells). 
Two possible reasons are conceivable for the low tagging efficiency: possibly tagging was 
equally efficient as with the constitutive control cassette but transcriptional squelching led to a 
high percentage of cell death. 
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Squelching is caused by excessive recruitment of transcription factors for transgene 
expression and a concomitant overall depletion of these factors for transcription of 
endogenous genes. Alternatively, demands of (auto)regulated expression on loci in mES cells 
are higher than for constitutive expression. Performance of the autoregulated cassette 
presumably is more submitted to influences from chromosomal neighbouring regulatory 
elements as compared to constitutively expressing constructs. Since mES cells are considered 
to be “open” for transcription in relation to other cell types, frequent integration of the 
cassette into transcriptionally silenced genomic sites is not likely a cause for low numbers of 
resistant clones. 
Previous experiments had shown that rtTA2(S)-M2 is capable of reducing transient 
expression of a cotransfected β-gal reporter plasmid in mES cells in the presence of dox (C. 
Wodarczyk, 2003). However, expression levels obtained transiently are usually much stronger 
than expression of integrated constructs. Further, expression levels of pTagTK/NPT are 
significantly weaker in mES cells as compared to NIH3T3 cells (C. Wodarczyk, 2003). Thus, 
it is not likely that too high expression of rtTA2(S)-M2 accounts for low clone numbers. 
The difference of expression levels between mES cells and NIH3T3 may be explained by the 
finding that tet dependent promoters contain binding motifs for GATA factors. Gould and 
Chernajovsky (2004) could show that endogenous GATA factors bind to these motifs 
suppressing basal promoter activity. Since GATA factors are more abundant in embryonic 
tissues they may be the cause of suboptimal performance of tet dependent expression in 
particular in mES cells. In addition, induction of the autoregulated system requires a certain 
degree of basal expression. If this is abolished by GATA factors, the cassette will be 
completely silenced.
Analysis of tagged clones revealed that only a minor percentage of cell clones – although 
being resistant to the selection drug – expressed the reporter gene upon induction with dox. In 
a certain number of clones this may have been caused by loss of (parts of) the luciferase gene 
or other essential elements during integration into genomic DNA. Alternatively, low 
expression levels might have been strong enough to mediate drug resistance whereas 
luciferase stayed below the detection threshold. This could account for the higher percentage 
of pTagPAC/∆NPT tagged, luciferase expressing clones (~20%) in contrast to pTagTK/NPT 
clones (6%): G418 resistance is already gained when relatively few npt molecules are present 
while pac requires a higher expression level concomitantly yielding more clones with 
detectable luciferase activity.
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3.2.2 Reporter levels from the autoregulated cassette strongly fluctuate in mES cells 
independent of the integration site
Measured luciferase expression levels of mES cell clones carrying the autoregulated cassette 
showed a standard deviation of at least 66%. This is true for two random integration sites 
(clones 1.1 and 6.2) as well as for the well characterised ROSA26 locus. In contrast, 
luciferase constitutively expressed from the endogenous ROSA26 promoter never deviated 
more than 15%. Consequently, strong fluctuations of expression seem to be an inherent
feature of the autoregulated system since they emerge independently of the integration site. 
Variations of protein levels between individual, isogenic cells under identical environmental 
conditions have been observed in both prokaryotes and eukaryotes and are considered to be 
closely connected to stochasticity of gene expression (“noise”; reviewed by Kaern et al., 
2005). The manifold causes of  cell-to-cell divergence are the subject of ongoing research and 
can be divided into two classes regarding their sources: a) extrinsic factors such as varying 
amounts of transcriptional activators and b) intrinsic determinants like the processes of 
transcription and translation (Raj et al., 2006).
To gain detailled insight into the mode of transcription and its implications for gene 
expression variability, Raj et al. (2006) performed in situ hybridisation of individual mRNA 
molecules of both reporter and endogenous genes in CHO cells. The authors found strong 
variations in the number of mRNA molecules in each cell because the molecules were 
synthesised in so called “transcriptional bursts”. These bursts are dependent on the transition 
of the respective gene from the inactive to the active state and vice versa. Interestingly, two 
reporter genes expressed from different chromosomal loci displayed no correlation of 
activation/inactivation whereas both genes integrated at the same site showed simultaneous 
bursting. These results indicate that fluctuations in mRNA levels are intrinsically random and 
not significally influenced by global, extrinsic factors. Also, they support the hypothesis that 
chromatin remodeling is a source of transcriptional bursting. When modeling events during 
stochastic gene activation and inactivation, Raj et al. could show that an increase of 
transcription factors leads to synthesis of more mRNA molecules per burst rather than 
enhancing the frequency of bursts.
Fluctuation of chromatin unfolding has been demonstrated to be associated with variable gene 
expression levels in isogenic cell clones (Sato et al., 2004). The authors detected fluctuating 
expression from a tandem array of 50-60 tet dependent GFP reporter cassettes in presence of 
constant levels of rtTA and saturating doses of dox. These variations appeared independently 
of the cell cycle stage and FAC sorted high and low expressing populations returned to a 
3 Discussion
68
steady state within less than 3d. Furthermore, FISH (fluorescence in situ hybridisation) 
analyses revealed that levels of GFP expression were correlated to the degree of chromatin 
unfolding at the integration site of the array.   
Regulated gene expression has been shown to follow two distinct patterns, which are not 
mutually exclusive. In the graded or rheostatic model expression gradually increases upon 
transcriptional activation in all cells. This applies e.g. when rtTA is constitutively expressed 
and the level of inducer determines the extent of activation of the transactivator pool (Niwa et 
al., 2000; Biggar and Crabtree, 2001; Bornkamm et al., 2005). Bimodal expression in contrast 
proceeds in a stochastic manner: activated rtTA increases the probability that the regulated 
transgene will be expressed but does not elevate the expression level as such. This model has 
been shown to be valid for positive feedback loops (Becksei et al., 2001; T. May, 2004). Of 
note, Isaacs et al. (2003) observed that the bimodal expression pattern of a positive feedback 
can change to a unimodal one depending on the strength of the feedback.
Regarding clones 1.1, 6.2, and ROSAautoLuc, which harbour a strong positive autoregulatory 
feedback, this means that in the absence of dox the probability of transgene expression is low. 
However, repression is not completely tight resulting in sporadic activation of transcription 
and presence low levels of rTA and reporter in the cells. Upon addition of dox, probability of 
expression is strongly increased which separates the cells into pools of expressing and non 
expressing cells. When full activation is reached, all cells have shifted to the expressing 
population. Hence, high luciferase readouts represent a situation when most cells express the 
cassette whereas low luciferase levels indicate that many cells have stopped transcription. 
Maybe the cells have an endogenous mechanism that counteracts too high levels of cassette 
expression caused by the positive feedback loop. Thus, when cells reach a certain peak of 
expression transcription is stopped and the majority of cells shifts to the inactive state again. 
After a defined period of recreation however, expression is initiated again. According to this 
model one would predict an oscillatory mode of expression, where cells increase and decrease 
frequency of transcription in a synchronised manner. To confirm this, luciferase expression 
would have to be assayed in short intervals after induction and repression. Oscillations should 
then be detectable provided half-life times of luciferase mRNA and protein are low enough so 
that enzyme activity would reflect the actual state of gene expression.   
Strong variations of reporter levels might also be related to an unknown factor required for tet 
dependent expression. If this factor is not homogeneously present it could be limiting for 
regulated expression and fluctuating reporter levels would consequently mirror its availability.  
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3.2.3 Hetrogeneity of autoregulated luciferase expression in transgenic mice derived of 
clones 1.1 and 6.2
Establishing a transgenic mouse line by random integration of a transgene into chromosomal 
loci strongly suffers from position effects which lead to unpredictable expression patterns. 
Thus, it is common practice to generate and evaluate several founder lines for each transgenic 
mouse model. For example, Robertson et al. (2002) generated 5 independent mouse lines 
carrying a tet dependent lacZ reporter gene of which only one displayed inducible expression 
after mating to a tTA expressing mouse strain. This represents the average outcome for 
transgenic mice created by random integration of the GOI. Since the screening cassette had 
also been integrated randomly in this work, one would not expect to identify a chromosomal 
locus that is perfectly suited for regulated transgene expression by analysis of only two 
reporter lines (i.e. mice derived from clones 1.1 and 6.2). 
Luciferase expression levels in mES cell clones 1.1 and 6.2 were well regulated by dox. In 
vitro differentiation experiments and analyses of teratomas induced by these clones indicated 
that both cell lines retain luciferase expression after diffferentiation and that reporter activity 
is dependably regulated in the case of clone 6.2 (chapter 2.2.3).
In vivo bioluminescence analysis of transgenic mice derived of clones 1.1 and 6.2 revealed 
that expression was heterogeneous between individual mice in both lines. This was true for 
basal expression as well as for the induced state. Unexpectedly, not all mice carrying the 
autoregulated cassette show basal expression. 
Clone 1.1 mice could not be reliably regulated which was documented by the finding that 
some animals even seemed to express less luciferase after administration of dox. Clone 6.2 
mice could be induced by adminsitration of dox provided they had displayed detectable basal 
levels. This coincides with the notion that only cells with a certain basal level of expression 
can induce the positive feedback loop. If basal expression is abolished as in the mice without 
a significant luciferase signal in the absence of dox, expression cannot be triggered but is 
completely silenced. So, the cassette seems to be shut off in some mice whereas in others it is 
kept inducible. 
Recently, Zhu et al. (2007) could show in a classical set-up (constitutive expression of the 
transactivator) that the bidirectional tet dependent promoter becomes silenced in neurons of 
mice if it is not active during development. This epigenetic silencing could be avoided by 
constant basal activity throughout embryonic development or could often be reversed by long-
term, high transactivator levels in neurons.
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A similar mechanism might be the cause of heterogeneity of expression in the transgenic lines
1.1 and 6.2: stochastic expression of the autoregulated cassette could have led to basal 
expression in some but not all embryos. Consequently, the tet dependent promoter got 
silenced in non-expressing embryos and cannot be activated again since rtTA transcription is 
shut off, too. Thus, only animals with basal expression maintained inducibility. 
Silencing of tet driven transgenes is not only a problem in transgenic mice but also requires 
screening for long term stably expressing clones in cell culture. Pankiewicz et al. (2005) 
investigated the effect of various regulatory proteins targeted to a silenced transgene 
juxtaposed to a tetO and a Gal4 binding site in cell culture. Interestingly, they found that a 
Gal4-VP16 fusion was able to reverse silencing whereas tTA (TetR-VP16) had no effect. This 
suggests that the TetR binding domain cannot interact productively with silent chromatin. 
When the Gal4 binding domain was fused to mammalian cell activators such as CTF/NF-1 or 
Sp1, these fusions alone were not capable of inducing silenced expression. However, these 
factors mediated chromatin remodeling restoring inducibility by tTA. Thus, reversal of 
epigenetic silencing appears to be a  biphasic process that involves transcription factors which 
remodel chromatin while others subsequently activate transcription. To determine whether 
heterogeneity of tet dependent expression is due to epigenetic silencing during development 
in a certain percentage of mice, clone 1.1 and 6.2 mice are currently being bred in presence of 
dox to ensure constant expression in embryos. Mice from these matings will then be examined 
by in vivo BLI in the presence and absence of dox.
Another factor that might have caused heterogeneous expression is the genetic background of 
the transgenic mice. Robertson et al. (2002) detected a considerable variation of tTA 
regulated lacZ reporter gene expression levels between individual animals that carried the 
reporter gene in the same chromosomal locus but were of a mixed CBA/Ca x C57BL/6 
background. Upon backcrossing into each parental mouse strain expression levels became 
considerably more homogeneous even after the first backcrossing step. In addition, the 
authors found that CBA/Ca mice were more permissive to tet regulated transgene expression 
than C57BL/6J mice. Similarly, clone 1.1 and 6.2 derived mice have a mixed background of 
Balb/C and 129/Ola strains which could influence heterogeneity of expression. Further 
backcrossing of 1.1 and 6.2 mice into the Balb/C strain and subsequent analysis of animals
will show if  expression will become homogeneous in a pure genetic background.
Tissue restriction of expression in both lines (clone 1.1: liver; clone 6.2: brain, stomach) is 
presumably caused by the individual integration site of the cassette. For example, regulatory 
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elements or heterochromatin may prevent widespread luciferase expression in all tissues of 
the animal. Also, the locus of clone 1.1 probably disrupts regulation of transcription. 
A recent publication reports that transgenes integrated closely to the telomeres are expressed 
at low levels in mES cells but are silenced in somatic cells derived thereof (Gao et al., 2007). 
This so called “telomere position effect” involves methylation of DNA and is conceived to be 
an evidence for epigenetic reprogramming of parts of the genome in the preimplantation 
embryo. Since the exact integration site of the tagging cassette in clones 1.1 and 6.2 is 
unknown, impairment of regulated expression in the transgenic animals due to subtelomeric 
location can not be excluded. 
The ROSA26 locus has been frequently used for expression of transgenes driven by either the 
endogenous or heterologous promoters and is known to permit expression in all tissues 
unhampered by major disturbances (Zambrowicz et al., 1997; Jonnalagadda et al., 2005; 
Strathdee et al., 2006; Seibler et al., 2007). Thus, it will be highly interesting to analyse 
animals generated from ROSAautoluc. With these animals, one will be able to clearly 
distinguish between properties of the autoregulated cassette and influences from the 
integration site that limit expression in 1.1 and 6.2 animals.  
3.2.4 Regulated luciferase expression in hematopoietic progenitors derived by in vitro
differentiation of mES cells 
In vitro differentiation of mES cells provides means to generate genetically manipulated 
precursors of specific lineages. The major advantages of this strategy are that hitherto no 
genetic modification as complex as RMCE is feasible in adult stem cells and that the time-
consuming generation of a transgenic mouse model may be circumvented.
To test the functionality of the autoregulated cassette and evaluate its potential in in vitro
differentiation approaches, clone 6.2 and ROSArtTAautoLuc were differentiated to ES-HCs 
(hematopoietic progenitores derived from mES cells) as described by Pilat et al. (2005). Of 
note, ROSArtTAautoLuc does not only carry the autoregulated cassette integrated in the 
ROSA26 locus but constitutively expresses a second rtTA reading frame under control of the 
ROSA26 promoter (figure 27). 
Clone 6.2 ES-HCs did not show any detectable luciferase signal after 35d in culture neither in 
the absence nor in the presence of dox. This may be due to the nature of the integration site of 
the construct, since in vivo bioluminescence analysis of clone 6.2 derived transgenic mice had 
not revealed distinct expression levels in the hematopoietic system. Luciferase expression 
specific to the hematopoietic lineage would have yielded strong signals from organs like 
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spleen and heart which are well supplied with blood (confirmed by in vivo BLI analysis of 
lethally irradiated, surviving mice that had received bone marrow cells from transgenic donors 
expressing luciferase driven by the ROSA26 promoter, data not shown). 
ROSArtTAautoLuc ES-HCs showed weak yet regulated luciferase expression on day 60 in 
culture. The chromosomal location of the cassette should support expression in blood 
precursors in this case as Zambrowicz et al. (1997) could show that lacZ reporter levels are 
very well detectable in the hematopoietic system if expressed from ROSA26. The more than 
500 fold decrease of reporter signal in the induced state as compared to the ES cell state could 
be connected to the long period of culture. Decrease of transgene expression during culture of 
mammalian cells is commonly observed when selection pressure is removed, representing a 
major concern e.g. for the production of recombinant proteins (e.g. Garrick et al., 1998; 
Garrick et al., 1996; Migliaccio et al., 2000). As discussed previously for the heterogeneous
and tissue specific expression pattern in clone 1.1 and 6.2 transgenic mice, epigenetic 
silencing is a mechanism that is considered to play an important role in the shut down of 
transgene transcription, especially when the transgene is not expressed (Pankiewicz et al., 
2005; Zhu et al., 2007). However, this effect is dependent on the individual integration site of 
the transgene and loci have been identified which provide long term, stable expression in the 
absence of selection pressure (e.g. Schucht et al., 2006). Since ROSA26 permits constant 
expression even in transgenic mice one would assume that this genomic locus is not prone to 
silencing in cell culture.
Krishnan et al. (2006) investigated the impact of epigenetic reporter gene silencing by 
analysing the effect of a DNA methyltransferase inhibitor (5-azacytidine, 5-aza) and a histone 
deacetylase inhibitor (trychostatin A, TSA) on CMV promoter driven luciferase expression. 
For this purpose, the authors transfected the reporter construct into an embryonic rat 
cardiomyoblast cell line and followed luciferase expression for up to 8 months of culture in 
the absence of any selection pressure. A progressive decline of luciferase expression could be 
observed within the highest expressor clone which could partly be rescued by both 5-aza or 
TSA treatment whereas addition of the transcriptional activator retinoic acid only marginally 
restored reporter gene expression. The authors further found that after transplantation to rats 
the cells were twice as long detectable by in vivo BLI when they had been cultured in 
presence of 5-aza beforehand than without any treatment (2 weeks treated vs. 1 week non 
treated cells). Thus, loss of reporter gene expression due to epigenetic silencing can be a 
critical factor when tracking stem cell localisation, survival, and differentiation after 
transplantation in rodents  by in vivo imaging approaches.
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The drop of dox induced luciferase expression during culture of ROSArtTAautoLuc ES-HCs 
can probably be overcome by constant selection pressure simultaneously forcing expression 
of luciferase or by treatment with 5-aza or TSA. However, the former alternative precludes 
regulation of transgene expression while the latter might affect crucial properties of ES-HCs, 
since the chemicals have a broad impact on cellular characteristics and may lead to 
undesirable differentiation of cells. Hence, for optimal results, ES-HCs should be used for 
(transplantation) experiments as early as possible after generation from EBs avoiding long 
periods of culture.
The fact that inducibility of expression was maintained in ROSArtTAautoLuc ES-HCs 
although no basal expression was detectable can be explained by the pressence of the 
additional rtTA reading frame constitutively driven by the ROSA26 promoter. This feature 
renders regulated expression independent from basal levels to initiate the feedback loop. 
3.3 Perspectives 
3.3.1 Caveats and improvements 
Heterogenic and tissue specific reporter gene expression in mice generated from clones 1.1 
and 6.2 is supposed to be caused by the nature of the respective integration sites of the 
autoregulated cassette. Evaluation of promising loci in mES cell is complicated by the fact 
that differentiation can have a severe impact on transgene expression characteristics. For 
example, clone 1.1 had displayed high and well regulated luciferase levels in the ES cell state 
but lost these properties upon generation of transgenic animals. This once more emphasises 
the need to identify genomic loci that dependably support regulated transgene expression in 
somatic tissues. 
Thus, a larger number of tagged mES cell clones will have to be screened for an appropriate 
integration site. This should be done with pTagPAC/∆NPT since the complementation of the 
truncated npt gene can efficiently be exploited to select for correct targeting events (chapter 
2.3.2). Screening procedures will be extended to cells differentiated by teratoma formation 
because this method successfully mimicked expression in transgenic mice: analysis of 
teratomas derived from clone 1.1 showed no consistent regulation by dox just like in the clone 
1.1 transgenics.
Initiation of the autoregulated positive feed back loop requires basal expression. This has to 
be kept in mind when designing experiments with this system. While in many cases basal 
expression will impose no effect, e.g. if transgene levels do not exceed a certain threshold  
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required for eliciting a reaction, certain biological questions demand strict suppression of the 
regulated gene. The latter applies for instance when antigens need to be repressed during 
development of mice to avoid immune tolerance. Mouse models for pathogenesis of HCV and 
HBV infections are only valid if the mice are not tolerant to the viral proteins due to low level 
expression during ontogenesis. Low levels of tet regulated viral proteins in the repressed state 
could not be detected biochemically but still induced immune tolerance in transgenic mice 
(reviewed by Sun et al., 2007). Accordingly, the autoregulated system can be employed for 
the generation of transgenic mice if the general framework of the experiment agrees with 
basal exression.
The inherent basal expression of the autoregulated cassette may even have a beneficial effect 
since it has been shown that activity of a tet regulated transgene can prevent silencing in 
developing neurons of transgenic mice (Zhu et al., 2007).
An issue that might be specific for autoregulated systems is fluctuation of reporter gene 
expression observed in clones 1.1, 6.2, and ROSAautoLuc. This may be neglected if the 
response to a regulated transgene is elicited by reaching a certain threshold level and if the 
lowest induced protein level is sufficient to induce this response. In case the deviating 
luciferase levels reflect periodic oscillation instead of random fluctuations, this could add 
another aspect to transgene regulation. 
3.3.2 Advantages and possible applications
The autoregulated mode of expression has been shown to principally work in transgenic mice, 
as luciferase expression in clone 6.2 derived animals that displayed basal activity was 
inducible and reversible within less than 4d. Limitations like heterogeneous expression levels 
between mice and loss of regulation (clone 1.1 mice) were most likely due to adverse effects 
from the cassette’s integration site, but were not caused by the autoregulated expression 
system as such.
Autoregulated expression has several distinct advantages. First, all necessary regulatory 
elements are combined in a single cassette requiring only a single supportive integration site. 
Since tagged loci had been screened for their potential to facilitate regulated expression, any 
cassette – be it constitutive or regulated by another system than tet – should be well expressed 
after integration into this site by RMCE. Thus, maximal flexibility for the design of 
expression cassettes is provided.
Another benefit of autoregulated expression is the fact that only very low levels of the 
transactivator are present in the uninduced state. Long term, high amounts of tet dependent 
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transactivator have been shown to have adverse effects in certain cells (e.g. Strathdee et al., 
1999) which has to be avoided in particular in transgenic mice. 
The positive feedback loop generated by autoregulation may be exploited to determine 
activity of moderately active promoters. Instead of directly subjecting a reporter gene to the 
control of the promoter of interest, a transactivator may be utilised. In addition, a silent 
autoregulated reporter cassette carrying another copy of the transactivator has to be integrated. 
If the promoter is active, the first transactivator will trigger initiation of the autoregulated 
positive feedback loop which in turn will amplify the signal. This principle was put into 
practice in the design of ROSArtTAautoLuc (depicted in figure 27; the ROSA26 promoter 
driving the single rtTA gene may be substituted by the promoter of interest). 
Targeted integration of transgenes into defined chromosomal sites by RMCE would be of 
great benefit for the manipulation of adult stem cells as it facilitates predictable gene 
expression patterns. However, this approach is precluded by the limited time that adult stem 
cells may be kept in culture and the fact that these cells cannot be cloned. This difficulty can 
be circumvented by the use of mES cells which may be genetically manipulated by RMCE 
and subsequently differentiated in vitro. By this strategy, not only fully committed somatic 
cells can be generated but also multipotent progentiors which retain the potential to 
differentiate into a specific subset of cell types, e.g. hepatic progenitors (Heo et al., 2006) or 
hematopoietic stem cells derived from mES cells (Pilat et al., 2005). In vitro differentiation to 
ES cell derived progenitors and subsequent transplantation into recipient mice allows to study 
the effect of certain transgenes on the respective organ system. Hence, the directed 
differentiation of modified mES cells circumvents the need to establish transgenic mouse 
lines and significantly speeds up investigation of gene functions.
The autoregulated cassette is expressed in a stochastic, bimodal manner generating pools of 
expressing and non expressing cells at intermediate induction. In nature, one would at first 
expect that such an expression behaviour might have adverse effects on the cells and could 
even play a role in development of diseases (Kaern et al., 2005). Indeed, evidence was found 
that for expression of essential genes strategies have evolved to reduce the impact of 
fluctuations indicating the presence of a certain selection pressure on this feature (Fraser et 
al., 2004). However, stochastic gene expression provides a mechanism to generate 
phenotypically distinct subpopulations from an identical genetic background. For prokaryotes, 
this mechanism might be exploited to react to a changing environment or sudden stresses. In 
eukaryotic, multi-cellular organisms stochastic gene expression has been proposed to play a 
role in differentiation of cells into certain lineages (Fiering et al., 2000). If a gene that 
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determines differentiation into a defined lineage is expressed stochastically, probability of 
transcription appoints the percentage of cells that will commit to this lineage while all non 
expressing cells will remain undifferentiated.
So, since fate decisions are of a stochastic nature, an autoregulated transgene expression 
cassette would perfectly meet the requirements for modeling processes in cell differentiation 
and development (exemplified in figure 29 by the in vitro differentiation to hematopoietic 
precursors). These processes could then be described by systems biology, extending means to 
elucidate e.g. signal cascades.
mES cells                    ES-HC      differentiated 
       cells      
genetic manipulation,                                                              analysis of the impact of transgene 
       e.g. RMCE                                                                         expression e.g. on commitment to 
                                                                                                                specific lineages 
    in vitro
in vitro
                                 transplantation
differentiation                        or further  
                                                 differentiation
Figure 29: Employment of in vitro differentiation and autoregulated gene expression to investigate 
processes during hematopoietic development
mES cells are first genetically modified, e.g. by introduction of an autoregulated expression cassette into a 
predefined locus via RMCE. Cells are then differentiated to mES cell derived hematopoietic stem cells (ES-HCs) 
in vitro. Further differentiation may take place either in recipient mice after transplantation or in vitro while 
transgene expression probability may be controlled by the addition of intermediate amounts of inducer. This 
strategy circumvents the time consuming and expensive generation transgenic mice. 
In conclusion, autoregulated tet dependent expression from defined, RMCE targetable loci in 
mES cells will allow the rapid and simple generation of transgenic mice with conditional 
transgene expression. In addition, this system permits fast functional studies by in vitro
differentiation of modified mES cells.   
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4 Material and Methods
4.1 Equipment 
Table top centrifuges Eppendorf 5417C
Heraeus Biofuge 13
Heraeus Christ Minifuge GL
Hettich Rontana/S
Cooling centrifuges Sorvall Superspeed RC5
Minifuge Heraeus-Christ
Biofuge fresco
inflexible rotors: GSA, GS3, SS34
swing rotor: HB4
Photometer Nanodrop Spectrophotometer ND-1000, Peqlab
ELISA Reader Multiskan EX reader, Thermo Electron Corporation
Gelelectrophoresis systems BRL Horizon 58
BRL Horizon 1114
BRL Horizon 2025
Owl Separation System A2
Power supplies Desaga Mains Power Supply Unit 1200/200
Biorad Power Pac 300
Microscopes Leica Labovert FS
Nikon TMS
UV-chamber Hanau
Phosphoimager Molecular Dynamics Storm 860
Videograph Biotec Fischer Video densitometer
Mitsubishi thermo printer and personal computer
FACS machines & Software FACSCalibur, Becton Dickinson
FACSVantage SE, Becton Dickinson
Macintosh Quadra 650
Luminometer Berthold Lumat LB 9501
In vivo bioluminescence imageing 
machine
Xenogen IVIS 200 system, Caliper
Cell counter Casy-DT 1, Schaerfe Systems
Cell culture incubators Forma Scientifc Water-jacketed Incubator 3336
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sterile work benches Mecaplex, Sterilcard Hood VBM600 and SG400
Heraeus HLB 2448
Heraeus HSP 18
pH Meter Beckmann  M340
Thermomixer Eppendorf Thermomixer 5436
Vortexer Scientific Industries Vortex Genie 2
Shaker Heidolph
Supply of ddH2O Millipore MilliQ
Oven for hybridisations Robbins Scientific Hybridization Incubator 310
Stuart Scientific Hybridization Incubator
Electroporators Biorad Gene Pulser and Pulse Controller
MicroPorator MP-100, Digital Bio
Thermocycler T3 Thermocycler, Biometra
4.2 Material
Chemicals, enzymes, and cytokines were purchased from the following companies: Abbot, 
Amersham, Bayer, Biolabs, Biowest, Difco, Flow, Fluka, Gibco, Hoechst, ICN Biomedicals, 
Invitek, Invitrogene, JRH Biosciences, Macherey-Nagel, Merck, NEB, Peqlab, Pharmacia, 
Promega, Qiagen, R&D, Roche, Roth, Serva, Sigma, Stratagene, Synchem OHG, and USB. 
Oligomeres were ordered from MWG and DNA was sequenced by the “Genome Analysis” 
group headed by Dr. Helmut Blöcker.
Plasticware for culture of eukaryotic cells  was ordered from Corning, Costar, Gibco, Greiner, 
Nunc, Sarstedt, and Seromed.
Texts, graphics and tables of this work were created using the programmes Corel Draw, 
Word, Power Point, and Excel (Microsoft). Other programmes employed were: Image Quant 
version 5.0 (Molecular Dynamics) for analysis of autoradiographies; Vector NTI 5.0 
(Invitrogen) for the design of primers and cloning strategies; Living image 2.60.1 for analysis 
of BLI data; and Chromas Version 1.45 (Conor McCarthy, School of Health Science, Griffith 
University Queensland, Australia) for analysing sequencing results.
4.3 Basic techniques
4.3.1 Sterilisation
Glassware was sterilised by exposition to 180°C for 4h in a cabinet drier. Plasticware like 
eppendorf cups and pipette tips and solutions were autoclaved for 25min at 121°C.
Temperature sensitive solutions were sterilised by filtering (pore width 0,2µm, Sartorius).
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4.3.2 Agarose gelelectrophoresis
1 x TAE-Buffer 40mM Tris/acetate, pH 7,5 ; 20mM NaOAc ; 1mM EDTA
.-
5 x loading buffer 15% Ficoll, 50mM EDTA, 1 x TAE; 0,05% Bromophenolblue; 
0,05% Xylenecyanole
For pouring a 1% gel, 1g of Agarose was dissolved by boiling in 100ml 1 x TAE and 1µl 
ethidiumbromide (10mg/ml) was added. After the gel had become solid in the tray it was 
transferred to an electrophoresis chamber filled with 1 x TAE. DNA samples were mixed with 
5 x loading buffer and loaded to the gel. For determining the size of DNA fragments, a marker 
was loaded in parallel (Hyperladder I, Bioline). Electrophoresis was performed at 80-100V 
and 30mA. Gels were monitored under UV-light (360nm). 
4.3.3 Purification of DNA
Purification from Agarose gels:
For preparation of DNA fragments, bands were excised from the gel and DNA was purified 
with the “QIAquick” gel extraction kit (Qiagen) according to the manufacturer’s instructions.
Purification of DNA by Phenole treatment:
Phenole (Roth) re-distilled, in TE buffer equilibrated phenole (pH 7,8-8,0)
TE buffer 0,1mM EDTA;10mM Tris/HCL, pH 8,0
For removal of proteins the DNA solution was vortexed with the same volume of phenole. 
The sample was shortly centrifuged to separate the phases and the upper, aeqous phase was 
transferred to a fresh eppi. The same volume of Chloroforme/Isoamylalcohol (24:1) was 
added, vortexed and centrifuged again. After transferring the upper phase to a new eppi, this 
step was repeated to remove residual phenole. The upper phase from the last rinsing step was 
further treated as described in 4.3.4 to concentrate DNA. 
Purification of PCR samples
To purify DNA from PCR samples the “QIAquick” PCR purification kit (Qiagen) was used 
according to the manufacturer’s instructions.
4.3.4 Precipitation of DNA
LiCl/Ethanol 0,6M LiCL in ethanol (stored at –20°C)
Twice the volume of the sample of LiCl/ethanol was added to the DNA solution, shortly 
mixed and incubated on ice for 10min. The sample was centrifuged (15000 rpm, 15 min, 4°C) 
and the supernatant was removed. The pellet was washed twice with 70% cold ethanol (with 
intermediate centrifugation steps) to remove salts. The DNA was finally dried and redissolved 
as required.
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4.4 Modification of DNA
4.4.1 Restriction of DNA
DNA was digested with restriction endonucleases under conditions (buffer, temperature) 
reccommended by the manufacturer (NEB, Roche). Reactions were stopped by heat 
inactivation (20min at 65°C/80°C).
4.4.2 Fill in reaction of 5’ overhangs
10 x Klenow buffer 50mM Tris/HCL in ddH2O, pH 7,2; 10mM MgSO4; 0,1mM DTT
dNTP-Mix 1mM of dATP, dCTP, dGTP, and dTTP each
1µg of DNA with overhanging 5’ ends was treated with 1 U Klenow enzyme (NEB) in 
presence of 3µl dNTP-Mix in a total volume of 50µl. The sample was incubated for 30min at 
25°C and the reaction was stopped by heat inactivation (20min at 80°C).
4.4.3 Dephosphorylation of DNA fragments
10 x Phosphatase buffer 500mM Tris/HCl, pH 9,0; 10mM MgCl2, 1mM ZnCl2,; 
1mM Spermidine
To prevent religation of a restricted vector, 5’ and 3’ overhanging ends were 
dephosphorylated by alkaline phosphatase (shrimp alkaline phosphatase, SAP). 20-100pmol 
DNA with overhanging ends were incubated with 1 x  phosphatase buffer and 1-2 U SAP 
(total volume 50µl) for 30min at 37°C. The reaction was stopped by heat inactivation (20min 
at 80°C).
4.4.4 Ligation of DNA fragments
5 x Ligase buffer 250mM Tris/HCl, pH7,6; 50mM MgCl2; 25% (w/v) PEG8000; 
5mM ATP; 5mM DTT
2µl 5 x ligase buffer, 1 U T4-DNA Ligase (NEB), ~ 20fmol of vector backbone, and ~60fmol 
of insert were incubated in a total volume of 10µl for > 4h at room temperature (or over night 
at 16°C). The reaction was stopped by addition of 1µl 0,5M EDTA. The ligation was used for 
transformation of E. coli. 
4.4.5 Polymerase Chain Reaction (PCR)
PCR was used to amplify desired DNA sequences. Forward and reverse oligo-nucleotide 
primers for DNA synthesis were ordered from MWG. PCR comprises a sequence of 3 basic 
steps that are reapeted 25-35 times (“cycles”): during Denaturation, dsDNA is separated to 
single strands by high temperatures (94-96°C); Annealing requires lower temperatures for 
binding of the primers to their complementary sequences; Elongation involves synthesis of 
complementary strands by the polymerase starting from bound primers.
For standard PCR in this work, the BIOTAQ DNA polymerase from Bioline was used with 
the provided MgCl2 and NH4 buffer stocks.
4 Material and Methods
81
Average PCR sample:
10 x NH4 buffer 5µl
50mM MgCl2 3µl
10mM forward primer 2,5µl
10mM reverse primer 2,5µl
10mM dNTP Mix
(10mM of each dNTP) 
4µl
DMSO 1µl
BIOTAQ (2,5 U) 0,5 µl
DNA template as required
ddH2O ad 50µl
Average PCR programme (using T3 Thermocycler, Biometra):
1) 95°C 5min initial denaturation
2) 95°C 45s denaturation
3) ~55°C 1min annealing
4)* 70°C 2min elongation
5) 70°C 5min final elongation
6) 4°C pause
* steps 2-4 were repeated 30 times before proceeding to step 5.
Annealing temperatures depend on the length and the GC-concentration of primers. 
Elongation time is dependent on the length of the DNA fragment that needs to be amplified 
(30s/kb).
4.5 Southern Blot analysis
4.5.1 Generation of radioactively labelled DNA probes using “Rediprime” Kit 
(Amersham)
Labelling-Mix dATP, dGTP, dTTP; exonuclease free Klenow enzyme; random 
oligonucleotide primers (9mers; concentrations as provided by the 
manufacturer)
2,5-100ng DNA (probe for Southern Blot analysis) were diluted in 45µl ddH2O and denatured 
in a 95°C hot water bath for 5min. The sample was cooled for 5min on ice and pipetted to the 
Labelling-Mix (no mixing!). 5µl of α-32P-dCTP (Amersham) were added and the sample was 
incubated for 30-45min at 37°C after thoroughly mixing. The reaction was stopped by adding 
2µl 0,5M EDTA. Labelled DNA was purified from non integrated nucleotides via Micro-Spin 
G50 columns (Pharmacia Biotech). Loaded columns were centrifuged (2800rpm, 2min) and 
the probe was again denatured as described above. After cooling on ice it was used for 
hybridisation. Npt and luciferase probes were generated by digestion of pTagTK/NPT as 
described in the figure legend of the Southern Blot. 
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4.5.2 Generation of radioactively labelled λ-DNA Marker
10 x dNTP-Mix 25mM of dCTP, dGTP, and dTTP each
To determine the length of the fragments detected by Southern blotting, EcoRI/HindIII
digested and 35S labelled λ-DNA was used. For labelling, 1µg of digested λ-DNA was mixed 
with 2µl 10 x dNTP-Mix, 4µl α-35S-dATP (>1000 Ci/mmol) and 2 U Klenow enzyme in a 
total volume of 20µl. The sample was incubated at 37° for 1h or longer and the reaction was 
stopped by 20µl 0,5M EDTA. Labelled DNA was purified from non integrated nucleotides 
via Micro-Spin G50 columns (Pharmacia Biotech). The marker was stored at –20°C.
4.5.3 Isolation of High Molecular Weight (HMW) DNA from mammalian cells/tissues
Isolation of genomic DNA from cells grown on 6-wells:
Modified Bradley’s solution 10mM Tris/HCl, pH 7,5 ; 2mM EDTA ; 10mM NaCl ; 
0,5% SDS ; 1mg/ml Proteinase K  
NaAc/ethanol 75mM Sodium acetate in ethanol
Cells from a confluent 6-well culture dish were washed with PBS and 0,5ml Modified 
Bradley’s were added (proteinase K always freshly added). The sample was transferred to an 
eppi and incubated at 55°C over night. The next day, 1ml of cold NaAc/ethanol was added 
and DNA was precipitated for 2-3h at room temperature. The sample was inverted a few 
times and centrifuged to pellet the DNA (5000rpm, 5min). The supernatant was removed and 
0,5ml cold 70% were added and incubated for 30min at room temperature. After 
centrifugation, this washing step was repeated. The DNA pellet was dried and dissolved in 
30-50µl ddH2O or TE buffer (0,1mM EDTA, 10mM Tris/HCL,  pH 8,0).
Isolation of genomic DNA from cells grown on microtiter plates:
Lysis buffer 10mM TRIS/HCl, pH 7,5; 10mM EDTA, 10mM NaCl; 0,5% SDS; 
1mg/ml Proteinase K
NaCl/ethanol 150µl 5M NaCl in 10ml ethanol
Confluent microtiter plates were washed twice with PBS and 50µl of the lysis buffer were 
addded to each well (proteinase K freshly added). The plates were covered, sealed with tape 
and incubated in a humidified box at 55°C over night. The next day, 100µl cold NaCl were 
added and the plates were left at room temperature for 1h. They were centrifuged (1000rpm, 
5min, 4°C), the supernatant was removed and each well was washed with 150µl cold 70% 
ethanol. This washing step was repeated (after centrifugation) and the plates were dried. DNA 
was redissolved in 30µl of ddH2O or TE buffer.
.
Isolation of DNA from mouse tail tips:
For isolation of genomic DNA from tail tips the DNeasy 96 Blood & Tissue Kit, Qiagen) was 
used according to the manufacturer’s instructions. The DNA dissolved in 400µl ddH2O was 
precipitated at 4°C over night by addition of 50µl 4M LiCl and 400µl Isopropanol. Samples 
were centrifuged (13000rpm, 5min, 4°C) and the pellet was washed twice with 0,5ml 70% 
ethanol with intermediate centrifugation steps. After drying, the pellet was redissolved in 50µl 
ddH2O or TE buffer.
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4.5.4 Restriction of HMW DNA for Southern blotting
8-10µg of genomic DNA were digested over night in a total volume of 20µl with 2µl 10 x 
reaction buffer, 0,5µl RNase (10µg/ml), 0,5µl BSA (100x) and 20-40 U restriction enzyme at 
the required temperature. Samples were mixed with 5 x loading buffer and loaded to a 0,8% 
agarose gel. A marker prepared as described in 4.5.2 was also loaded to determine length of 
fragments after Southern Blotting. Electroporation was performed with 80-100V.
4.5.5 Transfer of DNA to membrane
Electrophoretically separated DNA fragments were transferred from the agarose gel to a 
positively charged nylon membrane (Hybond-XL, Amersham). The agarose gel was treated 
with 0,4N NaOH for 10min and put upside down on a tray covered with Whatman paper 
(3mm). The paper was soaked with 0,4N NaOH and its ends were immersed in a basin with 
the same solution. The surface of the gel was covered with the wet nylon membrane and two 
layers of wet Whatman paper were added. A thick layer of absorbent paper tissue and a light 
weight were put on top. After >6h of DNA transfer from gel to membrane the membrane was 
neutralised in 2 x SSC and fixed for 2h at 80°C.
4.5.6 Hybridisation of transferred DNA
Hybridisation solution 1M NaCl; 50mM tris/HCl, pH 7,5 ; 10% Dextransulfate ; 1% SDS ;
250µg/ml salmon sperm DNA (sonicated) (stored at –20°C)
20 x SSC 3M NaCl; 0,3M Na3citrate, pH set to 7,0 with HCl
Wash solution 2 x SSC; 0,5% SDS
20ml of hybridisation solution were thawed, boiled for 5min in a water bath and cooled to 
65°C. It was then transferred to a prewarmed hybridisation tube and the membrane was put 
into the same tube with the DNA carrying side pointing inwards. The radioactively labelled, 
denatured probe was added and the membrane was hybridised at 65°C over night in a rotating 
rack. The next day, the membrane was washed 5min with the wash solution at RT and another 
30min at 65° while gently shaking. It was kept wet and wrapped in cling film before 
exposition in an appropriate cassette (Molecular Dynamics). Phospho screens were imaged 
after > 6h exposition with a Molecular Dynamics Storm 860 Phosphoimager.
4.5.7 Stripping of membranes and rehybridisation
To remove the old probe the membrane was washed with boiling 0,1% SSC/0,5%SDS 
solution for  ~30min. The membrane may be checked for residual probe by exposition and 
rehybridised as described above. 
4.6 Culture and manipulation of E. coli
4.6.1 Used strains
XL1-Blue recA1, endA1, gyrA96, thi-1, hsdR17, suppE44, relA1, lac [F’ proAB, 
lacIqZ∆M15, Tn10, (tetr)]
DH10B mcrA, mcrB, mmr, hsdR17, deoR, recA1, endA1, lacZDM15
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4.6.2 Media
LB-medium 10g/l Bacto-Trypton; 10g/l Bacto-Yeast extract, 5g/l NaCl
Ampicillin 50mg/ml ampicillin in ethanol, filter sterile
SOG-medium 20g/l Bacto-Trypton; 5g/l Bacto-Yeast extract, 10mM NaCl; 2,5mM 
KCl, 10mM MgCl2; 10mM MgSO4, 20mM glucose
(MgSO4 and glucoser were added directly before use.)
Preparation of Agar plates: 
15g agar were added to 1l LB-medium and boiled. After cooling the medium to ~45°C, 1ml 
of the ampicillin stock was added if required and ~30ml were poured into each petri dish.
4.6.3 Electrotransformation of competent bacteria
Generation of electrocompetent bacteria:
E. coli was cultured over night in 10ml LB-medium at 37°C while shaking (180rpm). This 
pre-culture was added to 1l of LB-medium the next morning and cultivated as described 
before. When the culture reached an optical density of 0,6 to 0,8 at 600nm (indicating 
exponential growth), it was centrifuged (3000rpm, 10min, 4°C, GS3-rotor) and resuspended 
in cold, sterile water. The bacteria were pelleted again by centrifugation and resuspended in 
20ml cold, 10% glycerol solution. Another centrifugation step followed (3500rpm, 15min, 
4°C, SS34-rotor). The pellet was resuspended in 2-3ml cold, 10% glycerol solution and 50µl 
aliquots were shock frozen in liquid nitrogen and stored at -70°C. Competence of bacteria 
may be determined by transformation with a standard plasmid.
Electrotransformation of competent bacteria:
An aliquot of competent bacteria was thawed on ice and ~1µl of DNA or ligation sample were 
added and mixed. The suspension was transferred to a cooled electroporation cuvette (2mm, 
Peqlab). Electroporation was performed using a Biorad Gene-pulser with pulse controller at 
2,5kV, 25µF and 200Ω. The pulse should last for 4-5ms. The sample was immediately 
transferred to 1ml SOG-medium and incubated for 30min at 37°C while shaking (180rpm). 
Aliquots of the suspension were spread on agar plates containing the required selection drug 
and incubated at 37°C over night for growth of resistant colonies.
4.6.4 Preservation of E. coli strains
For short term storage E.coli was expanded over night at 37°C on agar plates and 
subsequently kept at 4°C. For long-term storage 500µl of suspension culture were mixed with 
500µl 87% glycerol solution and stored in glass tubes at -70°C. 
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4.6.5 Small scale plasmid DNA isolation for analysis
STET buffer 80g/l Sucrose; 0,5% Triton X100; 50mM EDTA; 10mM tris/HCl 
pH8,0
TE buffer 0,1mM EDTA;10mM Tris/HCL, pH 8,0
Lysozyme 10mg/ml Lysozyme in TE buffer
Ammonium acetate 8M NH4OAc
TE RNase 10µg/ml RNase A in TE buffer 
2ml of LB-medium containing 50µg/ml ampicillin were inoculated with the respective E.coli
clone and cultured over night at standard conditions. Suspensions were transferred to eppis, 
centrifuged (13000rpm, 1min) and the supernatant was discarded. Pellets were resuspended in 
500µl STET buffer. After addition of 50µl lysozyme solution samples were incubated for 2-
3min at room temperature. The reaction was stopped by heat inactivation (95°C, 90s) and the 
eppis were centrifuged (13000rpm, 1min). The viscous pellets were removed with toothpicks 
and 50µl ammonium acetate and 500µl Isopropanol were added to the lysate. Samples were 
again centrifuged (13000rpm, 1min) to precipitate the DNA, the supernatant was removed and 
pellets were dried. The DNA was redissolved in 40-50µl of TE RNase.
4.6.6 Large scale plasmid DNA isolation (Qiagen Plasmid Maxi Kit)
For isolation of large amounts of plasmid DNA, the Plasmid Maxi Kit from Qiagen was used 
with the provided solutions according to the manufacturer’s instructions. For this purpose, 
200ml LB-medium containing the appropriate selection drug were inoculated with the desired 
E.coli clone and incubated over night (37°C, 180rpm). The suspension was pelleted by 
centrifugation (3000rpm, 10min, 4°C, GS3-rotor) and treated as described in the kit’s manual. 
DNA was dissolved in adequate amounts of TE buffer.
4.7 Culture and manipulation of eukaryotic cells
4.7.1 Cells and cell lines used
IB10 Subclone of murine embryonic stem cell line E14 derived from 129/Ola 
mouse strain blastocysts (Robanus-Maandag et al., 1998; Hooper et al., 
1987)
MEFs primary embryonic mouse fibroblasts isolated from different mouse 
strains  (129/Ola x Balb/C chimaeric embryos for analysis; C57BL/6J 
for feeder cells supporting mES cell culture)
293EBNA-LIF HEK293T cells stably expressing Leukaemia Inhibitory Factor (LIF) 
and recombinant LIF were provided by Dr. Martin Hafner (cloning  and 
cell culture) and Dr. Werner Müller from the department of 
“Experimental Immunology” (design of producer cell line employing 
EBNA system)
HEK-293T human embryonic kidney cell line transformed by adenovirus type 5 
(DSMZ ACC 110), into which the temperature sensitive gene for SV40 
T-antigen was inserted  
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4.7.2 Media components
for mES cells: DMEM+GlutaMAX-I (Gibco)DMEM 
(Dulbecco’s Modified Eagle’s 
Medium)
for differentiated cells: 13,63 g/l DMEM powder (Sigma,    
                                                     already containing sodium   
                                                      pyruvate, high glucose)
44 mM NaHCO3
                                     10 mM HEPES
                                      pH 7,2
PBS (phosphate buffered 
saline)
140 mM NaCL
  27 mM KCl
 7,2 mM Na2HPO4
14,7 mM KH2PO4
pH 6,8-7,0
TEP (trypsin EDTA) 6 mM EDTA; 0,1 % trypsin (Sigma) in PBS
100 x Pen/Strep 6,06 mg/ml ampicillin (10000 U/ml), 10 mg/ml streptomycin; set 
pH to 7,4 by addition of NaOH for dissolving 
(stored at –20°C)
100 x Glutamine 29,23 mg/ml Glutamine (stored at –20°C)
Gelatin solution 2% stock solution Type B: from bovine skin (Sigma); diluted to 
0,1% (w/v) with PBS for use (stored at 4°C)
for mES cells: ICN Biomedicals GmbHFCS 
(Fetal Calf Serum) for other cell lines: JRH Bioscience, Biowest
LIF
(Leukaemia Inhibitory Factor)
500-800µl/500ml supernatant; produced as described in 4.7.5
100 x Sodium Pyruvate 100 mM sodium pyruvate (Gibco)
100 x Nonessential 
Amino Acids 
Gibco
1000 x β-
Mercaptoethanol
100 mM β-mercaptoethanol (7,014µl/ml in ddH2O, filter sterile; 
stored at –20°C)
Doxycycline 2mg/ml doxycycline-hyclate (Sigma) in 70% ethanol, filter sterile 
(stored at –20°C)
G418 100mg/ml G418 in ddH2O, filter sterile (stored at –20°C)
Puromycin 5mg/ml puromycin in ddH2O, filter sterile (stored at –20°C)
Ganciclovir 10 mM ganciclovir in H2O (stored at 4°C)
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4.7.3 Media composition
for mES cells: 1 x Pen/Strep
1 x Sodium Pyruvate
1 x Nonessential amino acids
1 x β-Mercaptoethanol
15% FCS (heat inactivated: 30 min at 56°C)
500-800µl LIF/500ml
DMEM+GlutaMAX-I (Gibco)
for MEFs: 
(“5+” medium)
1 x Pen/Strep
1 x Glutamine
1 x nonessential amino acids
1 x β-Mercaptoethanol
10% FCS
DMEM 
for HEK-293 derived cells: 
(“3+” medium)
1 x Pen/Strep
1 x Glutamine
10% FCS
DMEM 
4.7.4 Culture of mammalian cells
mES cells were grown on suitable culture dishes either coated with gelatin or with feeder cells 
(preparation described in 4.7.6.1). For gelatin coating, a 0,1% gelatin solution was added so 
that it completely covered the surface of the dish. After incubation for > 15min at 37°C  
excess of gelatin was aspirated and dishes were used for culture. mES cells were kept at 37°C 
and 7% CO2 in humidifying incubators. The medium was changed daily and cells were split at 
~ 75% confluence (every 2-3d).
All other cells/cell lines were kept on untreated cell culture dishes at 37°C and 5% CO2 at 
maximal humidity. Medium was changed every 3-4d and cells were passaged at confluence.
For passageing, cells were washed with PBS and incubated with TEP for < 3min at 37°C. 
Detached cells were taken up in fresh medium and transferred to new culture dishes.
For determining the number of suspended cells an aliquot of the suspension was counted with 
a CASY-1 DT cell counter (Scharefe Systems, Germany). 
4.7.5 Production of LIF
Culture supernatant of LIF expressing 293EBNA-LIF cells was either produced by fermenter 
culture by Dr. Mariela Bollati Fogolin (formerly group of “Experimental Immunology” 
headed by Dr. Werner Müller) or by conventional cell culture. For the latter, cells were grown 
on big culture flasks in the presence of 0,3µg/ml puromycin. At ~ 80% confluence, the 
medium was changed removing puromycin pressure. The supernatant was harvested after 3 d, 
sterile filtered  and stored at - 20°C. Concentrations of LIF required for mES cell culture were 
determined by a growth assay culturing mES cells in presence of different dilutions of the 
supernatant. mES cells were assayed for appropriate morphology and the second lowest LIF 
concentration that produced undifferentiated mES colonies was used for preparing mES cell 
media (500-800µl/500ml).
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4.7.6 Preparation of Mouse Embryonic Fibroblasts (MEFs)  
For isolating MEFs, pregnant mice were sacrificed at day 13,5 by cervical dislocation and 
disinfected with 70% ethanol. Embryos were extracted and transferred to a dish with PBS.
The amniotic sac, the head and the blood building organs from each embryo were removed 
using forceps and a scalpel. The embryos were then chopped up to very small pieces which 
were taken up in 5ml of TEP and transferred to 15ml tubes. During an incubation time of 
30min at 37°C, tubes were thoroughly shaken every  5min. The suspension was transferred to 
50ml tubes and 30ml of medium were added for washing. Cells were pelleted (1000rpm, 
5min) and the supernatant was aspirated. The washing step was repeated and the cells 
obtained from one embryo were finally seeded to two 10cm culture dishes.
4.7.6.1 Use of MEFs as feeder cells for mES cell culture
For use as feeder cells supporting culture of mES cells, MEFs were expanded on 25 cm dishes 
for 4-5 passages, harvested by TEP and irradiated with ~24,8Gy (700s at a dose rate of 127,6 
Gy/h). Irradiation inhibits further cell division preventing potential overgrowth of feeders 
when coculturing mES cells. Irradiated feeders were cryoconserved for later use. When 
needed, they were thawed and seeded at a density of ~ 2,5x104 cells/cm2. 
4.7.7 Long term storage of mammalian cells
Cells were harvested with TEP and pelleted at 1000rpm for 5min. The pellet was resuspended 
in 0,5-1ml freeze medium (mES cells: 90% FCS, 10% DMSO; all other cells: 95% FCS, 5% 
DMSO) and transferred to cryo vials (Corning). For freezing cells a slow decrease of 
temperature is required. Thus, mES cells were frozen in isopropanol filled containers at-70°C. 
After > 1d they were transferred to liquid nitrogen for long term storage. All other cells were 
kept on ice for 30min and at –70°C for 24h  prior to storage in liquid nitrogen. Thawing was 
performed fast in a 37°C water bath and cells were washed with medium to remove residual 
DMSO. After centrifugation (100rpm, 5min) and aspiration of the supernatant they were 
seeded to fresh cell culture dishes. 
4.7.8 Production of HoxB4 transmitting viral particles
HoxB4 transmitting retroviral particles pseudotyped with VSV envelope protein were 
transiently produced by calcium phosphate transfection of the required plasmids into HEK-
293T cells as described in 4.7.9.2. 107 cells were seeded to a 25cm culture dish and 
transfected the following day with 2 ml CaCL2/HEBSbuffer containing 60µg of pSVGP1, 7µg 
of pVSV-G, and 20µg pHoxB4-2A in a total volume of 15 ml medium. Medium was 
exchanged for 10ml fresh medium containing 20mM HEPES after 6-12h and the supernatant 
was harvested twice at 48 and 72h post transfection. It was then filtered (pore width 0,45µm) 
and stored at –20°C. 
4.7.9 Gene transfer methods
4.7.9.1 Infection of mES cells with pHoxB4 retroviral particles
For transduction of mES cells with HoxB4 retroviral particles 106 cells were seeded to a 
gelatinised 10 cm dish and infected with a multiplicity of infection (moi) < 0,01 (i.e. less than
0,01 infectious particles/cell) on the following day.
The moi of the respective supernatant batch (produced as described in 4.7.8) was determined 
by test infections of mES cells with serial dilutions and subsequent FACS analysis (pHoxB4 
coexpresses eGFP).
8µg/ml polybrene were mixed with the concentrated viral supernatant which was then added 
to the cells (5ml on 10 cm dishes; 1ml on 6-wells). To reduce the probability of differentiation 
of mES cells, adequate amounts of LIF were added. After 10-18h cells were split to feeder 
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coated dishes and the pool of eGFP expressing mES cells was isolated by FACS 2d post 
infection (4.7.11).
4.7.9.2 Transfection by calcium phosphate/DNA precipitation 
2 x HEBS buffer 280mM NaCl, 50mM HEPES, 1,5mM Na2HPO4, pH 7,1 (filter sterile)
CaCl2 solution 2,5 M CaCl2 in ddH2O (filter sterile)
5 x 105 mES cells were seeded to gelatinised 6-wells for targeting approaches by CaPO4
precipitation. Similarly, HEK-293T cells were seeded as described in 4.7.8 for the production 
of retroviral particles. The next day, the DNA(s) to be transfected were mixed with the CaCl2
solution in a 5ml tube (15µl 2,5M CaCl2, x µl DNA, ddH2O ad 150µl for one 6-well; scale up  
to 1ml for a 25cm dish). The same amount (i.e. 150µl and 1ml, respectively) of 2 x HEBS 
buffer was slowly added while vortexing the tube. The mixture was incubated at room 
temperature for 3-10min and then added to the culture dish. Medium was changed after 6-12h. 
If needed, cells were induced with 2µg/ml dox after one day and selection pressure was 
imposed 2d post transfection. 
4.7.9.3 Electroporation of mES cells
Plasmid DNA was digested and purified as indicated in tables 1 and 6. 106-107  mES cells 
were harvested per electroporation, centrifuged (1000rpm, 5min) and the pellet was washed 
with PBS to remove residual medium. For electroporation with the Gene Pulser (Biorad) cells 
were resuspended in 500-700µl PBS, the DNA was added and the sample was transferred to 
an electroporation cuvette (4mm, Peqlab). Electroporations were performed under conditions 
indicated in tables 1 and 6. When applying the Microporator technology (Digital Bio), 100µl 
electroporation tips were used according to the manufacturer’s instructions (details see table 
6). After electroporation, cells were taken up in fresh medium containing 2µg/ml dox and 
seeded to feeder coated 10 cm dishes. Selection was started 2d after electroporation by either 
0,4mg/ml G418 or 1µg/ml puromycin in the presence of dox. Resistant clones were picked 
after 9-14d.
4.7.9.4 Transfection using commercial transfection reagents
5 x 105 mES cells were seeded to gelatinised 6-wells. GenePorterTM2 (Peqlab), FuGENE6 
(Roche) and Lipofectamine2000 (Invitrogen) were used for DNA transfer according to the 
manufacturers’ instructions. Of note, Lipofectamine2000 yielded the highest transfection 
efficiency in mES cells (7µl Lipofectamine2000/transfected 6-well). For targeting using 
Lipofectamine2000, 2,5µg of the Flpe expression vector and 1,5µg of the targeting vector 
were cotransfected. Medium was removed after 6-12h and cells were passaged to feeder 
coated 10 cm dishes in the presence of 2µg/ml dox. Selection was started 2d post transfection 
by either 10µM GCV and 0,4mg/ml G418 (pTagTK/NPT targeting) or solely 0,4mg/ml G418 
(pTagPAC/∆NPT targeting) in presence of dox. Resistant subclones were picked after 9-14d.  
4.7.10 Isolation of selected clones
Colonies of drug resistant clones were marked on the bottom of the culture dish. The plate 
was washed with PBS and a small amount of fresh PBS was added that covered the surface of 
the dish. The plate was put under a microscope in the clean bench and colonies representing 
cell clones were gently removed with a 20µl Gilson pipette. Cells were transferred to a 
microtiter dish, digeseted with 20µl of TEP for 1-2min, taken up in 150µl medium and 
transferred to fresh microtiter wells from which they were expanded..  
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4.7.11 Fluorescence Activated Cell Sorting (FACS)
FACS was used to determine titers of eGFP producing viral particles, to sort for pHoxB4-2A 
infected mES cells and to test co-transfection efficiency of two plasmids (eGFP and dsRed 
expression vectors). For FACS, cells were washed with PBS, harvested with TEP and  
resuspended in FACS buffer (PBS with 2% FCS) after centrifugation (1000rpm, 5min). Dead 
cells were stained by 50µg/ml propidium iodide when required. Analysis of cells was 
performed with a FACSCalibur machine (Becton Dickinson). Debris was eliminated from 
analysis by setting the forward scatter < 200 as were dead cells by excluding propidium 
iodide positive signals. Sorting of eGFP positive cells was done with a FACSVantage SE 
(Becton Dickinson).
4.7.12 In vitro differentiation of mES cells
4.7.12.1 Unspecific in vitro differentiation
Undirected differentiation of mES cells was performed by seeding ~7,5 x 105 cells in 13ml of 
3+ medium to bacterial dishes to prevent cells from adhering to the culture dish surface. 
Suspension culture and concomitant withdrawal of LIF led to the formation of embryoid 
bodies (EBs) which to a certain degree mimic developmental processes of a normal embryo. 
EBs were cultured for 5d, harvested by centrifugation (500rpm, 5 min) and plated to 
gelatinised 10cm dishes. There, they attached to the surface of the dish and formed so called 
“outgrowths” of differentiated cells. Cells were dissociated by TEP and split to gelatinised 6-
wells 4d later. They were cultured for another 4d in the presence or absence of dox. Finally, 
samples were harvested for analysis of luciferase activity.
4.7.12.2 In vitro differentiation to hematopoietic progenitors
IMDM
(Iscove’s modified Dulbecco’s 
medium)
IMDM powder as supplied by Gibco (already containing  
            glutamine and 20mM HEPES)
30,2g NaHCO3
ddH2O ad 10l
pH 7,2
IMDM based mES cell 
medium
1 x Pen/Strep
1 x Sodium Pyruvate
1 x Nonessential amino acids
1 x β-Mercaptoethanol
15% FCS (heat inactivated: 30 min at 56°C)
500-800µl LIF/500ml
IMDM
2 x Methylcellulose stocks
(prepared as described in 
4.7.11.3)
20g methylcellulose (Fluka)
IMDM powder 
3,025g NaHCO3
1l ddH2O
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Diff-medium 1 x Pen/Strep
1 x Glutamine
15% FCS
  5% PFHM-II (protein free hybridoma medium, Gibco)
300µg/ml human holo-transferrin (Sigma)
0,4mM MTG (monothioglycerol)
50µg/ml ascorbic acid
50% 2 x Methylcellulose stock
IMDM
SCM (Stem Cell Medium for 
culture of ES-HCs)
(prepared as described in 
4.7.11.4)
         1 x Pen/Strep
100ng/ml mSCF (murine Stem cell factor,Sigma)
    2ng/ml mIL3 (murine interleukin 3, R&D)
  10ng/ml Flt3-L (murine Flt3 ligand, R&D)
    5ng/ml hIL6 (human interleukin 6, R&D)
  40ng/ml Long R3 IGF-1 ( recombinant insulin-like growth    
factor analogue, Sigma)
1µM dexamethasone (Sigma)
StemPro34 + Nutrient supplement (Gibco)
In vitro differentiation of mES cells to ES-HCs (hematopoietic progenitors derived in vitro
from mES cells) was performed according to Pilat et al. (2005). Pools of mES cells 
overexpressing HoxB4 (established as described in 4.7.8, 4.7.9.1, 4.7.11) were cultured for 2d 
in IMDM based ES cell medium. Cells were harvested with TEP, centrifuged (1000rpm, 
5min) and washed with IMDM ES cell medium without LIF to remove any residual LIF that 
might disturb differentiation. 105 cells were taken up in < 500µl of IMDM-ES (without LIF) 
and pipetted on top of 20ml warm Diff-medium in a 50ml tube. The tube was vortexed to 
distribute the cells in the viscous medium. It was kept in a 37°C water bath for a few minutes 
until the majority of air bubbles had disappeared. The suspension was plated in a spiral on a 
25cm bacterial dish and the medium was dispersed by gently tilting the plate. The dishes were 
put into a box with a lose lid, wrapped in a plastic bag with small holes and areated for a few 
seconds with CO2 (this was done whenever handling the cells). The box was then kept for EB 
formation at 37°C, 7% CO2 and maximal humidity. On day 3 of differentiation, 10ml of fresh 
Diff-medium were added and dispersed by gently tilting the dish. Medium was changed on 
day 5: the plate was tilted and the suspension was carefully harvested with a plastic pipette 
(wide aperture prevents destruction of EBs) and transferred to a 50ml tube. The dish was 
washed with warm IMDM to recover all EBs. The tube was centrifuged at low speed 
(300rpm, 5min) and the supernatant was removed. EBs were carefully resuspended in fresh 
Diff-medium and replated using plastic pipettes. On day 6 or 7, EBs were harvested as 
described before and dissociated. For this purpose, the EB pellet was washed with PBS and 
3ml of TEP were added. The tube was incubated in a 37°C water bath and dissociation was 
stopped by addition of 3µ prewarmed FCS as soon as the suspension became cloudy (i.e. 
disaggregation of EBs). Cells were vigorously pipetted up and down, centrifuged (1000rpm, 
5min) and washed with PBS to completely remove FCS. A single cell suspension was 
obtained by using a cell strainer (70µm, Becton Dickinson). Cells were counted, centrifuged 
(1000rpm, 5min) and the pellet was resuspended in SCM and transferred to suspension 6-well 
plates. Cells were kept at a density of at least 106 cells/ml and debris and terminally 
differentiated cells were removed from the culture by Ficoll centrifugation (4.7.12.5) 2-3 
times per week. At least 50% of the medium was changed every day. Control cells not 
expressing HoxB4 stopped growing after approximately 35d.
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4.7.12.3 Preparation of 2x methylcellulose stocks
For preparation of 1l 2 x methylcellulose stock one sterile erlenmeyer flask was weighed and 
filled with 450 ml ddH2O. The water was boiled on a heater and 20g methylcellulose (Fluka) 
were added. This was simmered for 10min while being mixed with a magnetic stirrer, boiled 
up shortly for dissolving and sterilising and let cool down to room temperature. IMDM 
powder for 1l and 3,025g NaHCO3 were dissolved in 450ml ddH2O and filtered sterile. This 
2x medium was poured to the methylcellulose while stirring. ddH2O was added to a final 
weight of 1000g (- weight of flask). The stock was moved to 4°C and stirred over night. The 
next day, aliquots of ~40ml were poured into 50ml tubes and shock frozen in liquid nitrogen. 
The aliquots were stored at –70°C. For preparation of Diff-medium an adequate number of 
stocks was thawed over night at 4°C and centrifuged (2000rpm, 10min). 5ml of each 
methylcellulose stock were left in the tube to get rid of fibrous cellulose debris. 
4.7.12.4 Preparation of SCM (stem cell medium for culture of ES-HCs)
500ml StemPro34 was mixed with the 13ml of Nutrient supplement (Gibco) and adequate 
amounts of IGF-1 (dissolved as reccomended by the manufacturer), dexamethasone (1mM 
stock in 96% ethanol) and Pen/Strep were added as given in 4.7.12.2. After mixing, 45ml 
were aliquoted into 50ml tubes and shock frozen in liquid nitogen. These stocks were stored 
at –70°C. When needed, stocks were thawed over night at 4°C and cytokines were added 
freshly. Cytokine stocks had been prepared by dissolving the lyophilised powders in 0,1% 
BSA in PBS and aliquots were stored at –70°C.
cytokine stock concentration amount added to 45ml SCM
mIL3 20µg/ml 4,5µl
hIL6 20µg/ml 11,25µl
Flt3-L 100µg/ml 4,5µl
mSCF 100µg/ml 45µl
4.7.12.5 Ficoll gradient centrifugation
ES-HC cultures were cleared from debris and terminally differentiated cells by Ficoll density 
centrifugation 2-3 times per week. Cell suspensions were transferred to 15ml tubes. 3-5ml of 
cold Ficoll (Biochrom) were carefully pipetted under the cell suspension and the tubes were 
centrifuged (2100rpm, 10min). Upper phase and interphase containing the healthy cells were 
transferred to fresh tubes and centrifuged again (1200rpm, 5min). The pellet was resuspended 
in fresh SCM.
4.8 Protein analysis
4.8.1 Extraction of proteins from cells
To determine expression levels of firefly luciferase all water soluble proteins had to be 
extracted from the cells. For this purpose, cells were harvested from 6-wells and the cell pellet 
was resuspended in 50µl Tris-HCL (pH 7,6) by vortexing. Cells were broken by 4 repeated 
freeze-and-thaw cycles in liquid nitrogen and a 37°C water bath, respectively. After 
centrifugation (15000 rpm, 10min, 4°C) the supernatant was used for luciferase and BCA 
assays.
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4.8.2 Luciferase assay
Firefly luciferase catalyses oxidation of D-luciferin to oxyluciferin. Detection of 
concomitantly emitted photons allows to determine expression levels of the luciferase reporter 
gene.
Luciferase buffer 25mM glycylglycine, 15mM MgSO4 in ddH2O, pH 7,8 
(stored at 4°C)
ATP solution 5mM ATP in ddH2O, pH7,5 (stored at –20°C)
Luciferin solution 0,1mM synthetic D-luciferin (Promega), 25mM 
glycylglycine in ddH2O, pH 7,8 (stored at –20°C)
reaction buffer 1:5 ATP solution : luciferase buffer
10µl of the protein lysate (4.8.1) were added to 400µl of reaction buffer in a suitable tube and 
emitted light was measured with a Lumat LB9507 (Berthold) Luminometer after automatic 
injection of 50µl luciferin (measurement period: 10s). Luciferase activity was measured in 
relative light units (rlu).
4.8.3 BCA assay for determining protein concentration of samples
Results from the luciferase assay were normalised by relating them to the total protein content 
of the sample. Amounts of protein were determined by the BCA assay.
BCA A solution         1g bicinchoninic acid
    1,71g Na2CO3
    0,95g NaHCO3
    0,16g Na2Tartrat
   100ml ddH2O
pH set to 11,25 with 10N NaOH (stored at 4°C)
BCA B solution 4g CuSO4 x 5 H2O/100ml dissolved in ddH2O (stored at 4°C)
Reaction solution 98% BCA A, 2% BCA B, freshly prepared
Protein standard 5mg/ml lysozyme in ddH2O (stored at –20°C)
The first row of wells of a microtiter plate for optical tests was filled with 190µl of the 
reaction solution each. 100µl of the solution were added to all other wells. 10µl of Tris-HCL 
(pH 7,6) were pipetted into the first well of the first column to determine the background 
signal. 10µl of the protein standard were added to the first well of the second column to 
establish a calibration curve. The remaining wells of the first row were topped up with 10µl of 
each protein lysate. Contents of the first row were mixed by repeated pipetting using a 
multichannel pipette. 100µl of the first row were then transferred to the second row and mixed 
again. This was repeated to the last row of the dish and finally the excess of 100µl/column 
was discarded. The plate was incubated for 30-60min at 37°C and absorption at 595nm was 
measured by a Multiskan EX reader (Thermo Electron Corporation). Values from the first 
column were automatically subtracted. Protein concentrations were calculated on the basis of 
the calibration curve.
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4.9 Mouse strains
C57BL/6 Harlan
Balb/C Harlan
129/Ola Since transgenic mice were derived of IB10 mES cells 
injected into Balb/C blastocysts, they were of a mixed 
129/Ola/Balb/C background
CD1 Harlan; females were used as foster animals for 
blastocyst transfers
Rag-2/interleukin 2 gamma chain 
double KO mice 
(immunodeficient mice lacking B, 
T and NK cells; first described by 
Mazurier et al., 1999)
Double KO mice were generated by mating Rag-2 
deficient animals (Shinkai et al., 1992) to the interleukin 
2 receptor gamma chain KO strain (DiSanto et al., 1995); 
Double KO mice were of C57BL/6 background
4.9.1 Breeding and keeping of mice
Mice were bred and kept according to the common obligations in the central animal facility of 
the Helmholtz Centre for Infection Research. When needed, animals were administered with 
2mg/ml dox via the drinking water or with 2mg/100µl by gavage.
4.9.2 Induction of teratomas in mice
For teratoma induction, mES cells were harvested with TEP, counted and washed with PBS. 
After centrifugation (1000rpm, 5min), the pellet was resuspended in fresh PBS and kept on 
ice until 100-200µl containing 0,5-2x 106 were injected subcutaneously into the sides of 
anaesthetised Rag-2/interleukin 2 gamma chain double KO mice. These mice are 
immunodeficient and unable to reject the cells. Some, but not all injected mice developed 
tumors after 3-4 weeks. A good qualitiy of injected cells is critical for teratoma formation 
efficiency. Tumor bearing animals were subjected to dox treatment and imaged by in vivo BLI 
as described (figure 16). Of note, some factors limit the quantification of luciferase signals 
from teratomas: 1) individual tumors display different growth rates, 2) images of the same 
tumor on different days are not directly comparable since increase in size also augments 
luciferase signals, and 3) luciferin might penetrate individual teratomas with different rates. 
Still, analysis of teratomas derived from transgenic mES cells is a valuable tool to 
qualitatively evaluate transgene expression after differentiation since behaviour of transgenic 
mice seems to be faithfully mimicked. 
4.10 Bioluminescence imaging with Xenogen IVIS 200
The in vivo imaging technology (Xenogen/Caliper) provides means to repeatedly monitor 
luciferase activity in the same animal without the need to sacrifice it. Also, a large number of 
cell clones can be quickly screened for reporter gene expression. First, a grey-scale image of 
the sample in the light tight chamber is automatically taken. Then, photons are collected by a 
sensitive CCD (charge-coupled device) camera and the signals are overlayed to the grey-scale 
image. Parameters like aperture of the lense, exposition time and binning allow to regulate 
sensitivity and resolution of the image. The field of view may be adjusted to image up to 5 
mice in one group. Settings for each immage are given in the respective figure legend. 
Analyses of images were performed with the Living image 2.60.1 (Igor Pro 4.09A) computer 
programme. 
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4.10.1 ... in vivo
Animals were first anaesthetised in the induction chamber by 2-2,5% isoflurane (Abbot). In 
the case of black coat colour, body parts that needed to be imaged were depilated by treatment 
with commercial depilatory cream since dark fur absorbs a high percentage of the light signal. 
Mice were then injected i.p. with 100µl of lucifern (30mg/ml in PBS, Synchem OHG) and put 
on the heated (37°) platform in the acquisition chamber. Anaesthesia was maintained by 
constant administration of isoflurane via nose cones and images were taken. 
For imaging of extracted organs from transgenic mice, animals were injected with luciferin 
and sacrificed by cercvical dislocation after 3-4min. Organs were removed and immediately 
imaged in a petri dish.
4.10.2 ... in vitro
mES cells tagged with pTagPAC/∆NPT were grown to near confluence on gelatinised 
microtiter plates in the presence of dox for 3d. For imaging, wells were washed with PBS and 
50µl of 0,1mM luciferin dissolved in reaction buffer as described in 4.8.2 were added to each 
well. Plates were imaged 2-3min later.
   .....................................................................................
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5 Vectors and Oligonucleotides
Note that two vectors were termed pAutoTar* since they carry the same array of features. 
However, they differ in the reading frame that reconstitutes/maintains npt function upon 
targeting. pAutoTar(1) (pLuc3ATG, # 2593) was used to target pTagTK/NPT tagged sites. 
pAutoTar(2)* (pEMLuc3rTA2E, # 2741) was used to exchange the pTagPAC/∆NPT parental 
locus. The ROSA26 locus in IB10 ES cells had been modified by integration of 
pROSAantiluc via HR by U. Sandhu. The cell clone harbouring the ROSA26 locus tagged 
with heterologous FRT sites was called “C7Rosaluc”. RMCE in C7Rosaluc yielded the 
exchanged subclones ROSAautoluc (pAutoTar(2)), ROSAEMLuc (pEM-luc3), and 
ROSArtTAautoLuc (pEM-rTA2Luc3rTA2). These targetings were performed by S. Bantner.
5.1 Applied vectors
F3PGKbgF
(# 1926)
J. Seibler, 1999
flpepuro
(pCAGGSFlpeIRESpuro)
(# 1825)
F. Stewart, 1999, formerly EMBL Heidelberg
pHoxB4-2A
(SF91-
eGFP2AHOX+wPRE)
(# 3280)
Pilat et al., 2005
pAutoTar(2)*
(pEMLuc3rTA2E)
(# 2741)
unpublished, S. Herrmann, 2005
pDsredExpress-MCS
(# 2566)
unpublished, A. Oumard, 2004
pEGFPN1-MCS
(# 1957)
unpublished, A. Baer, 2000
pEM-luc3
(# 3032)
unpublished, S. Bantner, 2006
pEM-rTA2Luc3rTA2
(# 2844)
unpublished, S. Bantner, 2006
pTagTK/NPT
(Luc3rTA2E)
(# 2375)
C. Wodarczyk, 2003
pSVGP1
(# 604)
M. Wirth, 1990; the expression plasmid contains the MOV gagpol 
region with the 5' untranslated leader up to AatII under control of 
the SV40 early promoter and late pA signals
pVSV-G
(# 2855)
Invitrogen; CMV driven VSV-G; helper plasmid for lentivirus 
production
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5.2 Cloned vectors
pAutoTar(1)*
(pLuc3ATG)
(2593)
pTagTK/NPT (# 2375) was cut with SalI and BstZ17I (loss of EMCV 
IRES and tk/npt). TGALTA2E (# 2384) was cut with NheI, filled in by 
Klenow, cut with SalI. The 757bp fragment from TGALTA2E was 
ligated into the backbone of pTagTK/NPT
pCflpe
(# 2703)
flpepuro (# 1825) was cut with AvrII (loss of pac and most of the 
EMCV IRES). The vector was religated.
pFCL3EPF5
(# 2719)
pCL3EPF5 (# 2718) was cut with SpeI, blunt ends created by Klenow, 
cut with PvuI. pL3P5 (# 2701) was cut with HpaI and PvuI. The 1,0 kb 
fragment containing the FRT wt site was ligated into the pCL3EPF5 
backbone.
pFCL3ETKNF5
(# 2727)
pFCL3EPF5 (# 2719) was cut with PvuI and PflMI (loss of pac, 
SV40pA, FRT5, oriC and part of amp). pAutoTar(1) (# 2593) was cut 
with PvuI and PflMI and the 1,5 kb fragment containing FRT5, oriC 
and the complementing part of amp was ligated into the backbone.
pTagPAC/∆NPT
(pL3rtTAdneo)
(# 3210)
pTagTK/NPT (# 2375) was cut with PflMI and PvuII for generating 
the 7,4 kb backbone (removal of part of the EMCV IRES; tk gene; 
FRT-5 site and part of npt including loxP). pROSAantiluc (# 2684) 
was cut with PflMI and PvuII and the 1,9 kb fragment containing part 
of EMCV IRES, pac, SV40 pA, FRT5 and part of ∆npt was ligated 
into the backbone.
5.3 Oligomeres
Primers were ordered from MWG. For amplification of fragments containing the FRT sites 
from clone 6.2 genomic DNA, primer pairs P1/P3 (FRT5) and 5’AmpProm/ L3end (FRT wt) 
were used.
P1 (EMCV2, P2451) 5’ GCCACGTTGTGAGTTGGATA 3’
P2 (JunPA12, P834) 5’ GAGGAAATTGCATCGCATTGT 3’
P3 (neorev2, P1523) 5’ GTCATAGCCGAATAGCCTCTCC 3’
5’AmpProm (P1362) 5’ CGACACGGAAATGTTGAATA 3’
L3end (P2374) 5’ GCGGAAAGATCGCCGTG 3’
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6 Abbreviations
5-aza 5-azacytidine
A adenosine
amp ampicillin resistance gene
ATCC American Type Culture Collection
ATG translational start
ATP adenosine triphosphate
attB recognition target of ΦC31
attP recognition target of ΦC31
attL recognition target of ΦC31, after recombination
attR recognition target of ΦC31, after recombination
BAC bacterial artificial chromosome
bp base pair(s)
BLI bioluminescent imaging
BSA bovine serum albumine
C cytosine
CAGGS = 
CAG
Cytomegalo virus/chicken β-actin promoter
CHO cells chinese hamster ovary cell line
CID chemically induced dimerisation
CMV Cytomegalo virus
cp. compare
Cre Cre recombinase (cyclisation recombination)
CreER(T2) Cre recombinase fused to mutated oestrogen receptor binding domain
d day(s)
ddH2O double distilled H2O
∆npt 5’ truncated npt gene
DMEM Dulbecco’s modified Eagle’s medium
DMSO dimethylsulfoxide
DNA deoxyribo nucleic acid
dNTP deoxyribo nucleotide triphosphate
dox doxycycline
Dre Dre recombinase
DSMZ German Collection of Microorganisms and Cell Cultures
dsRed red fluorescent protein
DTT dithiothreitol
EB embryoid body
E. coli Escherichia coli
EDTA ethylenediamine tetraacetic acid
eGFP enhanced green fluorescent protein
EMCV Encephalomyocarditis virus
ES-HCs hematopoietic progenitors derived in vitro from mES cells
FACS fluorescence activated cell sorting
FCS fetal calf serum
FISH Fluorescence in situ hybridisation
Flp Flp recombinase 
Flpe enhanced Flp recombinase
FlpeER(T2) Flpe recombinase fused to mutated oestrogen receptor binding domain
FRT Flp recombinase recognition target
G guanine
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G418 aminoglycoside-2’-deoxystreptine (gentamycin derivative)
GCV ganciclovir
GFP green fluorescent protein
GOI gene of interest
h hour(s)
HBV Hepatitis B virus
HCV Hepatitis C virus
HeLa human cervix carcinom cell line
HEPES N-2-hydroxyethylpiperazine-N’-ethansulfonic acid
HMW high molecular weight (genomic) DNA
HPRT hypoxanthine-guanine phosphoribosyl transferase
HR homologous recombination
HSC hematopoietic stem cells
Hsp90 heat shock protein 90 complex
HSV Herpes simplex virus
IGTC International Gene Trap Consortium
IMDM Iscove’s modified Dulbecco’s medium
i.p. intraperitoneal
IPTG isopropyl-beta-D-thiogalactopyranoside
IRES internal ribosomal entry site
kb 1000 base(s)
kbp 1000 base pair(s)
KO knock out
KRAB Krüppel-associated box repressor domain
kV 1000 volt(s)
l liter(s)
LBD ligand binding domain
LacI Lac repressor
lacO operator sequence of the lac system
lacZ β-galactosidase gene
LIF leukaemia inhibitory factor
loxP locus of crossover (Cre recognition target)
MEF murine embryonic fibroblasts
mES cells murine embryonic stem cells
min minute(s)
ml milliliter(s)
moi multiplicity of infection
mRNA messenger RNA
MTG monothioglycerol
µF micro Farad
npt neomycin phosphotransferase gene
nls nuclear localisation signal
Ω ohm(s)
ORF open reading frame
ori origin of replication
pA poly adenylation signal
pac puromycin acetyl transferase gene
Pbi bidirectional, tet dependent promoter
PBS phosphate buffered saline
PCR polymerase chain reaction
PGK phosphoglycerate kinase
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ΦC31 ΦC31 recombinase
RAG-1 recombination activating gene 1
RAG-2 recombination activating gene 2
RI random integration
rlu relative light units
RMCE recombinase mediated cassette exchange
RNA ribo nucleic acid
RNAi RNA interference
rpm rounds per minute
RT recognition target
rtTA reverse transactivator of the tet system
rtTA2(S)-M2 reverse transactivator of the tet system
rtTS reverse transrepressor of the tet system
s second(s)
SBD steroid binding domain
SDS sodium dodecyl sulfate
shRNA small hairpin RNA
siRNA small interfering RNA
SSC sodium chloride/ sodium citrate
SSR site specific recombinases
T thymidine
TEP trypsin-EDTA
tet tetracycline
tetO operator sequence of the tet system
TetON tet dependent expression system
TetOFF tet dependent expression system
TetR tet system repressor domain
Tris 2-amino-2-hydroxymethyl-1,3-propanediol
tTA transcactivator of the tet system
tTA2 transcactivator of the tet system
tTA4 transcactivator of the tet system
tTS transrepressor of the tet system
tk thymidine kinase gene 
tk/npt fusion of tk and npt
TSA trychostatin A
U unit
V volt(s)
VSV Vesicular stomatitis virus
v/v volume/volume; percent by volume
wt wild type
w/v weight/volume; percent by weight
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